<?xml version="1.0" encoding="utf-8"?>
<add>
	<doc>
		<field name="docid">BR-TU.06040</field>
		<field name="filename">10537_arquivo2779_1.pdf</field>
		<field name="filetype">PDF</field>
		<field name="text">
 

UNIVERSIDADE FEDERAL DE PERNAMBUCO 

CENTRO DE CIÊNCIAS BIOLÓGICAS 

PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS BIOLÓGICAS 

NÍVEL DOUTORADO 

 
  
 

  
 

 

 

Purificação, caracterização estrutural e funcional da lectina do 

veneno de Bothrops leucurus: Modulação de eventos 

citotóxicos após a irradiação gamma. 
 
 
 
 
 
 
 
 
  

ERIKA DOS SANTOS NUNES 

 

 

 

 

RECIFE 

2011 



ERIKA DOS SANTOS NUNES 

 

 

 

 

Purificação, caracterização estrutural e funcional da lectina do 

veneno de Bothrops leucurus: Modulação de eventos 

citotóxicos após a irradiação gamma. 
 

 

 

 

                                                                         Tese apresentada ao Programa de Pós-Graduação em 
Ciências Biológicas da Universidade Federal de 
Pernambuco como pré-requisito para a obtenção do 
título em Doutor em Ciências Biológicas. 

 

 

Orientadora: Profa. Dra. Maria Tereza dos Santos Correia 

Co-orientadora: Profa. Dra. Míriam Camargo Guarnieri 

 

Banca examinadora: 

Profa. Dra. Maria Tereza dos Santos Correia (Presidente/UFPE) 

Profa. Dra. Luana Cassandra Breitenbach Barroso Coelho (UFPE) 

Profa. Dra. Vera Lúcia de Menezes Lima (UFPE) 

Profa. Dra. Márcia Vanusa da Silva (UFPE) 

Profa. Dra. Jeanne Claíne de Albuquerque Modesto (UFPE/CAV) 

 



 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 



 
 
 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

                                                                 

 

“É graça divina começar bem. Graça 

maior persistir na caminhada certa. Mas 

graça das graças é não desistir nunca.” 

                                                                                                   

                                                                                                    Dom Hélder Câmara 



AGRADECIMENTOS 

 

A Deus por guiar meus passos todos os dias de minha vida. 

A meus pais por me apoiarem em todos os momentos da minha existência.  

A meu esposo Roberto, por sua paciência, dedicação, por suas palavras de incentivo e 

principalmente por seu amor.  

As minhas irmãs e cunhados que me apoiaram e torceram por mim em todas as etapas desse 

trabalho. 

As profa. Dra Tereza Correia e a profa. Dra. Miriam Guarnieri, pela amizade, atenção e por 

acreditar no meu potencial para executar esse trabalho.  

A profa. Dra. Teresinha Gonçalves e a Jaciana Aguiar pela amizade e colaboração nesse trabalho. 

A profa. Dra. Maria Madalena e André Mariano do Departamento de Veterinária pela amizade e 

colaboração na análise de Microscopia de fluorescência.    

A profa. Dra. Maria Luiza V. Oliva e a profa. Dra. Rosemeire A. Silva-Lucca pela colaboração 

nesse trabalho. 

A todos que integram o Laboratório de Glicoproteínas, pela paciência, amizade e por me receberem 

de braços abertos....... bem abertos. 

A meu “filho” Fernando, a Lidiany, Giselly e Mary, pela paciência, amizade e colaboração...... 

“vocês moram no meu coração”.  

A Thiago e Francis pela ajuda nesse trabalho, amizade e atenção...... “eita dupla arretada de boa”. 

Aos meus colegas de Doutorado, em especial a minha amiga Dilênia, por sua amizade e incentivo 

sempre presentes. 

A todos os meus amigos e parentes que mesmo distantes torceram por mim. 

A Universidade do Estado da Bahia (UNEB) pelo afastamento temporário concedido para a 

realização desse trabalho. 

                                                                                                                                      Muito obrigada! 

 



RESUMO 

 

Lectinas são proteínas ou glicoproteínas de origem não imune cuja ligação reversível e específica a 
carboidratos resulta em aglutinação celular. Bothrops leucurus, serpente da Família Viperidae, 
representa um sério problema médico para a região Nordeste do Brasil. Uma lectina ligante de 
galactosídeo (BlL) foi purificada do veneno da serpente Bothrops leucurus através da combinação 
de cromatografia de afinidade e gel filtração. BlL aglutinou eritrócitos de coelho e humano, com 
preferência para eritrócitos de coelho, sendo especificamente inibida por galactose, rafinose e 
lactose, bem como por glicoproteinas. BlL é uma proteína ácida, com massa molecular de 30 kDa e 
composta de duas subunidades de 15 kDa, exibiu dependência de cátions divalentes, foi 
principalmente ativa em pH 4.0 a 7.0 e termoestável até 70°C. O espectro de emissão de 
fluorescência mostrou resíduos de triptófano completamente encobertos na sua estrutura. Dicroísmo 
Circular de BlL foi típico de uma proteína toda ? estrutural.  BlL mostrou ser efetivo contra 
bactérias gram-positivas (Staphylococcus aureus, Enterococcus faecalis e Bacillus subtilis). A 
atividade antitumoral de BlL foi avaliada em relação ao seu potencial citotóxico em linhagem 
tumoral (K562, Hep-2 e NCI-H292) e quanto à sua capacidade hemolítica. BlL apresentou uma 
significante atividade citotóxica em todas as linhagens tumorais testadas e não exibiu atividade 
hemolítica na máxima concentração testada (2000 µ g/mL). Além disso, foi realizada em células 
K562, a análise da externalização da fosfatidilserina e potencial de membrana mitocondrial, 
utilizando microscópio de fluorescência. Tratamento com BlL induziu externalização da 
fosfatidilserina e despolarização mitocondrial, indicando morte celular por apoptose. Após 
irradiação gamma, BlL apresentou mudanças estruturais e teve sua atividade hemaglutinante 
significante alterada. SDS-PAGE indicou que a irradiação causou fragmentação e com posterior 
agregação da lectina. A análise em cromatografia de fase reversa revelou fragmentação estrutural. A 
atividade citotóxica de BlL em linhagens tumorais (K562, Hep-2 e NCI-H292) foi abolida após 
irradiação, indicando que a irradiação de BlL se mostrou uma eficiente estratégia para inativar sua 
atividade citotóxica. Esses achados demonstram que o veneno de B.leucurus contem uma lectina 
ligante de galactosídeo com potencial promissor para aplicação terapêutica e biotecnológica.     

 

Palavras-chave: lectina, Bothrops leucurus, apoptose, irradiação gamma, veneno de serpente.   

 

  

 

 

 

 

 

 

 



ABSTRACT 

 

Lectins are proteins or glycoproteins of nonimmune origin which specific and reversible binding to 
carbohydrates resultins in cell clumps. Bothrops leucurus, Family Viperidae snake, represents a 
serious medical problem for the Northeast region of Brazil. A galactoside-binding lectin (BlL) was 
purified from the venom of Bothrops leucurus through a combination of affinity chromatography 
and gel filtration. BlL agglutinate rabbit erythrocytes and human, with a preference for rabbit 
erythrocytes and is specifically inhibited by galactose, raffinose and lactose, as well as 
glycoproteins. BlL is an acid protein with a molecular mass of 30 kDa and composed of two 
subunits of 15 kDa, exhibited dependence on divalent cations, was especially active at pH 4.0 to 7.0 
and heat stable up to 70°C. The emission spectra of tryptophan fluorescence showed residue 
completely buried in its structure. Circular Dichroism BlL was typical of an entire protein ? 
structure. BlL was show to be effective against gram-positive bacteria (Staphylococcus aureus, 
Enterococcus faecalis e Bacillus subtilis). Antitumor activity of BlL was assessed in relation to 
their cytotoxic potential in type of tumor (K562, Hep-2 e NCI-H292) and the its hemolytic capacity. 
BlL showed a significant cytotoxic activity in all tumor cell lines tested and showed no hemolytic 
activity at maximum concentration tested (2000 µ g/mL). Furthermore, it was held in K562 cells, 
analysis of externalization of phosphatidylserine and mitochondrial membrane potential using 
fluorescence microscope. BlL treatment induced phosphatidylserine externalization and 
mitochondrial depolarization, indicating cell death by apoptosis. After gamma irradiation, BlL 
showed structural changes and its hemagglutinating activity was significantly altered. SDS-PAGE 
indicated that irradiation caused fragmentation and subsequent aggregation of the lectin. The 
analysis in reverse-phase chromatography revealed structural fragmentation. Cytotoxic activity in 
tumor cell lines BlL (K562, Hep-2 e NCI-H292) was abolished after irradiation, indicating that the 
irradiation of BlL proved an efficient strategy for inactivating their cytotoxic activity. These 
findings demonstrate that the venom contains a B. leucurus galactoside-binding lectin with 
promising potential for therapeutic and biotechnological application. 

 

Keywords: lectin, Bothrops leucurus, apoptosis, gamma irradiation, snake venom.   

 

 

 

 

 

 

 



LISTA DE FIGURAS DA REVISÃO BIBLIOGRÁFICA 

 

Figura 1: Representação esquemática de lectinas tipo-C (CTLs) e proteínas relacionadas               

as lectinas tipo-C (CLRPs) de venenos de serpentes ou snaclecs. 

08 

Figura 2: Métodos cromatográficos para purificação de proteínas. 10 

Figura 3: Características das células tumorais. 13 

Figura 4: Vias intrínseca e extrínseca da apoptose. 15 

Figura 5: Serpente Bothrops leucurus. 20 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



LISTA DE FIGURAS DOS ARTIGOS 

 

ARTIGO I 

 

Fig.1. (A) Purification of BlL by affinity chromatography of B. leucurus venom (30 mg 

of protein) on a guar gel column. Elution with CTBS buffer (-?-) followed by 200 mM D-

galactose (-?-; arrow). Specific hemagglutinating activity (SHA, -?-). (B) Purification of 

BlL by chromatography in Superdex 75 column coupled to an ÄKTA purifier system. (C) 

SDS-PAGE of BlL. (MW) molecular weight markers; BlL under non-reducing (lane 1) or 

reducing conditions (lane 2); electrophoresis under native conditions for acidic proteins 

(lane 3). (D) Reverse phase HPLC on a C4 column. (E) BlL chain separation after 

desalting on a C4 column. The column was equilibrated with 0.1% TFA (solvent A) and 

eluted using 90% acetonitrile/10% H2O/0.1% TFA (solvent B) in a non-linear gradient, 

where B = 0% at t = 5 min, 45% at t = 10 min, 50% at t = 30 min and 100% at t = 35 min. 

(F) Hemagglutinating activity (HA) of EDTA-treated BlL after addition of Ca2+ in 

different concentrations. 

 

53 

Fig.2. (A) Intrinsic fluorescence emission of BlL excited at 280 nm (---) and 295 nm (—). 

(B) CD spectrum of BIL in 50 mM phosphate buffer, pH 7.2, at 25°C. Measurements are 

the average of eight scans using a solution containing 0.25 mg of protein/mL. CD 

spectrum deconvolution using CDPro software calculated 1% ?-helix, 44% ?-sheet, 24% 

?-turn, 31% unordered structures and an RMS of 2%. 

 

57 

  

 

 

 

 

 

 

 

 



ARTIGO II 

 

Fig.1. Effect of BlL in K562 cell population determined by fluorescence microscopy 

using Annexin V–FITC Kit, after 48 h incubation. The negative control (NC) was the 

vehicle used (DMSO). Etoposide was used as positive control (E). *p &amp;lt;0.01 in 

comparison to control by ANOVA followed by Newman Keulls test. Data are presented 

as mean ± S.D. from three independent experiments. 

74 

 

Fig.2. Effect of BlL in K562 cell population determined by fluorescence microscopy 

using JC-1, after 48 h incubation. The negative control (NC) was the vehicle used 

(DMSO). Etoposide was used as positive control (E). *p &amp;lt;0.01 in comparison to control 

by ANOVA followed by Newman Keulls test. Data are presented as mean ± S.D. from 

three independent experiments. 

 

74 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



ARTIGO III 

 

Fig.1. Effect of ?-radiation on lectin activity and molecular weight. (a) The percentage of 

remaining specific hemagglutination activity, %SHAREM is represented after irradiation. 

Error in the determination of %SHAREM for the different doses was approximately ± 1%, 

which is less than the size of the symbols. * Significant difference (p &amp;lt;0.05) compared to 

non-irradiated lectin. (b) SDS-PAGE from irradiated BlL. SDS-PAGE was performed in 

a discontinuous system with 15% separating and 5% stacking gels. (MW) Molecular 

weight; (C) non-irradiated control; (1) 1 kGy and (2) 2 kGy. (c) Reverse phase 

chromatography on an HPLC system: (?) control and irradiated lectins at (?) 1 kGy and 

(?) 2 kGy. (d) Light scattering was measured at 90° for the aggregation assays. 

90 

Fig.2. BlL intrinsic fluorescence. (a) Mass center; Lectin excitation (280 nm) and 

emission (295–450 nm). (b) Mass center tryptophan; Lectin excitation (295 nm) and 

emission (305-450 nm).  

91 

Fig.3. BlL bis-ANS fluorescence. Mass center; Lectin excitation (360 nm) and emission 

(400–600 nm).   

92 

 

 

 

 

 

 

 

 

 

 

 

 



LISTA DE TABELAS DOS ARTIGOS 

 

ARTIGO I 

 

Table 1. Summary of B. leucurus lectin (BlL) purification. 52 

Table 2. Inhibition of hemagglutinating activity of BlL by carbohydrates and 
glycoproteins. 

55 

Table 3. Minimum inhibitory (MIC) and minimum bactericidal concentrations (MBC) of 
BlL. 

58 

 

ARTIGO II 

 

Table 1. Cytotoxic activity of BlL against tumor cell lines. 70 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



LISTA DE ABREVIATURAS 

 

AH   Atividade Hemaglutinante 

APAF-1 Fator Ativador de Apoptose-1 

ADP Adenosina difosfato 

BlL                       Lectina de Bothrops Leucurus 

Bis-ANS   4.4'-Bis 1-anilinonaphthaleno 8-sulfonato 

BJcuL Lectina de Bothrops jararacussu 

BmLec Lectina de Bothrops moojeni 

CD Dicroísmo Circular 

CfLEC-2 Lectina de Chlamys farreri 

CFU Unidades Formadoras de Colônia 

CI50 Concentração Inibitória Média 50% 

CLEC-2 Receptor transmembrana tipo II C-tipo lectina-like 

CM Carboximetil 

CMB Concentração Mínima Bactericida 

CMI Concentração Mínima Inibitória 

ConA Concanavalina A 

CRD Domínio de Reconhecimento de Carboidratos 

CRLPs Proteínas Relacionadas Lectinas tipo-C 

CTLs Lectinas tipo-C  

CTBS Tampão Tris Base Salina 

DEAE Dietilaminoetil 

DMEM Meio Dulbecco’s Modificado Eagle’s 

DMSO Dimetilsulfóxido 

DTT Dithiolthreitol 

EDTA Ácido etilenodiaminotetracético 



FBS Soro Fetal Bovino 

FITC Isotiocianato de Fluoresceína 

FPLC Cromatografia Líquida de Rápida Resolução 

GPIb Glicoproteína Ib 

HPLC-RP Cromatografia Líquida de Alta Resolução em Fase Reversa 

IgG2 Imunoglobulina G subclasse 2 

MML Lectina de Musca domestica 

MMP Permeabilidade da Membrana Mitocondrial 

MTT Brometo de (3-(4, 5-dimetiltiazol-2-il)-2, 5-difeniltetrazólio) 

PCL Lectina de Polygonatum cyrtonema  

PAGE Eletroforese em gel de poliacrilamida 

PI Iodeto de propídeo 

POL lectina de Polygonatum odoratum 

SDS-PAGE Eletroforese em gel de poliacrilamida com dodecilsulfato de sódio 

SHA Atividade Hemaglutinante Específica 

Snaclecs Lectina Tipo-C de Veneno de Serpente 

Th1 Linfócito T auxiliar 

ThT Thioflavina 

 

 

                    

                           

 

                     

 

 

 

 



SUMÁRIO 

 

RESUMO  

ABSTRACT  

Lista de Figuras  

Lista de Tabelas  

1 INTRODUÇÃO 01 

2 OBJETIVOS 03 

2.1 Objetivo Geral 03 

2.2 Objetivos Específicos 03 

3 REVISÃO BIBLIOGRÁFICA 04 

3.1 Lectinas 04 

3.2 Lectinas de venenos de serpentes 05 

3.3 Purificação e Caracterização de lectinas 09 

3.4 Câncer 11 

3.5 Morte celular (apoptose) 13 

3.6 Atividade antitumoral 15 

3.7 Atividade antibacteriana 17 

3.8 Radiação 18 

3.9 Serpente Bothrops leucurus 20 

4 REFERÊNCIAS BIBLIOGRÁFICAS 22 

5 ARTIGO CIENTÍFICO I 

Purification of a lectin with antibacterial activity from Bothrops leucurus snake venom 

44 

6 ARTIGO CIENTÍFICO II  



Cytotoxic effect and apoptosis induction by Bothrops leucurus venom lectin on tumor cell 

lines 

67 

7 ARTIGO CIENTÍFICO III 

Gamma irradiation abolish in vitro cytotoxicity of lectin of Bothrops leucurus snake 
venom 

 

82 

8 CONCLUSÕES 98 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

1 INTRODUÇÃO 

 

O Interesse em lectinas tem se intensificado com a constatação que estas são extremamente 

valiosas para a investigação de açúcares na superfície celular, na interação de células com o seu 

meio e também em uma variedade de processos patológicos (SHARON, 2007). Lectinas são 

proteínas ou glicoproteinas de origem não imunológica, ubiquamente distribuídas na natureza, as 

quais reconhecem e ligam-se reversivelmente a carboidratos de maneira não-catalítica (LAM et al., 

2010).  

A habilidade de ligar-se seletivamente a glicoconjugados faz dessas proteínas notáveis 

ferramentas para pesquisa experimental e clínica. Em microbiologia, as lectinas têm assumido um 

importante papel no estudo de glicoconjugados e superfície de células microbianas. Evidências 

suportam sua interação com bactérias gram-negativas e gram-positivas, detectando sutis diferenças 

na estrutura de carboidratos complexos (LUO et al., 2007), onde lectinas podem atuar interferindo 

com o seu crescimento e desempenhando um papel em sistemas de defesa (SUN et al., 2008). Com 

o resultado da alta prevalência de bactérias multi-resistentes, a pesquisa por novos protótipos 

antimicrobianos são continuamente necessários, uma vez que pode permitir uma otimização no 

tratamento de infecções bacterianas relacionadas com cepas resistentes aos antibióticos 

convencionais (WORLD HEALTH ORGANIZATION, 2007). 

Na Cancerologia Experimental, alterações na glicosilação durante a transformação maligna, 

desempenham um importante papel no comportamento metastático das células tumorais e essas 

modificações podem ser detectadas por lectinas (DAMODARAN et al., 2008; ARAB et al., 2010). 

Interação lectina-carbohidrato causa aglutinação das células tumorais, citotoxicidade, indução da 

apoptose e inibição do crescimento tumoral, criando uma variedade de possibilidades para a 

produção de medicamentos anticancer (De MEJÍA &amp;amp; PRISECARU, 2005; NAKAHARA et al., 

2005). A identificação de novos compostos citotóxicos que melhorem ou restaurem a capacidade 

das células malignas em sofrer apoptose pode ser crucial para terapias mais eficazes contra o câncer 

(REYES-ZURITA et al., 2009)  

A descoberta também incentiva os pesquisadores a buscarem moléculas similares em 

venenos de serpentes, uma vez que esses são uma fonte rica em componentes bioativos, como 

enzimas, proteínas e peptídeos com importantes propriedades farmacológicas, que podem levar a 

produção de novos agentes com valor terapêutico (KOH et al., 2006). 



2 

 

Venenos de serpentes são empregados como imunógenos para produção de soro antiofídico 

e vários esforços tem sido realizados para diminuir sua toxicidade, visando minimizar os danos 

causados aos animais imunizados, prolongando o seu tempo de vida (GALLACI et al., 2000). 

Radiação ionizante vem sendo empregada com sucesso para atenuar venenos de serpentes e suas 

toxinas isoladas, diminuindo ou abolindo suas atividades biológicas e tóxicas, sem alterar sua 

imunogenicidade, mostrando-se uma potente ferramenta para modificar e destoxicar biomoléculas. 

(FERREIRA JUNIOR et al., 2005; BAPTISTA et al., 2009; CAPRONI et al., 2009). 

Com base nessas considerações, o estudo das propriedades e funções da lectina de Bothrops 

leucurus contribui para o entendimento da interação proteína-carboidrato, como também para 

aplicações médicas e biológicas.  

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



3 

 

2 OBJETIVOS 

 

2.1 Objetivo Geral  

 

Purificar, caracterizar estrutural e funcionalmente a lectina do veneno de Bothrops leucurus: 

Destoxicação do efeito citotóxico após a irradiação gamma. 

 

2.2 Objetivos Específicos 

 

? Purificar e caracterizar a lectina do veneno da serpente Bothrops Leucurus (BlL); 

? Avaliar a atividade antibacteriana da lectina em bactérias patogênicas humanas; 

? Determinar a citotoxicidade da lectina em linhagens tumorais humanas (Hep-2, K562 e NCI-

H292) in vitro; 

? Examinar a atividade hemolítica da lectina em eritrócitos de camundongos; 

? Avaliar o mecanismo de ação envolvida na atividade citotóxica da lectina em células K562 

in vitro; 

? Determinar o efeito da radiação gamma na estrutura da lectina purificada; 

? Avaliar a citotoxicidade da lectina purificada após irradiação gamma em células tumorais 

Hep-2, K562 e NCI-H292.  

 

 

 

 

 

 

 

 

 



4 

 

3 REVISÃO BIBLIOGRÁFICA 

 

3.1 Lectinas 

  

O termo “lectina” (originado do latim lectus, que significa escolhido, selecionado) foi 

primeiro empregado por BOYD &amp;amp; SHAPLEIGH em 1954, para designar um grupo de proteínas que 

apresentava a característica comum de seletividade na interação com carboidratos. Em 1980, 

GOLDSTEIN et al. (1980) definiram as lectinas como proteínas ou glicoproteínas de origem não 

imunológica, que apresentavam dois ou mais sítios de ligação a carboidratos, através dos quais 

interagem com carboidratos, aglutinando células vegetais e/ou animais e precipitando 

polissacarídeos, glicoproteínas e glicolipídeos de forma irreversível. O termo aglutinina é utilizado 

como sinônimo para lectina, porque se refere à habilidade de aglutinar eritrócitos ou outras células 

(PEUMANS &amp;amp; VAN DAMME, 1995).  

De acordo com a nova definição, são consideradas lectinas proteínas ou glicoproteínas de 

origem não imune que possuem pelo menos um sítio-não catalítico, o qual se liga reversívelmente a 

mono ou oligossacarídeos específico (PEUMANS &amp;amp; VAN DAMME, 1995, 1998; PEUMANS et 

al., 2001). Cada lectina liga-se a um carboidrato específico ou grupo de carboidratos em 

oligossacarídeos ou glicoproteínas, através dos seus sítios de ligação que tendem a se localizar na 

superfície da molécula protéica e a seletividade da ligação são obtidas através de pontes de 

hidrogênio, interações hidrofóbicas e de van der Waals (COMINETTI et al., 2002; SHARON &amp;amp; 

LIS, 2002). 

As lectinas apresentam ampla variedade estrutural, sendo comum entre elas a presença de, 

ao menos, um sítio específico de ligação a carboidrato, denominado “Domínio de Reconhecimento 

de Carboidrato” (CRD), o qual se liga a carboidratos ou glicoconjugados em solução ou que estejam 

conectadas ao envoltório celular (WEIS &amp;amp; DRICKAMER, 1996).    

A presença de lectinas pode ser detectada pelo ensaio de hemaglutinação em eritrócitos 

humanos ou de outras espécies animais. Nesse ensaio é realizada uma diluição serial e em seguida, 

incubação com os eritrócitos, onde a atividade hemaglutinante é detectada pela formação de uma 

malha decorrente da interação entre a lectina e os carboidratos localizados na superfície dos 

eritrócitos. A capacidade de aglutinação por lectinas pode ser intensificada quando os eritrócitos são 

submetidos a tratamentos com enzimas ou com soluções químicas (COELHO &amp;amp; SILVA, 2000). 



5 

 

Para assegurar que o agente aglutinante é uma lectina, são realizados ensaios subseqüentes de 

inibição da atividade hemaglutinante (AH) com diferentes carboidratos (KAWAGISHI et al., 2001; 

JAYATI et al., 2005). 

As lectinas têm ampla distribuição na natureza, sendo encontradas em microorganismos 

(SINGH et al., 2010), plantas (YAN et al., 2010; YAO et al., 2010) e animais (BATTISON &amp;amp; 

SUMMERFIELD, 2009; CHEN et al., 2010). O reino animal tem demonstrado ser um rico 

manancial para obtenção de lectinas, servindo como fonte para o isolamento e caracterização dessas 

macromoléculas. A primeira atividade de lectina animal, provavelmente, foi observada no veneno 

de serpentes, o qual foi capaz de promover a aglutinação em eritrócitos humanos (KILPATRICK, 

2002).   

Diferentes funções têm sido atribuídas as lectinas de animais, incluindo reconhecimento de 

patógenos (DUTTA et al, 2005; XU et al., 2010), inibição da agregação plaquetária (SARRAY et 

al., 2004), atividade antiproliferativa sobre células tumorais (CAO et al., 2010) e indutores da 

apoptose (ZHAO et al., 2010).  

As lectinas animais podem ser classificadas com base na estrutura molecular em cinco 

principais categorias: tipo-C, tipo-S (galectinas), tipo-I (siglecs), tipo-P (receptor de manose-6P) e 

tipo-N (SHARON &amp;amp; LIS, 2004). De acordo com a seqüência do CRD, lectinas animais tipo-C 

podem ser classificadas dentro de 17 grupos (I ao XVII) (ZELENSKY &amp;amp; GREADY, 2005), estando 

as lectinas de venenos de serpentes incluídas no grupo VII (OGAWA et al., 2005).   

   

3.2 Lectinas de venenos de serpentes 

 

Envenenamentos ofídicos representam um problema médico-social de considerável 

magnitude, uma vez que cerca de 2.5 milhões de pessoas são picadas por serpentes anualmente, 

sendo mais de 100.000 casos fatais. Contudo, venenos de serpentes constituem em uma fonte 

biológica natural que contém diversos componentes farmacologicamente ativos, os quais, com o 

advento da biotecnologia podem ser isolados e delineados suas propriedades terapêuticas (KOH et 

al., 2006; ANGULO &amp;amp; LOMONTE, 2009). 



6 

 

Venenos de serpentes possuem uma variedade de proteínas, tais como serinoproteases, 

fosfolipases, desintegrinas (LIMA et al., 2005), toxinas three-finger (3FTxs) (PAHARI et al., 2007), 

metaloproteases e lectinas tipo-C (DOLEY &amp;amp; KINI, 2009).  

 Lectinas de serpentes tem sido encontrada em diversas serpentes da família Viperidade, 

Elapidae and Crotalidae (GUIMARÃES-GOMES et al., 2004; LIN et al., 2007; SILVA JR. et al., 

2008; WANG, 2008). Essas exibem alta homologia na seqüência primária, com alguns invariantes 

resíduos de aminoácidos, incluindo um padrão conservado de ligações dissulfeto. Sua 

especificidade de ligação é mais freqüentemente atribuída à galactose, mas também a manose 

(SHARON et al., 2003).  

De acordo com sua estrutura e funções biológicas, essas proteínas podem ser classificadas 

em dois subgrupos: lectinas tipo-C verdadeiras (CTLs), as quais contem um domínio de 

reconhecimento de carboidratos (CRD) que se liga a açúcar e aglutina eritrócitos; e proteínas 

relacionadas com lectinas tipo-C (CRLPs), com CRDs incompleto e, portanto, apresentando outras 

atividades biológicas contra os fatores de coagulação e plaquetas, afetando a hemostasia 

(DRICKAMER, 1999; WEI et al., 2002; MORITA et al., 2004). Em recente nomenclatura, esse 

grupo foi renomeado para snaclecs (lectinas tipo-C de venenos de serpentes) (CLEMETSON et al., 

2009).  

A primeira lectina isolada e parcialmente caracterizada de serpente foi obtida do veneno de 

Bothrops atrox. Essa proteína foi denominada de trombolectina e apresentou as seguintes 

características bioquímicas e biológicas: proteína homodimérica, ligante de ?-galactosídeo, não 

glicosilada e dependente de íons cálcio para exercer sua atividade de hemaglutinação (GARTNER 

et al., 1980; GARTNER &amp;amp; OGILVIE, 1984).  

CTLs consistem em uma família de proteínas estruturalmente homólogas, as quais são 

geralmente homodímeros ?? ligados por ponte dissulfeto com dois polipeptídeos homólogos de 

aproximadamente 14 kDa, apresentando atividade de aglutinação de eritrócitos e ligação a 

carboidratos, principalmente galactose (Figura 1b) na presença de íons Ca2+ (LU et al., 2005; 

OGAWA et al., 2005). Esses homodímeros têm sido reportados em várias serpentes, tais como 

Bothrops jararaca (OZEKI et al., 1994), Lachesis muta stenophyrs (ARAGON-ORTIZ et al., 

1996), Trimeresurus stejnegeri (XU et al., 1999), Crotalus ruber (HAMAKO et al., 2007) e 

Bungarus multicinctus (LIN et al., 2007). Em adição, CTLs podem ser constituídas por 

homooligômeros (HIRABAYASHI et al., 1991; WANG, 2008).     



7 

 

 Várias dessas proteínas têm sido parcialmente ou completamente seqüenciadas (KOMORI et 

al., 1999; NIKAI et al., 2000; CARVALHO et al., 2002; HAMAKO et al., 2007) e, em alguns casos 

seus genes clonados (GUIMARÃES-GOMES et al., 2004; KASSAB et al., 2004; LIN et al., 2007; 

JEBALI et al., 2009). Estudos de cristalografia e dicroísmo circular estão revelando particularidades 

na estrutura das lectinas de serpentes. WALKER et al. (2004) isolaram uma lectina de Crotalus 

atrox (RSL) e observaram uma organização intrigantemente oligomérica de acordo com os dados 

cristalográficos, por exemplo, uma estrutura decamérica formada por cinco dímeros. Espectros de 

dicroísmo circular da lectina de Bothrops jararacussu (BJcuL), mostraram 32,2% de estrutura ? e 

18.8% de estrutura ?, estando de acordo com a maioria das lectinas de venenos de serpentes, as 

quais pertencem a classe ?+? (SILVA JR. et al., 2008). Contudo, a lectina isolada de Lachesis muta 

apresentou 78% ? de estrutura e 1% ? como característica de sua estrutura secundária (ARAGON-

ORTIZ et al., 1989).  

 Diversos efeitos biológicos das CTLs de venenos de serpentes têm sido relatados, incluindo 

atividade mitogênica sobre linfócitos (MASTRO et al., 1986), liberação de cálcio do retículo 

sarcoplasmático (OHKURA et al., 1996), inibição da proliferação de várias linhagens tumorais 

(PEREIRA-BITTENCOURT et al., 1999), aglutinação de eritrócitos (KASSAB et al., 2001), 

citotoxicidade para alguns tumores e células endoteliais (CARVALHO et al., 2001), efeitos renais 

(HAVT et al., 2005; BRAGA et al., 2006), aumento a aderência de leucócitos sobre células 

endoteliais de vênulas (ELÍFIO-ESPOSITO et al., 2007), inibição viral in vitro (ISLAS et al., 2007) 

e ação inibitória sobre patógenos de plantas (RÁDIS-BAPTISTA et al., 2006; BARBOSA et al., 

2010).   

 Em contraste com CTLs, snaclecs não apresentam o clássico loop de ligação a açúcar/cálcio 

e possuem a habilidade de interagir com fatores de coagulação e receptores de membranas nas 

plaquetas (XU et al., 2004; LU et al., 2005; CLEMETSON, 2010). Geralmente, apresentam uma 

estrutura básica de heterodímeros (??) ligadas covalentemente por pontes dissulfeto ou oligômeros 

de heterodímeros (Figura 1c, d) (MORITA, 2004, 2005; CHEN et al., 2010).  



8 

 

 

Figura 1: Representação esquemática de lectinas tipo-C (CTLs) e proteínas relacionadas as lectinas 

tipo-C (CLRPs) de venenos de serpentes ou snaclecs (Fonte: DOYLE &amp;amp; KINI, 2009). 

 Snaclecs apresentam uma variedade de atividades biológicas, como anticoagulantes e 

agonistas ou antagonistas da agregação plaquetária (CLEMETSON, 2010). Por exemplo, 

jerdonuxina purificada de Trimeresurus jerdonii induziu agregação plaquetária, provavelmente, 

através da ligação ao receptor GPIb (CHEN et al., 2011). Agretina, isolada do veneno de 

Calloselasma rhodostoma, estimula agregação plaquetária através de um novo receptor de 

plaquetas, denominado CLEC-2 (SUZUKI-INOUE et al., 2006). Por outro lado, flavocetina-A se 

liga a GPIb e fortemente inibe a agregação plaquetária dependente do fator de von Willebrand 

(FUKUDA et al., 2000). Muitos membros dessa família interagem com os fatores de coagulação 

IX/X ou ?-trombina e formam complexos bloqueando as subseqüentes reações da cascata de 

coagulação, exibindo atividade anticoagulante (KOO et al., 2002; MONTEIRO &amp;amp; ZINGALI, 2002; 

ZANG et al., 2003). 

Apesar das diversas atividades descritas para as lectinas de serpentes, o papel destas no 

envenenamento não está claramente definido. Entretanto, se supõem que esses componentes tenham 

uma função de defesa assim como nos invertebrados, porém de uma maneira mais ofensiva. Tem 

sido proposto que CTLs juntamente com as snaclecs, que inibem trombina e fatores de coagulação 

(CASTRO et al., 1999), provavelmente, ajudam a causar a desordem hematológica particularmente 

evidente nos acidentes com as serpentes do gênero Bothrops. Além disso, a atividade de 

hemaglutinação (HAVT et al., 2005), bem como a indução de edema em camundongos e o aumento 

da permeabilidade vascular (LOMONTE et al., 1990; PANUNTO et al., 2006) induzidos por essas 

proteínas, podem contribuir para os severos efeitos locais observados após o envenenamento pelas 

serpentes desse gênero, incluindo Bothrops leucurus.  



9 

 

  3.3 Purificação e Caracterização de lectinas  

 

A utilização de técnicas cromatográficas purifica as lectinas de acordo com a massa 

molecular, carga e afinidade específica de ligação a carboidratos. Na cromatografia de troca iônica a 

proteína é separada em função de sua carga ao se ligar a um suporte com carga contrária a sua. A 

coluna é lavada com solução tampão e as proteínas com nenhuma ou pouca interação com o 

trocador de íons são excluídas. As proteínas adsorvidas na matriz podem ser eluídas pelo aumento 

da força iônica ou alteração do valor de pH do meio (DATTA et al., 2001). Como exemplo tem a 

dietilaminoetil (DEAE) celulose (LI et al., 2008), um trocador aniônico, e a carboximetil (CM) 

celulose um trocador catiônico. 

A cromatografia de filtração em gel ou exclusão molecular (ROJO et al., 2003; POHLEVEN 

et al., 2009) separa as proteínas de acordo com o tamanho molecular (Figura 2B), onde as proteínas 

maiores migram em maior velocidade que as menores devido a sua exclusão dos poros do gel. Este 

tipo de cromatografia é usado tanto para obter preparações protéicas homogêneas (FREIRE et al., 

2002) como para definição de massa molecular da proteína (KAWAGISHI et al., 2001). A 

cromatografia de afinidade (Figura 2C), técnica mais comumente utilizada, baseia-se na habilidade 

das lectinas se ligarem especificamente a suportes polissacarídeos através dos seus sítios 

específicos. A proteína desejada pode ser obtida com alto grau de pureza (YE &amp;amp; NG, 2002), 

alterando-se as condições de pH (SÁ et al., 2008), força iônica (FREIRE et al., 2002) ou pela 

eluição com uma solução contendo um competidor (OLIVEIRA et al., 2002). As matrizes de 

afinidade podem ser selecionadas de acordo com a especificidade da lectina a carboidratos. Gel de 

guar é uma dessas matrizes composta de um polissacarídeo com cadeias de manose substituídas por 

resíduos de galactose ? 1-6, sendo uma matriz versátil para isolamentos de lectinas ligantes de D-

galactopiranosil e N-acetil-galactosaminil (COELHO &amp;amp; SILVA, 2000). 

    



10 

 

 

Figura 2: Métodos cromatográficos para purificação de proteínas. (Fonte: STRYER et al., 2004) 

 

Métodos eletroforéticos são utilizados para caracterizar estruturalmente as lectinas, bem 

como para estabelecer o grau de pureza das mesmas. A eletroforese em gel de poliacrilamida 

(PAGE) pode ser realizada usando um gel contendo dodecilsulfato de sódio (SDS) ou ?-

mercaptoetanol (condições redutoras), que sob condições redutoras revela o grau de pureza, a 

composição, a massa molecular de subunidades (REYNOSO-CAMACHO et al., 2003; PAIVA et 

al., 2006) e através de coloração específica, a natureza glicoprotéica (COELHO &amp;amp; SILVA, 2000; 

FENG et al., 2006).  

 Cromatografia líquida de rápida resolução (FPLC) e cromatografia líquida de alta resolução 

em fase reversa (HPLC-RP) têm sido amplamente utilizadas com um processo final de purificação 

mais refinada de lectinas, após a utilização de outros métodos cromatográficos (WONG &amp;amp; NG, 

2003; JIANG et al., 2009). FPLC e HPLC podem estabelecer a homogeneidade de lectinas, como 

também separar subunidades protéicas, assim determinar se essas biomoléculas são monoméricas 

ou não (KAWSAR et al., 2008; SILVA et al., 2009).      

 Lectinas podem ser caracterizadas através da avaliação da AH em diferentes temperaturas, 

bem como a inibição da AH por carboidratos e/ou glicoconjugados e o efeito de íons na atividade 

hemaglutinante. Em relação ao pH, a verificação da faixa de estabilidade pode ser realizada 

submetendo-se a lectina a tampões em diferentes valores de pH (MANSOUR &amp;amp; ABDUL-SALAM., 

2009). Quanto ao efeito da temperatura algumas lectinas permanecem estáveis até 80°C e a partir de 



11 

 

então, com a elevação da temperatura, a AH diminui até ser abolida, como no caso da lectina de 

Aplysia kurodai (KAWSAR et al., 2009). Contudo, lectina ativa após aquecimento a 100°C também 

foi isolada (SANTOS et al., 2009).  

 Muitas lectinas necessitam de íons metálicos bivalentes para exibir sua atividade. Ficou 

demonstrado que a lectina de Macrotyloma axillare necessita de Ca2+ e Mn2+ para capturar o 

carboidrato pelo qual tem afinidade (SANTANA et al., 2008). Por outro lado, a lectina da folha de 

Phthirusa pyrifolia não teve sua AH abolida quando tratada com EDTA e, portanto, a AH é 

independente de íons metálicos, tais como Ca2+, Mg2+ and Mn2+ (COSTA et al., 2010).  

 Muitos outros métodos também são ferramentas relevantes para a caracterização das 

lectinas, tais como a determinação da seqüência de aminoácidos, cristalização, estudos de 

fluorescência e dicroísmo circular (FUJII et al., 2011; DING et al., 2010; VAZ et al., 2010; 

VAREJÃO, 2010).  

 

3.4 Câncer 

 

Os primeiros relatos da ocorrência de câncer foram encontrados nos papiros do Egito e data 

de aproximadamente 1.600 a.C., os quais são referentes à descrição de oito casos de tumores ou 

úlceras de mama que foram tratados por cauterização. A palavra câncer, no grego, significa 

caranguejo e está associada a uma analogia entre o crescimento infiltrante do câncer e a forma como 

esse crustáceo se prende ao solo usando suas patas (AMERICAN CANCER SOCIETY, 2009).  

O câncer constitui-se em um importante problema de saúde pública em países desenvolvidos 

e em desenvolvimento, sendo responsável por mais de seis milhões de óbitos a cada ano, 

representando cerca de 12% de todas as causas de morte no mundo. Embora as maiores taxas de 

incidência de câncer sejam encontradas em países desenvolvidos, dos dez milhões de casos novos 

anuais de câncer, cinco milhões e meio são diagnosticados nos países em desenvolvimento 

(WORLD HEALTH ORGANIZATION, 2002). 

No Brasil, as estimativas para o ano de 2010, válidas para o ano de 2011, apontam para a 

ocorrência de 489.270 casos novos de câncer, sendo 236.240 (sexo masculino) e 235.030 para o 

sexo feminino. Os tipos mais incidentes, à exceção do câncer de pele do tipo não-melanoma, serão 

os cânceres de próstata e de pulmão no sexo masculino e os cânceres de mama e do colo do útero no 



12 

 

sexo feminino, acompanhando o mesmo perfil observado na América Latina (INSTITUTO 

NACIONAL DO CÂNCER, 2010). 

Câncer pode ser causado por dieta incorreta, predisposição genética e fatores ambientais. 

Cerca de 35% dos cânceres no mundo são causados por uma dieta incorreta, e no caso do câncer de 

cólon, esse fator pode responder por 80% dos casos. Quando adiciona álcool e cigarros na dieta, a 

percentagem pode aumentar para 60%. A predisposição genética é responsável por 20% dos casos 

de câncer. Então, a grande maioria dos casos de câncer está associada com a carcinogênese 

ambiental (REDDY et al., 2003).    

O processo de carcinogênese inclui três estágios: iniciação, promoção e progressão tumoral. 

No primeiro estágio as células sofrem o efeito de uma agente carcinógeno, levando a formação de 

uma célula geneticamente transformada. O segundo estágio da carcinogênese envolve a ação de 

substâncias classificadas como oncopromotores, que induzem a expressão de genes envolvidos no 

crescimento celular. A célula iniciada é transformada em célula maligna de forma lenta e gradual. O 

terceiro e último estágio, o de progressão, caracteriza-se pela multiplicação descontrolada das 

células mutadas, onde começam a surgir as primeiras manifestações clínicas da doença (ALMEIDA 

et al., 2005).     

As mutações envolvem amplificação e/ou supra-expressão de oncogenes aliada à deleção 

e/ou silenciamento de genes supressores de tumor (HAHN &amp;amp; WEINBERG 2002). Segundo LUO et 

al. (2009), as mutações no câncer promovem a reativação ou modificação de programas celulares 

que regulam mecanismos relacionados à embriogênese e a homeostasia, tais como proliferação, 

diferenciação, migração e apoptose. 

As células tumorais apresentam auto-suficiência para os sinais de crescimento e resistência 

aos sinais antiproliferativos, evasão de morte celular programada (apoptose), potencial de 

replicação ilimitado, angiogênese, invasão tecidual e metástase (HANAHAN &amp;amp; WEINGERG, 

2000). Recentes trabalhos (Figura 3) têm mostrado a adição de outras características, tais como: 

escape do sistema imune (KROEMER &amp;amp; POUYSSEGUR, 2008) e fenótipos de estresse, incluindo 

metabólico, mitótico, proteotóxico, oxidativo e de dano ao DNA (LUO et al., 2009). 

   

 

 



13 

 

 

 

 

 

 

 

Figura 3: Características das células tumorais. (Fonte: LUO et al., 2009) 

 

Atualmente, o tratamento do câncer é considerado como um dos problemas mais 

desafiadores da medicina (CHABNER &amp;amp; JR., 2005). A partir do momento que a neoplasia primária 

metastatiza o prognóstico se torna ruim, sendo a quimioterapia antineoplásica a principal forma de 

tratamento nesse estágio. A vantagem desse tratamento é o de atingir igualmente as metástases 

disseminadas pelo corpo. Contudo, esses medicamentos apresentam diversos efeitos colaterais, pois 

sua grande maioria possui baixo índice terapêutico, ou seja, dose terapêutica muito próxima da dose 

tóxica. Dessa forma, torna-se fundamental estimular as pesquisas, as quais medicamentos 

antineoplásicos mais eficazes e seguros sejam descobertos (FUKUMASU et al., 2008).  

 

3.5 Morte celular (Apoptose) 

 

O equilíbrio entre a morte celular e proliferação celular regula e controla o número de 

células no organismo. A cascata de eventos, bioquímicos e fisiológicos, que leva a mudança na 

síntese de macromoléculas, na homeostase e volume celular, bem como na perda da viabilidade 

celular estão relacionadas às alterações morfológicas características de cada tipo de morte celular 

(TINARI et al., 2008).   

Apoptose é considerado um mecanismo vital em diversos processos, tais como homeostase 

dos tecidos, apropriado funcionamento do sistema imune e desenvolvimento embrionário (BRAS et 

al., 2005: ELMORE, 2007). Por outro lado, a desregulação da apoptose pode afetar o balanço entre 

Invasão tecidual e 
metástase

Angiogênese
sustentada

Inibição de 
vigilância imune

Estresse 
metabólico

Estresse 
Proteotóxico

Estresse 
mitótico

Estresse 
oxidativo

Danos no DNA

Potencial 
replicativo
ilimitado

Insensível a sinais de 
anti-crescimento

Auto-suficiente em 
sinais de crescimento

Evasão da 
apoptose

Hipóxia Senescência

Aneuploidia

Baixo

pH

Sobrevida e 
proliferação em novos 

ambientes

Invasão tecidual e 
metástase

Angiogênese
sustentada

Inibição de 
vigilância imune

Estresse 
metabólico

Estresse 
Proteotóxico

Estresse 
mitótico

Estresse 
oxidativo

Danos no DNA

Potencial 
replicativo
ilimitado

Insensível a sinais de 
anti-crescimento

Auto-suficiente em 
sinais de crescimento

Evasão da 
apoptose

Hipóxia Senescência

Aneuploidia

Baixo

pH

Sobrevida e 
proliferação em novos 

ambientes



14 

 

proliferação celular e morte celular, resultando no aparecimento de várias doenças humanas, 

incluindo o câncer (ZORNING et al., 2001; DANIAL &amp;amp; KORSMEYER, 2004). 

O termo apoptose foi introduzido por KERR et al (1972), para definir um conjunto de 

características morfológicas e bioquímicas, como redução de volume nuclear e celular, condensação 

da cromatina (OTT et al., 2007), fragmentação do núcleo, formação de prolongamentos da 

membrana plasmática (blebbs), fragmentação celular (corpos apoptóticos) (KIECHLE &amp;amp; ZHANG, 

2002; KROEMER et al., 2005), exposição da fosfatidilserina (ZIEGLER &amp;amp; GROSCRURTH, 2004) 

e mudanças na permeabilidade de membrana mitocondrial com perda do potencial de membrana 

(RICCI &amp;amp; ZONG, 2006). 

Em condições normais, os fosfolipídios são assimetricamente distribuídos, com o 

fosfolipídio fosfatidilserina normalmente confinada na face citoplasmática da membrana plasmática 

por um mecanismo de transporte ativo. Essa assimétrica distribuição pode ser perturbada 

principalmente durante o processo de apoptose, na qual serve como um sinal primário para remoção 

fagocítica de células apoptóticas (BALASUBRAMANIAN &amp;amp; SCHROIT, 2003). A externalização 

da fosfatidilserina corresponde a um evento quase universal da apoptose, que ocorre poucas horas 

após o estímulo apoptótico, e apresenta um alvo muito abundante (milhões de sítios por célula), 

sendo facilmente acessível na face externa da membrana (BOERSMA et al., 2005; 

BLANKENBERG, 2008).  

Essa alteração da membrana plasmática levou KOOPMAN et al (1994) e outros a delinear 

um ensaio de detecção da fosfatidilserina por coloração com isotiocianato fluoresceína (FITC)-

conjugado com Anexina V, uma proteína com forte afinidade natural para fosfatidilserina 

(MARTIM et al. 1995; OZGEN et al., 2000; BRUMATI et al., 2008). Por ser capaz de distinguir 

entre células apoptóticas e necróticas, as quais têm comprometida a integridade da membrana, 

iodeto de propídeo (IP) foi adicionado. Por esse ensaio, células viáveis, apoptóticas e necróticas 

podem ser discriminadas por microscopia de fluorescência ou citômetro de fluxo (VERMES et al., 

1995; BOERSMA et al., 2005; GROSSE et al., 2009). 

Apoptose pode ser induzida por uma via extrínseca, envolvendo receptores de morte 

presentes na superfície celular, ou por via intrínseca induzida por estímulos extracelular que 

transmite um sinal para a mitocôndria (Figure 4) (BRENNER &amp;amp; KROEMER, 2000; KUO et al., 

2010). A via extrínseca é caracterizada por interação de um ligante com receptores de morte, que 

desencadeia a formação de um complexo multimérico, seguido por recrutamento e ativação da 

caspase-8 (LAVRIK et al., 2005).  



15 

 

A via intrínseca envolve alteração no potencial de membrana mitocondrial, levando a 

permeabilização da membrana mitocondrial (MMP), e seguida por liberação do citocromo C 

(CHIPUK et al., 2006; KROEMER et al., 2007). O citocromo C citosólico liga-se a proteína APAF-

1 (“Fator 1 ativador da apoptose”), desencadeando a formação de um complexo protéico chamado 

de apoptosomo, o qual permite o recrutamento e ativação da caspase-9 (BAO &amp;amp; SHI, 2007). MMP 

é regulada por membros da família Bcl-2 e Bax, que inibe ou promove a permeabilização da 

membrana mitocondrial, respectivamente (REED, 2006). Ambas as vias, convergem para a caspase-

3 executora, cuja atividade produz as características morfológicas da apoptose (PORTER &amp;amp; 

JANICKE, 1999). Então, MMP e principalmente, a perda do potencial de membrana mitocondrial 

marca o ponto de não retorno do processo de morte celular (KROEMER, 2003). Por causa deste 

papel central na cascata da apoptose, a avaliação do potencial de membrana mitocondrial fornece 

uma importante direcionamento para o mecanismo de morte celular (GOTTLIEB &amp;amp; GRANVILLE, 

2002), bem como a caracterização de novos agente indutores da apoptose (BUENZ et al., 2007).       

 

 

 

 

 

 

 

 

 

 

 

Figura 4. Vias intrínseca e extrínseca da apoptose (Fonte: ANDERSEN et al., 2005) 

 

 

3.6 Atividade antitumoral  

 

Diversas proteínas produzidas em células de mamíferos ocorrem como glicoproteínas e 

recentes avanços na glicobiologia têm revelado que suas cadeias de açúcar desempenham papéis 

importantes no reconhecimento celular, sendo essenciais para manutenção da ordem social no 

Estímulo apoptótico

(quimioterapia,  UV)
Intrínseco

Mitocôndria

Morte Celular

Extrínseco

Ligante

Receptor

Estímulo apoptótico

(quimioterapia,  UV)
Intrínseco

Mitocôndria

Morte Celular

Extrínseco

Ligante

Receptor



16 

 

comportamento das células que constituem organismos multicelulares (KOBATA &amp;amp; AMANO, 

2005).  

Glicosilação é uma modificação pós-translational comum em proteínas celulares, ocorrendo 

durante o desenvolvimento normal das células (LEHLE et al., 2006; CAMPBELL et al., 2007). 

Entretanto, a biossíntese das cadeias de oligossacarídeos presentes nas glicoproteínas se encontra 

freqüentemente alterada na diferenciação e transformação maligna. Algumas dessas mudanças 

podem ser reconhecidas por proteínas ligantes de carboidratos, as lectinas (GAJ et al., 2009). 

Nos últimos anos lectinas têm recebido atenção especial devido as suas importantes 

atividades biológicas exploráveis, como citoaglutinação, sonda histoquímica, atividade mitogênica, 

citotoxicidade, ação antiproliferativa e indutora da apoptose (SOBRAL, 2010; LAM &amp;amp; NG, 2010; 

YAN et al., 2010; ZHANG et al., 2010). 

O campo da pesquisa terapêutica vem se desenvolvendo no sentido de testar novas formas 

de tratamento, bem como novas substâncias potencialmente eficazes contra as neoplasias (SAAD-

HOSNE et al., 2004). Nesse contexto, estudos experimentais utilizando lectinas de serpentes e 

células tumorais têm revelado resultados promissores, indicando sua potencial atividade antitumoral 

através da prevenção e/ou tratamento do câncer. Lectina de Bothrops jararacussu (PEREIRA-

BITTENCOURT et al, 1999) demonstrou uma potente atividade inibitória para linhagens celulares 

de câncer humano (renal e pancreático). Em outro estudo, CARVALHO et al. (2001) sugeriram que 

essa lectina pode servir como uma interessante ferramenta para combater a progressão do câncer, 

por inibir o crescimento de linhagens celulares humanas de câncer de mama metastático (MDA-

MB-435) e carcinoma de ovário (OVCAR-5).  

Recentes trabalhos mostram um efeito inibitório de lectinas de serpentes sobre diversas 

funções mediadas por integrinas em células tumorais. Lebectina, uma lectina tipo-C isolada do 

veneno de Macrovipera lebetina, apresenta notável atividade anti-integrina, sendo hábil para 

prevenir adesão, migração, invasão e proliferação de células tumorais in vitro (SARRAY, et al., 

2004).  

Lebecetina, uma segunda lectina tipo-C purificada desse mesmo veneno, também exerce o 

mesmo efeito de lebectina sobre células tumorais, e ambas, provavelmente, atuam via interação com 

a integrina ?5?1 (SARRAY et al., 2001, 2007). De acordo com SARRAY et al. (2009) lebectina foi 

capaz de controlar a adesão célula-célula mediada por N-caderina, e em conjunto com seu efeito 



17 

 

inibitório sobre a integrina ?5?1, pode contribuir para o bloqueio da migração de células tumorais 

previamente observado.  

 

3.7. Atividade antibacteriana 

 

 A história da humanidade pode ser considerada, do ponto de vista médico, como uma luta 

contra microorganismos que causam infecções e doenças. Embora, no início do século XX, doenças 

infecciosas se apresentassem como a principal causa de morte no mundo, a introdução dos 

antibióticos como a sulfa e penicilina em uso clínico em 1930 e 1940, respectivamente, teve um 

notável impacto sobre o tratamento de infecções, diminuindo drasticamente a mortalidade 

(COHEN, 2000; BUYNAK, 2004). 

 No entanto, a euforia no potencial controle das doenças infecciosas teve vida curta, pois 

quase tão rapidamente como drogas antibacterianas foram implantadas, bactérias responderam por 

manifestar várias formas de resistência (TENOVER et al., 2006; SPELLBERG et al., 2008). 

Embora tenham surgido inúmeras classes de antibióticos, observa-se atualmente que existe pelo 

menos uma cepa resistente a esses fármacos, seja em comunidade ou em hospitais (FLUIT &amp;amp; 

SCHMITZ, 2004; MATLOW &amp;amp; MORRIS, 2009), acarretando um sério problema para a saúde 

pública em todo o mundo (LEVI &amp;amp; MARSHALL, 2004; RAGHUNATH, 2008). Permanece, 

portanto, a necessidade de novos antimicrobianos ou protótipos antibacterianos, que possam ser 

empregados no delineamento de antibióticos contra bactérias multidroga-resistentes. 

Peptídeos e proteínas têm sido avaliados como antibióticos para o controle de bactérias 

patogênicas (NAIR et al., 2007; WANG et al., 2008). Lectinas tem assumido um importante papel 

em interações com patógenos, através do reconhecimento específico de glicoconjugados presentes 

na superfície das células bacterianas (TATENO et al., 2002), como peptidioglicanos, ácido teicóico, 

lipopolisacarídeos e glicolipídeos (SCHAFFER &amp;amp; MESSNER, 2005; CLOUD-HANSEN et al., 

2006), resultando em atividade antibacteriana (MOURA et al., 2006). Além disso, lectinas podem 

ativar proteínas ou enzimas associadas ao processo de eliminação de microorganismos patogênicos 

(WANG et al., 2008). Em animais, são ferramentas notáveis para agregar e opsonizar patógenos 

(FUJITA, 2002).  

Devido a essa habilidade, diversas lectinas de animais vêm sendo avaliadas quanto ao seu 

potencial antibacteriano. Lectina do anelídeo Perineresis nuntia foi capaz de inibir o crescimento de 



18 

 

Bacillus megeterium e Bacillus subtilis e foi sugerido que a proteína está envolvida na defesa imune 

do hospedeiro (KAWSAR et al., 2010). CfLEC-2, uma lectina de Chlamys farreri, apresentou 

atividade agregante quando testada frente a bactéria Staphylococcus haemolyticus, atuando como 

mecanismo de defesa (ZHENG et al., 2008). A lectina de Holothuria scabra apresentou potente 

atividade antimicrobiana contras às bactérias gram-negativas e gram-positivas, indicando seu efeito 

antibacteriano de amplo espectro (GOWDA et al., 2008). 

Em venenos de serpentes, lectinas tipo-C com ação antibacteriana também tem sido 

purificadas em recentes estudos. Crotacetina, isolada de Crotalus durissus terrificus, inibiu 

significativamente o crescimento de dois patógenos de plantas: X. axonopodis pv. passiflorae e C. 

michiganensis michiganensis, bactérias gram-negativa e gram-positiva, respectivamente (RÁDIS-

BAPTISTA et al., 2006). Uma lectina tipo-C BmLec, isolada de Bothrops moojeni, exibiu potente 

efeito antibacteriano contra Xanthomonas axonopodis pv. (bactéria gram-negativa), causando 

vacuolização do citoplasma e ruptura da membrana celular (BARBOSA et al., 2010). 

A relevância biológica dessa atividade, induzida por proteínas, no envenenamento por 

serpentes não está clara, no entanto, alguns autores sugerem que possa contribuir para a baixa 

freqüência de infecções bacterianas no local da picada (TALAN et al., 1991; TRABI et al., 2001; 

SAMPAIO et al., 2010) ou como mecanismo de defesa contra microorganismos presentes na sua 

presa durante a alimentação (SHIVIK, 2006).   

 

3.8. Radiação  

 

 Radiação ionizante consiste de ondas eletromagnéticas resultantes de transições nucleares, 

que se propagam com alta velocidade, possuindo energia suficiente para quebrar ligações químicas, 

bem como a capacidade de promover a ionização e excitação nos meios com elevado poder de 

penetração (BREWER, 2004, 2009). Radiação gamma ou raio gamma (?) é um tipo de radiação 

eletromagnética produzida por elementos radioativos, em um processo subatômico como a 

aniquilação de um par pósitron-elétron. Possui comprimento de onda de alguns picometros e por 

causa das altas energias, constituem um tipo de radiação capaz de penetrar mais profundamente na 

matéria. Devido à sua elevada energia irradiação gamma emite elétron e gera radicais a partir da 

quebra do isótopo cobalto 60, ao quais afetam a estrutura das proteínas intactas, seguido por um 

ataque ao resíduo radio-sensível ou ligações (SEO et al., 2007).  



19 

 

Irradiação causa danos ou inativam proteínas através de dois diferentes mecanismos 

(KEMPNER, 2001). Primeiro, pode provocar quebra de ligações covalentes em moléculas de 

proteínas alvo, como resultado direto de um fóton de energia. Segundo, atua indiretamente via 

radiólise da água, produzindo radicais livres e espécies reativas de oxigênio (ROS), responsável 

pela maioria dos danos na proteína (ZBIKOWSKA, 2006). 

 A exposição de proteínas a radiação produz alterações em sua estrutura química e física por 

fragmentação, “ cross-linking ”, agregação, desnaturação, formação de novos grupos reativos, e 

oxidação por radicais oxigênios que são gerados na radiólise da água, resultando em distorções na 

estrutura secundária e terciária, levando a diminuição ou perda da função biológica da proteína 

(SHACTER, 2000; MOON &amp;amp; SONG, 2001).  

 Os radicais hidroxila e anion superóxido que são gerados por radiação podem modificar as 

propriedades moleculares das proteínas, que resultam em alterações de proteínas por ligações 

cruzadas covalentes em proteínas formadas após a irradiação (SHAWRANG et al., 2008). O efeito 

da irradiação sobre a conformação das proteínas depende de vários fatores, como concentração da 

proteína, a presença de oxigênio e da sua estrutura quaternária (LEE et al., 2003; GABER, 2005). 

Radiação gamma vem sendo empregada como agente atenuante de venenos ofídicos e 

toxinas isoladas, resultando em um produto de baixa ou nenhuma toxicidade, preservando, porém, 

suas propriedades imunológicas. Crotamina, uma toxina de Crotalus durissus terrificus, irradiada 

na dose de 2.0 kGy foi duas vezes menos tóxica para camundongos que a crotamina nativa (BONI-

MITAKE et al., 2001). SOUZA et al. (2002) demonstraram que o veneno irradiado de Bothrops 

jararacussu, o qual apresenta miotoxinas em sua composição, não exibiu efeitos miotóxicos nas 

preparações musculares in vitro, quando comparado com o veneno nativo. Em outro estudo, 

CASARE et al. (2006) observaram que Crotoxina quando submetida à radiação, em diferentes 

doses, apresentou diminuição significativa na mortalidade de camundongos. O tratamento de 

Bothropstoxina-1 com radiação na dose de 2.0 kGy promoveu modificações estruturais na toxina, 

no entanto, manteve muita das propriedades antigênicas da proteína nativa. Esses autores 

verificaram também que a toxina irradiada induziu altos títulos de IgG2, sugerindo que células Th1 

estão envolvidas na resposta imune (CAPRONI et al., 2009).  

Em recente estudo, irradiação gamma foi utilizada como um tratamento alternativo para 

abolir alergenicidade de lectinas em alimentos. VAZ et al. (2010) observaram que a irradiação da 

lectina isolada da entrecasca de Sebastiana jacobinenses (SejaBL), em altas doses (acima de 1kGy), 



20 

 

induziu uma significante perda da atividade hemaglutinante e causou alterações estruturais na 

proteína, incluindo fragmentação e agregação após irradiação.       

 

3.9. Serpente Bothrops leucurus 

 

 No Brasil, serpentes do gênero Bothrops são responsáveis por 90% de todos os acidentes 

ofídicos nos quais a serpente é identificada. Bothrops leucurus (jararaca-do-rabo-branco) é uma 

serpente que apresenta uma ampla distribuição na costa brasileira, do estado do Maranhão até o 

Espírito Santo (LIRA-DA-SILVA, 2009). Na Bahia, essa espécie é a principal causadora de 

envenenamentos por picadas de serpentes em humanos (LIRA-DA-SILVA &amp;amp; NUNES, 1993; MISE 

et al., 2007), representando um sério problema médico para a região Nordeste do Brasil (Figura 5). 

 

 

Figura 5. Serpente Bothrops leucurus (Fonte: LIRA-DA-SILVA et al. 2009) 

 

Em um estudo sobre atividades biológicas de venenos de serpente da América do Sul, 

SANCHES et al. (1992) demonstraram que a letalidade, como também as atividades 

edematogênica, coagulante, hemorrágica e necrosante de B. leucurus foram semelhantes às de 

várias outras espécies botrópicas, incluindo B. jararaca.  Em adição, B. leucurus exibiu ação 

neuromuscular e miotóxica em preparações de nervo-músculo de aves (PRIANTI JR et al., 2003). 

Componentes implicados em uma variedade de efeitos tóxicos locais, assim como em 

profundas perturbações no sistema hemostático das vítimas foram isolados do veneno de B. 



21 

 

leucurus. BELLO et al. (2006) purificou uma proteinase fibrinolítica, denominada leuc-a, a qual 

exibiu efeito inibitório sobre agregação plaquetária induzida por ADP. Uma L-amino oxidase, 

purificada desse veneno, inibiu agregação plaquetária estimulada por colágeno, contribuindo para o 

sangramento típico de pessoas picadas por essa serpente (SILVA et al., 2007). HIGUCHI et al. 

(2007) demonstrou a presença duas fosfolipases no veneno de B. leucurus, e observou que essas 

inibiram significantemente a coagulação e foram hábeis em estimular o crescimento tumoral. Outras 

toxinas também foram isoladas, incluindo uma enzima trombina-like (MAGALHÃES et al., 2007), 

uma P-III metaloproteinase hemorrágica (SANCHEZ et al., 2007), uma metaloproteinase não 

hemorrágica, com atividade edematogênica e trombolítica (GREMSKI et al., 2007). Recentemente, 

foi purificado uma metaloproteinase fibrinogenolítica não hemorrágica (BleucMP), com habilidade 

para diminuir significantemente o nível de fibrinogênio plasmático provocado por incoagulabilidade 

sanguínea (Gomes et al., 2010). 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



22 

 

4 REFERÊNCIAS BIBLIOGRÁFICAS 

 

ALMEIDA, V.L.; LEITÃO, A.; REINA, L.C.B.; MONTANARI, C.A.; DONNICI, C.L. (2005) 

Cancer and cell cicle-specific and cell cicle nonspecific anticancer DNA-interactive agents. 

Quimica Nova, 28(1): 118-129. 

AMERICAN CANCER SOCIETY (ACS). The history of cancer. Disponível em: 

&lt;http://www.cancer.org/&gt;. Acesso em: 30 out. 2010. 

ANDERSEN, M.H.; BECKER, J.C.; STRATEN, P.T. (2005) Regulators of apoptosis: suitable 

targets for immune therapy of cancer. Nature Reviews Drug Discovery, 4:399-409. 

ANGULO, Y.; LOMONTE, B. (2009) Biochemistry and toxicology of toxins purified from the 

venom of the snake Bothrops asper. Toxicon, 54(7): 949-957. 

ARAB, M.R.; SALARI, S.; KARIMI, M.; MODIFIDPOUR, H. (2010) Lectin histochemical study 

of cell surface glycoconjugate in gastric carcinoma using Helix pomatia agglutinin. Acta 

Medica Iranica, 48(4): 209-213. 

ARAGON-ORTIZ, F.; BRENES, J.R.B.; GUBENSEK, F. (1989) Characterization of a lectin-like 

protein isolated from Lachesis muta snake venom. Revista de Biologia Tropical, 37:70-83. 

ARAGON-ORTIZ, F.; MENTELE, R.; AUERSWALD, E.A. (1996) Amino acid sequence of a 

lectin-like protein form Lachesis muta stenophyrs venom. Toxicon, 34:763-769. 

BALASUBRAMANIAN, K.; SCHROIT, A.J. (2003) Aminophospholipid asymmetry: a matter of 

life and death. Annual Reviews Physiology, 65:701-734. 

BAO, Q.; SHI, Y. (2007) Apoptosomo: a platform for the activation of initiator caspases. Cell 

Death Differentiation, 14(1): 56-65. 

BAPTISTA, J.A.; VIEIRA, D.P.; GALISTEO-JÚNIOR, A.J.; CAPRONI, P.; CASARE, M.; 

ANDRADE-JÚNIOR, H.F.; SPENCER, P.J.; NASCIMENTO, N. (2009) Immunological 

properties of 60Co gamma-rays irradiated bothropstoxin-I. Journal of Radioanalytical and 

Nuclear Chemistry, 279(3): 817-821. 

BARBOSA, P.S.F.; MARTINS, A.M.C.; TOYAMA, M.H.; JOAZEIRO, P.P.; LOS, B.; 

FONTELES, M.C.; MONTEIRO, H.S.A. (2010) Purification and biological effects of a C-type 



23 

 

lectin isolated from Bothrops moojeni. Journal of Venomous Animals and Toxins including 

Tropical Diseases, 16(3): 493-504. 

BATTISON, A.L.; SUMMERFIELD, R.L. (2009) Isolation and partial characterization of four 

novel plasma lectins from the American lobster Homarus americanus. Developmental &amp;amp; 

Comparative Immunology, 33:198-204. 

BELLO, C.A.; HERMOGENES, A.L.N.; MAGALHAES, A.; VEIGA, S.S.; GREMSKI, L.H.; 

RICHARDSON, M.; SANCHEZ, E.F. (2006) Isolation and biochemical characterization of a 

fibrinolytic proteinase from Bothrops leucurus (white-tailed-jararaca) snake venom. 

Biochemie, 88:189-200. 

BLANKENBERG, F.G. (2008) In vivo detection of apoptosis. Journal Nuclear Medicine, 49(2): 

81S-91S. 

BOERSMA, H.H.; KIETSELAER, B.L.J.H.; STOLK, L.M.L.; BENNAGHMOUCH, A.; 

HOFSTRA, L.; NARULA, J.; HEIDENDAL, G.A.K.; REUTELINGSPERGER, C.P.M. (2005) 

Past, present, and future of annexin A5: from protein discovery to clinical applications. 

Journal Nuclear of Medicine, 46:2035-2050. 

BONI-MITAKE, M.; COSTA, H.; SPENCER, P.J.; VASSILIEFF, V.S.; ROGERO, J.R. (2001) 

Effects of 60Co gamma radiation on crotamine. Brazilian Journal of Medical and Biological 

Research, 34(12): 4531-4538. 

BOYD, W.C.; SHAPLEIGH, E. (1954) Specific precipitating activity of plant agglutinins (Lectins). 

Science, 119(3091): 419. 

BRAGA, M.D.M.; MARTINS, A.M.C.; AMORA, D.N.; MENEZES, D.B.; TOYAMA, M.H.; 

TOYAMA, D.O.; MARANGONI, S.; BARBOSA, P.S.F.; ALVES, R.S.; FONTELES, M.C.; 

MONTEIRO, H.S.A. (2006) Purification and biological effects of C-type lectin isolated from 

Bothrops insularis venom. Toxicon, 47:859-867.    

BRAS, M.; QUEENAN, B.; SUSIN, S.A. (2005) Programmed cell death via mitochondria: 

different modes of dying. Biochemistry, 70(2): 231-239. 

BRENNER, C.; KROEMER, G. (2000) Apoptosis: mitochondria-the death signal integrators. 

Science, 289(5482): 1150-1151. 

BREWER, M.S. (2004) Irradiation effects on meat color-a review. Meat Science, 68:1-17. 



24 

 

BREWER, M.S. (2009) Irradiation effects on meat flavor: a review. Meat Science, 81:1-14. 

BRUMATTI, G.; SHERIDAN, C.; MARTIN, S. (2008) Expression and purification of recombinant 

annexin V for the detection of membrane alterations on apoptotic cells. Methods, 44:235-240. 

BUENZ, E.J.; LIMBURG, P.J.; HOWE, C.L. (2007) A high-throughput 3-parameter flow 

cytometry-based cell death assay. International Society for Analytical Cytology, 71:170-173.  

BUYNAK, J.D. (2004) The discovery and development of modified penicillin- and cephalosporin-

derived beta-lactamase inhibitors. Current Medicinal Chemistry, 11:1951-1964. 

CAMPBELL, C.T.; SAMPATHKUMAR, S.G.; YAREMA, K.J. (2007) Metabolic oligosaccharide 

engineering perspectives, applications, and future directions. Molecular Biosystems, 3: 187-

194   

CAO, X.; SUN, Y.; WANG, C.; ZENG, B. (2010) Purification and characterization of a new 

galactose-specific lectin the housefly, Musca domestica and its antiproliferative effect on 

human K562 and tumor cells. Journal of Insect Science, 79:1-12. 

CAPRONI, P.; BAPTISTA, J.A.; ALMEIDA, T.L.; PASSOS, L.A.C.; NASCIMENTO, N. (2009) 

Study of irradiated bothropstoxin-1 with 60Co gamma rays: immune system behavior. Journal 

of Venomous Animals and Toxins include Tropical Diseases, 15(2): 216-225. 

CARVALHO, D.D.; MARANGONI, S.; NOVELLO, J.C. (2002) Primary structure characterization 

of Bothrops jararacussu snake venom lectin. Journal of Protein Chemistry, 21:43-50. 

CARVALHO, D.D.; SCHMITMEIER, S.; NOVELLO, J.C.; MARKLAND, F.S. (2001) Effect of 

BJcuL (a lectin from the venom of the snake Bothrops jararacussu) on adhesion and growth of 

tumor and endothelial cells. Toxicon, 39:1471-1476 

CASARE, M.S.; SPENCER, P.; CAMPOS, L.A.; NASCIMENTO, N. (2006) Study of gamma-

radiation effects on crotamine and crotoxin. Journal of Radioanalytical and Nuclear 

Chemistry, 269(3): 571-577. 

CASTRO, H.C.; FERNANDES, M.; ZINGALI, R.B. (1999) Identification of bothrojaracin-like 

proteins in sanke venoms from Bothrops species and Lachesis muta. Toxicon, 37(10): 1403-

1416. 



25 

 

CHABNER, B.A.; JR., R.T.G. (2005) Timeline: chemotherapy and the war on cancer. Nature 

Reviews Cancer, 5(65): 65-72.  

CHEN, Y.S.; HUANG, C.H.; CHIOU, S.H. (2010) Characterization and molecular cloning of one 

novel C-type lectin from the venom of Taiwan habu (Trimeresurus mucroquasmatus). 

Toxicon, 55(4): 762-772. 

CHEN, Z.M.; WU, J.B.; ZHANG, Y.; YU, G.Y.; LEE, W.H.; LU, Q.M. (2011) Jerdonuxin, a novel 

snaclec (snake C-type lectin) with platelet aggregation activity from Trimeresurus jerdonii 

venom. Toxicon, 57(1): 109-116.    

CHIPUK, J.E.; BOUCHIER-HAYES, L.; GREEN, D.R. (2006) Mitochondrial outer membrane 

permeabilization during apoptosis: the innocent bystander scenario. Cell Death &amp;amp; 

Differentiation, 13(8): 1396-1402. 

CLEMETSON, K.J. (2010) Snaclecs (snake C-type lectins) that inhibit or active platelets by 

binding to receptors. Toxicon, 56(7): 1236-1246. 

CLEMETSON, K.J.; MORITA, T.; MANJUNATHA KINI, R. (2009) Scientific and 

standardization committee communications: classification and nomenclature of snake venom 

C-type lectins and related proteins. Journal Thrombosis and Haemostasis, 7:360.  

CLOUD-HANSEN, K.A.; PETERSON,S.B.; STABB, E.V.; GOLDMAN, W.E.; MACFALL-

NGAI, M.J.; HANDELSMAN, J. (2006) Breaching the great wall: peptidoglican and microbial 

interactions. Nature, 4:710-716. 

COELHO, L.C.B.B.; SILVA, M.B.R. (2000) Simple method to purify milligram quantities pf the 

galactose-specific lectin from the leaves of Bauhinia monandra. Phytochemical Analysis, 

11:295-300. 

COHEN, M. (2000) Changing patterns of infectious disease. Nature, 406:762-767.  

COMINETTI, M.R.; MARQUES, M.R.F.; LORENZINI, D.M.; LOFGREN, S.E.; DAFFRE, S.; 

BARRACCO, M.A. (2002) Characterization and partial purification of a lectin from the 

hemolymph of the white shrimp Litopenaeus schmitti. Developmental &amp;amp; Comparative 

Immunology, 26:715-721. 



26 

 

COSTA, R.M.P.B.; VAZ, A.F.M.; OLIVA, M.L.V.; COELHO, L.L.B.B.; CORREIA, M.T.S.; 

CARNEIRO-DA-CUNHA, M.G. (2010) A new mistletoe Phthirusa pyrifolia leaf lectin with 

antimicrobial properties. Process Biochemistry, 45:526-533. 

DAMODARAN, D.; JEYAKANI, J.; CHAUHAN, A.; KUMAR, N.; CHANDRA, N.R.; 

SUROLIA, A. (2008) CancerLectin DB: a database of lectins relevant to cancer. Glycoconjugate, 

25:191-198. 

DANIAL, N.N.; KORSMEYER, S.J. (2004) Cell death: critical control points. Cell, 116:205-219.  

DATTA, K.; USHA, R.; DUTTA, S.K.; SINGH, M.A. (2001) A comparative study of the winged 

bean protease inhibitors and their interaction proteases. Plant Physiology and Biochemistry, 

39:949-959. 

DE MEJÍA, E.G.; PRISECARU, V.I. (2005) Lectins as bioactive plant proteins: a potential cancer 

treatment. Critical Reviews in Food Science and Nutrition, 45:425-445. 

DING, J.; BAO, J.; ZHU, D.; ZHANG, Y.; WANG, D.C. (2010) Crystal structures of a novel anti-

HIV mannose-binding lectin from Polygonatum cyrtonema Hua with unique ligand-binding 

property and super-structure. Journal of Structural Biology, 171(3): 309-317. 

DOYLE, R.; KINI, R.M. (2009) Protein complexes in snake venom. Cellular and Molecular Life 

Sciences, 66:2851-2871. 

DRICKAMER, K. (1999) C-type lectin-like domains. Current Opinion in Structural Biology, 

9(5): 585-590. 

DUTTA, S.; SINHA, B.; BHATTACHARYA, B.; VHATTERJEE, B.; MAZUMDER, S. (2005) 

Characterization of a galactose binding serum lectin from the Indian catfish, Clarias batrachus: 

possible involvement of fish lectins in differential recognition of pathogens. Comparative 

Biochemistry and Physiology Part C, 141(1): 76-84. 

ELÍFIO-ESPOSITO, S.L.; HESS, P.L.; MORENO, A.N.; LOPES-FERREIRA, M.; RICART, 

C.A.O.; SOUZA, M.V.; HASSELMAN-ZIELINSKI, F.; BECKER, J.A.; PEREIRA, L.F. 

(2007) A C-type lection from Bothrops jararacussu venom can adhere to extracellular matrix 

proteins and induce the rolling of leukocytes. Journal of Venomous Animals and Toxins 

including Tropical Diseases, 13(4): 782-799. 



27 

 

ELMORE, S. (2007) Apoptosis: a review of programmed cell death. Toxicologic Pathology, 35(4): 

495-516. 

FENG, K.; LIU, Q.H.; NG, T.B.; LIU, H.; LI, J.Q.; CHEN, G.; SHENG, H.Y.; XIE, Z.L.; WANG, 

H.X. (2006) Isolation and characterization of a novel lectin from the mushroom Armillaria 

luteo-virens. Biochememical and Biophysical Research Communications, 345:1573-1578. 

FERREIRA JUNIOR, R.S.; NASCIMENTO, N.; MARTINEZ, J.C.; ALVES, J.B.; MEIRA, D.A.; 

BARRAVIERA, B. (2005) Immunological assessment of mice hyperimmunized with native 

and cobalt-60-irradiated Bothrops venoms. Journal of Venomous and Toxins including 

Tropical Diseases, 11(4): 447-464. 

FLUII, A.C.; SCHMITZ, F.J. (2004) Resistance integrons, super integrons. Clinical Microbiology 

and Infection, 10:272-288. 

FREIRE, M.G.; GOMES, V.M.; CORSINI, R.E.; MACHADO, O.L.T.; DE SIMONE, S.G.; 

NOVELLO, J.C.; MARANGONI, S.; MACEDO, M.L.R. (2002) Isolation and partial 

characterization of a novel lectin from Talisia esculenta seeds that interferes with fungal 

growth. Plant Physiology Biochemistry, 40:61-68.  

FUJII, Y.; KAWSAR, S.M.A.; MATSUMOTO, R.; DOGASKI, C.; HOSONO, M.; NITTA, K.; 

HAMAKO, J. (2011) A D-galactose-binding lectin purified from coronate moon turban, Turbo 

(Lunella) coreensis, with a unique amino acid sequence and the ability to recognize lacto-series 

glycosphingolipids. Comparative Biochemistry and Physiology Part B, 158:30-37. 

FUJITA, T. (2002) Evolution of the lectin-complement pathway and its role in innate immunity. 

Nature, 2:347-353.      

FUKUDA, K.; MIZUNO, H.; ATODA, H.; MORITA, T. (2000) Crystal structure of Flavocetin-A, 

a platelet glycoprotein Ib-binding protein, reveals a novel cyclic tetramer of C-type lectin-like 

heterodimers. Biochemistry, 39: 1915-1923.  

FUKUMASU, H.; LATORRE, A.O.; BRACCI, N.; GÓRNIAK, S.L.; DAGLI, M.L.Z. (2008) 

Fitoterápicos e potenciais interações medicamentosas na terapia do câncer. Revista Brasileira 

de Toxicologia, 21(2): 49-59. 

GABER, M.H. (2005) Effect of ?-irradiation on the molecular properties of bovine serum albumin. 

Journal of Bioscience and Bioengineering, 100(2): 203-206. 



28 

 

GAJ, Z.; KRZESLAK, A.; POMORSKI, L.; LIPINSKA, A. (2009) Intracelular glycoproteins 

binding galectin-1 in thyroid lesions. Tumori, 95: 352-356. 

GALLACI, M.; NASCIMENTO, N.; ROGERO, J.R.; VASSILIEFF, V.S. (2000) Influence of 

temperature upon effects of crotoxin and gamma-irradiated crotoxin at rat neuromuscular 

transmission. Toxicology Letters, 114:77-80. 

GARTNER, T.K.; STOCKER, K.; WILLIAMS, K.C. (1980) Thrombolectin: a lectin isolated from 

Bothrops atrox venom. FEBS Letters, 117: 13-16. 

GARTNER, T.K.; OGILVIE, L. (1984) Isolation and characterization of three Ca2+ dependent ?-

galactoside-specific lectin from snake venom. Biochemical Journal, 224:301-307. 

GOLDSTEIN, I.J.; HUGHES, R.C.; MONSIGNY, M.; OSAWA, T.; SHARON, N. (1980) What 

should be called a lectin?. Nature,  285:66. 

GOMES, M.S.; de QUEIROZ, M.R.; MAMEDE, C.C.; MENDES, M.M.; HAMAGUCHI, A.; 

HOMSI-BRANDEBURGO, M.I.; SOUSA, M.V.; AQUINO, E.N.; CASTRO, M.S.; de 

OLIVEIRA, F.; RODRIGUES, V.M. (2010) Purification and functional characterization of a 

new metalloproteinase (BleucMP) from Bothrops leucurus snake venom. Comparative 

Biochemistry and Physiology Part C Toxicology Pharmacology. In press. 

GOTTLIEB, R.A.; GRANVILLE, D.J. (2002) Analyzing mitochondrial changes during apoptosis. 

Methods, 26:341-347. 

GOWDA, N.M.; GOSWAMI, U.; KHAN, M.I. (2008) T-antigens binding lectin with antibacterial 

activity from marine invertebrate, sea cucumber (Holothuria scabra): possible involvement in 

differential recognition of bacteria. Journal of Invertebrate Pathology, 99:141-145. 

GREMSKI, L.H.; CHAIM, O.M.; PALUDO, K.S.; SADE, Y.B.; OTUKI, M.F.; RICHARDSON, 

M.; GREMSKI, W.; SANCHEZ, E.F.; VEIGA, S.S. (2007) Cytotoxic, thrombolytic and 

edematogenic activities of leucurolysin-a, a metalloproteinase from Bothrops leucurus snake 

venom. Toxicon, 50:120-134. 

GROSSE, J.; GRIMM, D.; WESTPHAL, K.; ULBRICH, C.; MOOSBAUER, J.; POHL, F.; 

KOELBL, O.; INFANGER, M.; EILLES, C.; SCHOENBERGER, J. (2009) Radiolabeled 

annexin V for imaging apoptosis in radiated human follicular thyroid carcinomas – is an 

individualized protocol necessary? Nuclear Medicine and Biology, 36:89-98.  



29 

 

GUIMARÃES-GOMES, V.; OLIVEIRA-CARVALHO, A.L.; JUNQUEIRA-AZEVEDO, I.L.M.; 

DUTRA, D.L.S.; PUJOL-LUZ, M.; CASTRO, H.C.; HO, P.L.; ZINGALI, R.B. (2004) 

Cloning, characterization and structural analysis of a C-type lectin from Bothrops insularis 

(BiL) venom. Archives of Biochemistry and Biophysics, 432:1-11. 

HAHN, W.C.; WEINBERG, R.A. (2002) Modelling the molecular circuitry of cancer. Nature 

Reviews Cancer, 2(5): 331-341. 

HAMAKO, J.; SUZUKI, Y.; HAYASHI, N.; KIMURA, M.; OZEKI, Y.; HASHIMOTO, K.; 

MATSUI, T. (2007) Amino acid sequence and characterization of C-type lectin purified from 

the snake venom of Crotalus ruber. Comparative Biochemistry and Physiology Part B, 

146:299-306.  

HANAHAN, D.; WEINGERG, R.A. (2000) The hallmarks of cancer. Cell, 100:57-70.   

HAVT, A.; TOYAMA, M.H.; NASCIMENTO, N.R.F.; TOYAMA, D.O.; NOBRE, A.C.L.; 

MARTINS, A.M.C.M.; BARBOSA, P.S.F.; NOVELLO, J.C.; BOSCHERO, A.C.; 

CARNEIRO, E.M.; FONTELES, M.C.; MONTEIRO, H.S.A. (2005) A new C-type animal 

lectin isolated from Bothrops pirajai is responsible for the snake venom major effects in the 

isolated kidney. The International Journal of Biochemistry &amp;amp; Cell Biology, 37:130-141.   

HIGUCHI, D.A.; BARBOSA, C.M.V.; BINCOLLETO, C.; CHAGAS, J.R.; MAGALHÃES, A.; 

RICHARDSON, M.; SANCHEZ, E.F.; PESQUERO, J.B.; ARAUJO, R.C.; PESQUERO, J.L. 

(2007) Purification and characterization of two phospholipases A2 from Bothrops leucurus 

(white-tailed-jararaca) snake venom. Biochimie, 89:319-328.  

HIRABAYASHI, J.; KUSUNOKI, T.; KASAI, K. (1991) Complete primary structure of a 

galactose-specific lectin from de venom of the rattlesnake Crotalus atrox homologies with Ca2+ 

-dependent-type lectins. The Journal of Biological Chemistry, 266:2320-2326. 

INSTITUTO NACIONAL DO CÂNCER (INCA). Estimativa 2010: Incidência de câncer no 

Brasil. Rio de Janeiro. 2009. p.23-24. Disponível em: 

&lt;http:www.inca.gov.br/estimativa/2010/versãofinal.pdf&gt;. Acesso em: 13 Out. 2010. 

ISLAS, A.A.; TRUJILLO, A.H.S.; VILLAFÁN, O.P.; ROMERO, B.L.B.; BAUMGARTEN, E.H.; 

GUTIÉRREZ, V.R.T.; SETIÉN, A.A. (2007) Interference of a hemagglutinant fraction of 

crotalic venom in the adsortion of parainfluenza-3 (PI-3) virus. Veterinaria México, 

38(2):165-175. 



30 

 

JAYATI, B.; ARUN, K.G.; BISHNU, P.C. (2005) Purification and molecular characterization of a 

sialic acid specific lectin from the phytopathogenic fungus Macrophomina phaseolina. 

Carbohydrate Research, 340:1973-1982. 

JEBALI, J; BAZAA, A.; SARRAY, S.; BENHAJ, K.; KARBOUL, A.; EL AYEB, M.; 

MARRAKCHI, N.; GARGOURI, A. (2009) C-type lectin protein isoforms of Macrovipera 

lebetina: cDNA cloning and genetic diversity. Toxicon, 53(2): 228-237.   

JIANG, L.; PENG, L.; ZHANG, Y.; CHEN, J.; ZHANG, D.; LIANG, S. (2009) Expression, 

purification and characterization of a group of a lectin-like peptides from the spider 

Ornithoctomus huwena. Peptides, 30(4): 669-674. 

KASSAB, B.H.; CARVALHO, D.D.; OLIVEIRA, M.A.; BAPTISTA, G.R.; PEREIRA, G.A.G.; 

NOVELLO, J.C. (2004) Cloning, expression, and structural analysis of recombinant BJcuL, a 

C-type lectin from the Bothrops jararacussu snake venom. Protein Expression and 

purification, 35:344-352.  

KASSAB, B.H.; CARVALHO, D.D.; MARANGONI, S.; NOVELLO, J.C. (2001) Characterization 

of a hemagglutinating glycoprotein isolated from Bothrops moojeni snake venom. Protein and 

Peptide Letters, 8(1): 13-20. 

KAWAGISHI, H.; TAKAGI, J.; TAIRA, T.; MURATA, T.; USUI, T. (2001) Purification and 

characterization of a lectin from the mushroom Mycoleptodonoides aitchisonii. 

Phytochemistry, 56:53-58. 

KAWSAR, S.M.; MATSUMOTO, R.; FUJII, Y.; YASUMITSU, H.; DOGASAKI, C.; HOSONO, 

M.; NITTA, K.; HAMAKO, J.; MATSUI, T.; KOJIMA, N., OZEKI, Y. (2009) Purification and 

biochemical characterization of a D-galactose binding lectin from japanese sea hare (Aplysia 

kurodai) eggs. Biochemistry, 74(7): 709-716. 

KAWSAR, S.M.; FUJII, Y.; MATSUMOTO, R.; ICHIKAWA, T.; TATENO, H.; 

HIRABAYASHI, J.; YASUMITSU, H.; DOGASAKI, C.; HOSONO, M.; NITTA, K.; 

HAMAKO, J.; MATSUI, T.; OZEKI, Y. (2008) Isolation, purification, characterization and 

glycan-binding profile of a D-galactoside specific lectin from the marine sponge Halichondria 

okadai. Comparative Biochemistry and Physiology Part B, 150:349-357. 

KAWSAR, S.M.A.; MAMUN, S.M.A.; RAHMAN, S.; YASUMITSU, H.; OZEKI, Y. (2010) 

Biological effects of a carbohydrate-binding protein from an Annelid, Perinereis nuntia against 



31 

 

human and phytopathogenic microorganisms. International Journal of Biological and Life 

Sciences, 6:44-50.  

KEMPNER, E.S. (2001) Effects of high-energy electrons and gamma rays directly on protein 

molecules. Journal of Pharmaceutical Sciences, 90:1637-1646. 

KERR, J.F.R.; WYLLIE, A.H.; CURRIE, A.R. (1972) Apoptosis: A basic biological phenomenon 

with wide-ranging implications in tissue kinetics. British Journal of Cancer, 26:239-257. 

KIECHLE, F.L.; ZHANG, X. (2002) Apoptosis: biochemical aspects and clinical implications. 

Clinica Chimica Acta, 326:27-45. 

KILPATRICK, D.C. (2002) Animal lectins: a historical introduction and overview. Biochimica et 

Biophysica Acta, 1572:187-197. 

KOBATA, A.; AMANO, J. (2005) Altered glycosilation of proteins produced by malignant celss, 

and application for the diagnosis and immunotherapy of tumours. Immunology and Cell 

Biology, 83: 429-439. 

KOH, D.C.; ARMUGAN, A.; JEYASEELAN, K. (2006) Snake venom components and their 

applications in biomedicine. Cellular and Molecular Life Science, 63(24): 3030-3041. 

KOMORI, Y.; NIKAI, T.; TOHKAI, T.; SUGIHARA, H. (1999) Primary structure and biological 

activity of snake venom lectin (APL) from Agkistrodon p. piscivorus (Eastern cottonmouth). 

Toxicon, 37:1053-1064. 

KOO, B.H.; SOHN, Y.D.; HWANG, K.C.; KIM, D.S.; CHUNG, K.H. (2002) Characterization and 

cDNA cloning of halyxin, a heterogeneous three-chain anticoagulant protein from the venom of 

Agkistrodon halys brevicaudus. Toxicon, 40:947-957. 

KOOPMAN, G.; REUTELINGSPERGER, C.P.; KUIJTEN, G.A.; KEEHNER, R.M.; PALS, S.T.; 

VAN OERS, M.H. (1994) Annexin V for flow cytometric detection of phosphatidylserine 

expression on B cells undergoing apoptosis. Blood, 84:1415-1420.  

KROEMER, G. (2003) Mitochondrial control of apoptosis: an introduction. Biochemical 

Biophysical and Research Communication, 304:433-435.  

KROEMER, G.; GALLUZZI, L.; BRENNER, C. (2007) Mitochondrial membrane permeabilization 

in cell death. Physiology Reviews, 87:99-163 



32 

 

KROEMER, G.; EL-DEIRY, W.S.; GOLSTEIN, P.; PETER, M.E.; VAUX, D.; 

VANDENABEELE, P.; ZHIVOTOVSKY, B.; BLAGOSKLONNY, M.V.; MALORNI, W.; 

KNIGHT, R.A.; PIACENTINI, M.; NAGATAS, S.; MELINO, G. (2005) Classification of cell 

death: recommendations of the Nomenclature Committee on Cell Death. Cell Death &amp;amp; 

Differentiation, 2:1463-1467. 

KROEMER, G.; POUYSSEGUR, J. (2008) Tumor cell metabolism: cancer´s Achilles´hell. Cancer 

Cell, 13:472-482.    

KUO, W.T.; HO, Y.J.; KUO, S.M.; LIN, F.H.; TSAI, F.J.; CHEN, Y.S.; DONG, G.C.; YAO, C.H. 

(2010) Induction of the mitochondria apoptosis pathway by phytohemagglutinin 

erythroagglutinating in human lung cancer cells. Annals of Surgical Oncology. In press.  

LAM, S.K.; NG, T.B. (2010) Lectins: production and practical applications. Applied Microbiology 

and Biotechnology, 89:45-55. 

LAVRIK, I.; GOLKS, A.; KRAMMER, P.H. (2005) Death receptor signaling. Journal of Cell 

Science, 118(2): 265-267. 

LEE, S.; LEE, S.; SONG, K.B. (2003) Effect of gamma-irradiation on the physicochemical 

properties of porcine and bovine blood plasma proteins. Food Chemistry, 82:521-526. 

LEHLE, L.; STRAH, S.; TANNER, W. (2006) Protein glycosylation, conserved from yeast to man: 

a model organism helps elucidate congenital human diseases. Angewandte Chemie 

International Edition, 45:6802-6818. 

LEVI, S.B.; MARSHAL, B. (2004) Antibacterial resistance worldwide: causes, chalenges and 

responses. Nature Medicine, 10:122-129.  

LI, Y.; LIU, Q.H.; WANG, H.X.; NG, T.B. (2008) A novel lectin with potent antitumor, mitogenic 

and HIV-1 reverse transcriptase inhibitory activities from the edible mushroom Pleurotus 

citrinopileatus. Biochimica et Biophysica Acta, 1780:51-57  

LIMA, D.C.; ABREU, P.A.; FREITAS, C.C.; SANTOS, D.O.; BORGES, R.O.; SANTOS, T.C.; 

CABRAL, L.M.; RODRIGUES, C.R.; CASTRO, H.C. (2005) Snake venom: any clue for 

antibiotics and CAM?. Evidence-based Complementary and Alternative Medicine, 2(1): 39-

47.  



33 

 

LIN, L.P.; LIN, Q.; WANG, Y.Q. (2007) Cloning, expression and characterization of two C-type 

lectins from the venom gland of Bungarus multicinctus. Toxicon, 50:411-419. 

LIRA-DA-SILVA, R.M.; NUNES, B.T. (1993) Ophidic accidents by Bothrops leucurus Wagler, 

1824 in Bahia, Brazil. Toxicon, 31:143-144. 

LIRA-DA-SILVA, R.M. (2009) Bothrops leucurus Wagler, 1824 (Serpentes; Viperidae): natural 

history, venom and envenomation. Gazeta Médica da Bahia, 79(1): 56-65. 

LOMONTE, B.; ROJAS, G.; GUTIÉRREZ, J.M.; RAMÍREZ, G. (1990) Isolation of a galactose-

binding lectin from the venom of the snake Bothrops godmani (Godmann´s pit viper). Toxicon, 

28:75-81 

LU, Q.; NAVDAEV, A.; CLEMETSON, J.M.; CLEMETSON, K.J. (2005) Snake venom C-type 

lectins interacting with platelet receptors. Structure-function relationships and effects on 

haemostasis. Toxicon, 45:1089-1098. 

LUO, Y.; XU, X.; LIU, X.; LI, J.; SUN, Y.; LIU, Z.; LIU, J.; VAN DAMME, E.; BALZARI, J.; 

BAO, J. (2007) A novel mannose-binding tuber lectin from Typhonium divaricatum (L.) Decne 

(family Araceae) with antiviral activity against HSV-II and antiproliferative effect on human 

cancer cell lines. Journal of Biochemistry and Molecular Biology, 40(3): 358-367. 

LUO, J.; SOLIMINI, N.L.; ELLEDGE, S.J. (2009) Principles of cancer therapy: Oncogene and 

non-oncogene addiction. Cell, 136(5): 823-837. 

MAGALHÃES, A.; MAGALHÃES, H.P.B.; RICHARDSON, M.; GONTIJO, S.; FERREIRA, 

R.N.; ALMEIDA, A.P.; SANCHEZ, E.F. (2007) Purification and properties of a coagulant 

thrombin-like enzyme from the venom of Bothrops leucurus. Comparative Biochemistry and 

Physiology Part A, 146:565-575. 

MANSOUR, M.H.; ABDUL-SALAM, F. (2009) Characterization of fucose-binding lectins in rock-

and mud-dwelling snails inhabiting Kuwait Bay. Immunobiology, 214(1): 77-85. 

MARTIM, S.J.; REUTELINGSPERGER, C.P.M.; MACGAHON, A.J.; RADER, J.A.; VAN 

SCHIE, R.C.A.A.; LAFACE, D.M.; GREEN, D.R. (1995) Early redistribution of plasma 

membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating 

stimulus: inhibition by overexpression of Bcl-2 and Abl. The Journal of Experimental 

Medicine, 182:1545-1556. 



34 

 

MASTRO, A.M.; HURLEY, D.J.; WINNING, R.K.; FILIPOWSKI, R.; OLGIVIE, M.L.; 

GARTNER, T.K. (1986) Mitogenic activity of snake venom lectins. Cell &amp;amp; Tissue Kinetics, 

19:557-566. 

MATLOW, A.G.; MORRIS, S.K. (2009) Control of antibiotic-resistant bacteria in the office and 

clinic. Canadian Medical Association Journal, 180(10): 1021-1024. 

MISE, Y.F.; LIRA-DA-SILVA, M.R.; CARVALHO, F.M. (2007) Envenomation by Bothrops in 

the state of Bahia: epidemiological and clinical aspects. Revista da Sociedade Brasileira de 

Medicina Tropical, 40(5): 569-573. 

MONTEIRO, R.Q.; ZINGALI, R.B. (2002) Bothrojaracin, a proexosite I ligand, inhibits factor Va-

accelerated prothrombin activation. Thrombosis and Haemostasis, 87:288-293. 

MOON, S.; SONG, K.B. (2001) Effect of ?-irradiation on the molecular properties of ovalbumin 

and ovomucoid and protection by ascorbic acid. Food Chemistry, 74:479-483.   

MORITA, T. (2004) C-type lectin-related proteins from snake venoms. Current Drug Targets, 

4(4): 357-373.  

MORITA, T. (2005) Structure-function relationships of C-type lectin-related proteins. 

Pathophysiology of Haemostasis and Thrombosis, 35:156-159.   

MOURA, M.R.; QUEIROZ, A.F.S.; FOOK, J.M.S.L.L.; DIAS, A.S.F.; MONTEIRO, N.K.V.; 

RIBEIRO, J.K.C.; MOURA, G.E.D.D.; MACEDO, L.L.P.; SANTOS, E.A.; SALES, M.P. 

(2006) CvL, a lectin from the marine sponge Cliona varians: isolation, characterization and its 

effects on pathogenic bacteria and Leishmania promastigotes. Comparative Biochemistry and 

Physiology Part A, 145:517-523. 

NAIR, D.G.; FRY, B.G.; ALEWOOD, P.; KUMAR, P.P. (2007) Antimicrobial activity of 

omwaprin, a new member of the waprin family of snake venom proteins. Biochemical 

Journal, 402:93-104.  

NAKAHARA, S.; OKA, N.; RAZ, A. (2005) On the role of galectin-3 in cancer apoptosis. 

Apoptosis, 10:267-275. 

NIKAI, T.; KATO, S.; KOMORI, Y.; SUGIHARA, H. (2000) Amino acid sequence and biological 

properties of the lectin from the venom of Trimeresurus okinavensis (himehabu). Toxicon, 

38:707-711. 



35 

 

OGAWA, T.; CHIJIWA, T.; ODA-UEDA, N.; OHNO, M. (2005) Molecular diversity and 

accelerated evolution of a C-type lectin-like proteins from snake venom. Toxicon, 45:1-14. 

OHKURA, M.; MYASHITA, Y.; NIKAI, T.; SUZUKI, J.; KOMORI, Y.; SUGIHARA, H.; 

OHIZUMI, Y. (1996) Properties of Ca++ release induced by puff adder lectin, a novel lectin 

from the snake Bitis arietans, in sarcoplasmic reticulum. The Journal of Pharmacology and 

Experimental Therapeutics, 277(2): 1043-1048. 

OLIVEIRA, J.T.A.; MELO, V.M.M.; CAMARA, M.F.L.; VASCONCELOS, I.M.; BELTRAMINI, 

L.M.; MACHADO, O.L.T.; GOMES, V.M.; PEREIRA, S.P.; FERNANDES, C.F.; NUNES, 

E.P.; CAPISTRANO, G.G.G.; MONTEIRO-MOREIRA, A.C.O. (2002) Purification and 

physicochemical characterization of a cotyledonary lectin from Luetzelburgia auriculata. 

Phytochemistry, 61:301-310. 

OTT, M.; GOGVADZE, V.; ORRENIUS, S.; ZHIVOTOVSKY, B. (2007) Mitochondria, oxidative 

stress and cell death. Apoptosis, 12(5): 913-922. 

OZEKI, Y.; MATSUI, T.; HAMAKO, J.; SUZUKI, M.; FUJIMURA, Y.; YOSHIDA, E.; 

NISHIDA, S.; TITANI, K. (1994) C-type galactoside-binding lectin from Bothrops jararaca 

venom: comparison of its structure and function with those of botrocetin. Archives of 

Biochemstry and Biophysics, 308:306-310. 

OZGEN, U.; SAVASAN, S.; BUCK, S.; RAVINDRANATH, Y. (2000) Comparison of 

DiOC(6)(3) uptake and annexin V labeling for quantifications of apoptosis in leukemia cells 

and non-malignant T lymphocytes from children. Cytometry, 42: 74-78. 

PAHARI, S.; BICKFORD, D.; FRY, B.G.; KINI, R.M. (2007) Expression pattern of three-finger 

toxin and phospholipase A2 genes in the venom glands of two sea snakes, Lapemis curtus and 

Acalyptophis peronii: comparison of evolution of these toxins in land snakes, sea kraits and sea 

snakes. BMC Evolutionary Biology, 7:175. 

PAIVA, P.M.; OLIVA, M.L.; FRITZ, H.; COELHO, L.C.; SAMPAIO, C.A. (2006) Purification 

and primary structure determination of two Bowman-Birk type trypsin isoinhibitors from 

Cratylia mollis seeds. Phytochemistry, 67(6): 545-552.   

PANUNTO, P.C.; SILVA, M.A.; LINARDI, A.; BUZIN, M.P.; MELO, S.E.S.F.C.; MELLO, S.M.; 

PRADO-FRANCESCHI, J.; HYSLOP, S. (2006) Biological activities of a lectin from Bothrops 

jararacussu snake venom. Toxicon, 47:21-31. 



36 

 

PEREIRA-BITTENCOURT, M.; CARVALHO, D.D.; GAGLIARDI, A.R.; COLLINS, D.C. (1999) 

The effect of a lectin from the venom of the snake, Bothrops jararacussu, on tumor cell 

proliferation. Anticancer Research, 19:4023-4026. 

PEUMANS, W.J.; VAN DAMME, E.J. (1995) Lectins as plant defense proteins. Plant Physiology, 

109(2): 347-352. 

PEUMANS, W.J.; VAN DAMME, E.J. (1998) Plant lectins: specific tools for the identification, 

isolation, and characterization of O-linked glycans. Critical Reviews in Biochemistry and 

Molecular Biology, 33(3): 209-258. 

PEUMANS, W.J.; VAN DAMME, E.J.; BARRE, A.; ROUGE, P. (2001) Classification of plant 

lectins in families of structurally and evolutionary related proteins. Advances in Experimental 

Medicine and Biology, 491:27-54. 

POHLEVEN, J.; OBERMAJER, N.; SABOTIC, J.; ANZLOVAR, S.; SEPCIC, K.; KOS, J.; 

KRALJ, B.; STRUKELJ, B.; BRZIN, J. (2009) Purification, characterization and cloning of a 

ricin B-like lectin from mushroom Clitocybe nebularis with antiproliferative activity against 

human leukemic T cells. Biochimica et Biophysical Acta, 1790(3): 173-181.  

PORTER, A.G.; JANICKE, R.U. (1999) Emerging roles of caspase-3 in apoptosis. Cell Death &amp;amp; 

Differentiation, 6(2): 99-104. 

PRIANTI JR, A.C.G.; RIBEIRO, W.; LOPES-MARTINS, R.A.B.; LIRA-DA-SILVA, R.J.; 

PRADO-FRANCESCHI, J.; RODRIGUES-SIMIONI, L.; CRUZ-HOFLING, M.A.C.; LEITE, 

G.B.; HYSLOP, S.; COGO, J.C. (2003) Effect of Bothrops leucurus venom in chick biventer 

cervicis preparations. Toxicon, 41:595-603. 

RÁDIS-BAPTISTA, G.; MORENO, F.B.M.B.; NOGUEIRA, L.L.; MARTINS, A.M.C.; 

TOYAMA, D.O.; CAVADA, B.S.; AZEVEDO, W.F.; YAMANE, T. (2006) Crotacetin, a 

novel snake venom C-type lectin homolog of convulxin, exhibits na unpredictable 

antimicrobial activity. Cell Biochemistry and Biophysics, 44:412-423. 

RAGHUNATH, D. (2008) Emerging antibiotic resistance in bacteria with special reference to 

India. Journal Bioscience, 33(4): 593-603. 

REDDY, L.; ODHAV, B.; BHOOLA, K.D. (2003) Natural products for cancer prevention: a global 

perspective. Pharmacology &amp;amp; Therapeutics, 99:1-13. 



37 

 

REED, J.C. (2006) Proapoptotic multidomain Bcl-2/Bax family proteins: mechanisms physiological 

roles, and therapeutic opportunities. Cell Death &amp;amp; Differentiation, 13(8): 1378-1386. 

REYES-ZURITA, F.J.; RUFINO-PALOMARES, E.E.; LIPIÁÑEZ, J.A.; CASCANTE, M. (2009) 

Maslinic acid, a natural triterpene from Olea europaea L., induces apoptosis in HT29 human 

colon-cancer cells via the mitocondrial apoptotic pathway. Cancer Letters, 273:44-54. 

REYNOSO-CAMACHO, R.; DE MEJIA, G.E.; LOARCA-PINA, G. (2003) Purification and acute 

toxicity of a lectin extracted from tepary bean (Phaseolus acutifolius). Food and Chemical 

Toxicity, 41:21-27. 

RICCI, M.S.; ZONG, W.X. (2006) Chemotherapic approaches for targeting cell death pathway. 

Oncology, 11:342-347. 

ROJO, M.A.; CITORES, L.; JIMENEZ, P.; FERRERAS, J.M.; ARIAS, F.J.; MENDEZ, E.; 

GIRBES, T. (2003) Isolation and characterization of a new d-galactose-binding lectin from 

Sambucus racemosa L. Protein Peptide Letters, 10:287-293. 

SÁ, R.A.; NAPOLEÃO, T.H.; SANTOS, N.D.L.; GOMES, F.S.; ALBUQUERQUE, A.C.; 

XAVIER, H.S.; COELHO, L.C.B.B.; BIBIER, L.W.; PAIVA, P.M.G. (2008) Induction of 

mortality on Nasutitermes corniger (Isoptera, Termitidae) by Myracrodruon urundeuva 

heartwood lectin. International Biodeterioration Biodegradation, 62(4): 460-464. 

SAAD-HOSSNE, R.; SAAD-HOSSNE, W.; PRADO, R.G. (2004) Efeito de soluções aquosas de 

fenol, ácido acético e glicerina sobre o tumor ascítico de Erlich. Estudo experimental in vitro. 

Acta Cirúrgica Brasileira, 19(1): 56-58.  

SAMPAIO, S.C.; HYSLOP, S.; FONTES, M.R.M.; PRADO-FRANCESCHI, J.; ZAMBELLI, 

V.O.; MAGRO, A.J.; BRIGATTE, P.; GUTIERREZ, V.P.; CURY, Y. (2010) Crotoxin: novel 

activities for a classic ?-neurotoxin. Toxicon, 55:1045-1060. 

SANCHEZ, E.F.; FREITAS, T.V.; FERREIRA-ALVES, D.L.; VELARDE, D.T.; DINIZ, M.R.; 

CORDEITO, M.N.; AGOSTINI-COTTA, G.; DINIZ, C.R. (1992) Biological activities of 

venoms from South American snakes. Toxicon, 30:95-103. 

SANCHEZ, E.F.; GABRIEL, L.M.; GONTIJO, S.; GREMSKI, L.H.; VEIGA, S.S.; 

EVANGELISTA, K.S.; EBLE, J.A.; RICHARDSON, M. (2007) Structural and functional 



38 

 

characterization of a P-III metalloproteinase lecurolysin-B, from Bothrops leucurus venom. 

Archives of Biochemistry and Biophysics, 408:193-304. 

SANTANA, M.A.; SANTOS, A.M.C.; OLIVEIRA, M.E.; OLIVEIRA, J.S.; BABA, E.H.; 

SANTORO, M.M.; ANDRADE, M.H.G. (2008) A novel and efficient and low-cost 

methodology for purification of Macrotyloma axillare (Leguminosae) seed lectin. 

International Journal of Biological Macromolecules, 43:352-358.  

SANTOS, A.F.S.; LUZ, L.A.; ARGOLO, A.C.C.; TEIXEIRA, J.A.; PAIVA, P.M.G.; COELHO, 

L.C.B.B. (2009) Isolation of a seed coagulant Moringa oleifera lectin. Process Biochemistry, 

44:504-508. 

SARRAY, S; VIRGINIE, B.; CALVETE, J.J.; SECCHI, J.; MARVALDI, J.; EL AYEB, M.; 

MARRAKCHI, N.; LUIS, J. (2004) Lebectin, a novel C-type lectin from Macrovipera lebetina 

venom, inhibits integrin-mediated adhesion, migration and invasion of human tumour cells. 

Laboratory Investigation, 84: 273-581.  

SARRAY, S.; SRAIRI, N.; LUIS, J.; MARVALDI, J.; EL AYEB, M.; MARRAKCHI, N. (2001) 

Lebecetin, a C-lectin protein from the venom of Macrovipera lebetina that inhibits platelet 

aggregation and adhesion of cancerous cells. Haemostasis, 31:173-176. 

SARRAY, S.; DELAMARRE, E.; MARVALDI, J.; EL AYEB, M.; MARRAKCHI, N.; LUIS, J. 

(2007) Lebectin and lebecetin, two C-type lectins from snake venom, inhibit ?5?1 and ?v-

containing integrins. Matrix Biology, 26(4): 306-313.  

SARRAY, S.; SIRET, C.; LEHMANN, M.; MARRAKCHI, N.; LUIS, J.; EL AYEB, M.; ANDRÉ, 

F. (2009) Lebectin increases N-cadherin-mediated adhesion throught PI3K/AKT pathway. 

Cancer Letters, 285(2): 174-181. 

SCHAFFER, C.; MESSNER, P. (2005) The structure of a secondary cell wall polymers: how gram-

positive bacteria stick their cell walls together. Microbiology, 151:643-651. 

SEO, J.H.; KIM, J.H.; LEE, J.W.; YOO, Y.C.; KIM, M.R.; PARK, K.S.; BYUN, M.W. (2007) 

Ovoalbumin modified by gamma irradiation alters its immunological functions and allergic 

responses. International Immunopharmacology, 7:464-472. 

SHACTER, E. Q. (2000) Quantification and significance of protein oxidation in biological samples. 

Drug Metabolism Reviews, 32:307-326. 



39 

 

SHARON, N.; LIS, H. (2002) How Proteins bind carbohydrates: lessons from legume lectins. 

Journal of Agricutural and Food Chemistry, 50:6586-6591. 

SHARON, N. (2007) Lectins: carbohydrate-specific reagents and biological recognition molecules. 

The Journal of Biological Chemistry, 285(5): 2753-2764. 

SHARON, N.; LIS, H. (2004) History of lectins: from hemagglutinins to biological recognition 

molecules. Glycobiology, 14:53-62. 

SHARON, E.; SHARON, N.; BEN-TAL, N. (2003) Evolutionary analysis reveals collective 

properties and specificity in the C-type lectin and lectin-like domain superfamily. Structure, 

Function and Genetics, 52:44-55.  

SHAWRANG, P.; NIKKHAH, A.; ZARE-SHAHNEH, A.; SADEGHI, G.; RAISALI, A.A.; 

MORADI-SHAHREBABAK, M. (2008) Effects of gamma irradiation on chemical 

composition and ruminal protein degradation of canola meal. Radiation Physics and 

Chemistry, 77: 918-922. 

SHIVIK, J.A. (2006) Are vultures birds and to snakes have venom, because of macro-and 

microscavenger conflict? Bioscience, 56:819-823. 

SILVA, E.F.; RICHARDSON, M.; GOMES, M.V.; SANCHEZ, E.F. (2007) Biochemical 

properties of a L-amino acid oxidase from Bothrops leucurus (white-tailed-jararaca) snake 

venom. Comparative Biochemistry and Physioloy Part A, 148:S103-S108. 

SILVA JR.; ALEXANDRE, G.M.C.; RAMOS, C.H.I.; DE-SIMONE, S.G. (2008) On the 

quaternary structure of a C-type lectin from Bothrops jararacussu venom – BJ-32 (BJcuL). 

Toxicon, 52:944-953. 

SILVA, M.D.C.; SÁ, R.A.; NAPOLEÃO, T.H.; GOMES, F.S.; SANTOS, N.D.L.; 

ALBUQUERQUE, A.C.; XAVIER, H.S.; PAIVA, P.M.G.; CORREIA, M.T.S.; COELHO, 

L.C.B.B. (2009) Purified Cladonia verticillaris lichen lectin: insecticidal activity on 

Nasutitermes corniger (Isoptera: Termitidae). International Biodeterioration &amp;amp; 

Biodegradation, 63(3): 334-340. 

SINGH, R.S.; BHARI, R.; TIWARY, A.K. (2010) Optimization of culture conditions, partial 

purification and characterization of a new lectin from Aspergillus nidulans. Romanian 

Biotecnology Letters, 15(1): 4990-4999. 



40 

 

SOBRAL, A.P.V.; REGO, M.J.B.M.; CAVALCANTI, C.L.B.; CARVALHO-JR, L.B.; BELTRÃO, 

E.I.C. (2010) ConA and UEA-I lectin histochemistry of parotid gland mucoepidermoid 

carcinoma. Journal of Oral Science, 52(1): 49-54, 2010. 

SOUZA, F.A.D.; SPENCER, P.J.; ROGERO, J.R.; NASCIMENTO, N.; DAL PAI-SILVA, M.; 

GALLACI, M. (2002) 60Co gamma irradiation prevents Bothrops jararacussu venom 

neurotoxicity and myotoxicity in isolated mouse neuromuscular junction. Toxicon, 40:1101-

1106.     

SPELLBERG, B.; GUIDOS, R.; GILBERT, D.; BRADLEY, J.; BOUCHER, H.W.; SCHELD, 

W.M.; BARTLETT, J.G.; JR, J.E. (2008) The epidemic of antibiotic-resitant infections: a call 

to action for the medical community form the infectious diseases society of America. Clinical 

Infectious Diseases, 46(2): 155-164.   

STRYER, LUBERT. Bioquímica. 5a ed. Rio de Janeiro: Guanabara Koogan, 2004, 999p. 

SUN, J.; WANG, L.; GUO, Z.; LIU, M.; JIANG, K.; TAO, R.; ZHANG, G. (2008) Purification and 

characterization of a natural lectin from the plasma of the shrimp Fenneropenaeus chinensis. 

Fish &amp;amp; Shellfish Imunnology, 25:290-297. 

SUZUKI-INOUE, K.; FULLER, G.I.; GARCIA, A.; EBLE, J.A.; POHLMANN, S.; INOUE, O.; 

GARTNER, T.K.; HUGHAN, S.C.; PEARCE, A.C.; LAING, G.D.; THEAKSTON, R.D.; 

SCHWEIGHOFFER, E.; ZITZMANN, N.; MORITA, T.; TYBULEWICZ, V.I.; OZAKI, Y.; 

WATSON, S.P. (2006)  A novel Syk-dependent mechanism of platelet activation by the C-type 

lectin receptor CLEC-2. Blood, 107:542-549. 

TALAN, D.A.; CITRON, D.M.; OVERTURF, G.D.; SINGER, B.; FROMAN, P.; GOLDSTEIN, 

E.J. (1991) Antibacterial activity of crotalid venoms against oral snake flora and other clinical 

bacteria. Journal of Infections Diseases, 164:195-198. 

TATENO, H.; OGAWA, T.; MURAMOTO, K.; KAMIYA, H.; SANEYOSHI, M. (2002) 

Rhamnose-binding lectins from Steelhead trout (Oncorhynchus mykiss) eggs recognize 

bacterial lipopolysaccarides and lipoteichoic acid. Bioscience Biotechnology and 

Biochemistry, 66(3): 604-612. 

TRABI, M.; SCHIRRA, H.J.; CRAIK, D.J. (2001) Three-dimensional structure of RTD-1, a cyclic 

antimicrobial defensin from Rhesus macaque leukocytes. Biochemistry, 40:4211-4221. 



41 

 

TENOVER, F.C. (2006) Mechanisms of antimicrobial resistance in bacteria. The American 

Journal of Medicine, 119(6): 53-510. 

TINARI, A.; GIAMMARIOLI, A.M.; MANGANELLI, V.; CIARLO, L.; MARLONI, W. (2008) 

Analyzing morphological and ultraestructural features in cell death. Methods Enzimology, 

442:1-26.   

VAREJÃO, N.; ALMEIDA, S.M.; CICCO, N.N.T.; ATELLA, G.C.; COELHO, L.C.B.B.; 

CORREIA, M.T.S.; FOGUEL, D. (2010) Heterologous expression and purification of a 

biologically active legume lectin from Cratylia mollis seeds (CRAMOLL 1). Biochimica et 

Biophysica Acta, 1804(9): 1971-1924. 

VAZ, A.F.M.; COSTA, R.M.P.B.; MELO, A.M.M.A.; OLIVA, M.L.V.; SANTANA, L.A.; 

SILVA-LUCCA, R.A.; COELHO, L.C.B.B.; CORREIA, M.T.S. (2010) Biocontrol of 

Fusarium species by a novel lectin with low ecotoxicity isolated from Sebastiana jacobinenses. 

Food Chemistry, 119(4): 1507-1513. 

VERMES, I.; HAANEN, C.; STEFFENS-NAKKEN, H.; REUTELINGSPERGER, C. (1995) A 

novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early 

apoptotic cells using fluorescein labeled annexin V. Journal Imunnology Methods, 184:39-

51. 

WALKER, J.R.; NAGAR, B.; YOUNG, N.M.; HIRAMA, T.; RINI, J.M. (2004) X-ray crystal 

structure of a galactose-specific C-type lectin possessing a novel decameric quaternary 

structure. Biochemistry, 43:3783-3792. 

WANG, W.J. (2008) Agglucetin, a tetrameric C-type lectin-like venom protein regulates 

endhotelial cell survival and promotes angiogenesis by activating integrin ?v?3 signaling. 

Biochemical and Biophysical Research Communications, 369:753-760. 

WANG, Y.; HING, J.; LIU, X.; YANG, H.; LIU, R.; WU, J.; WANG, A.; LIN, D.; LAI, R. (2008) 

Snake cathelicidin from Bungarus fasciatus is a potent peptide antibiotics. PLoS ONE, 

3:e3217. 

WANG, N.; WHANG, I.; LEE, J. (2008) A novel C-type lectin from abalone, Haliotis discus 

discus, agglutinates Vibrio alginolyticus. Developmental and Comparative Immunology, 

32:1034-1040.  



42 

 

WEI, Q.; LU, Q.M.; JIN, Y.; LI, R.; WEI, J.F.; WANG, W.Y.; XIONG, Y.L. (2002) Purification 

and cloning of a novel C-type lectin-like protein with platelet aggregation activity from 

Trimeresurus mucrosquamatus venom. Toxicon, 40:1331-1338. 

WEIS, W.; DRICKAMER, K. (1996) Structural basis of lectin-carbohydrate recognition. Annual 

Review of Biochemistry, 65:441-473. 

WONG, J.H.; NG, T.B. (2003) Purification of a trypsin-stable with antiproliferative and HIV-1 

reverse transcriptase inhibitory activity. Biochemical and Biophysical Research 

Communications, 301:545-550. 

WORLD HEALTH ORGANIZATION. Policies and managerial guidelines for national cancer 

control programs. Geneva: WHO, 2002, 366-370p. 

WORLD HEALTH ORGANIZATION. Global strategy for containment of antimicrobial resistance. 

Geneva: WHO, 2007, 105p. 

XU, Q.; WU, X.F.; XIA, Q.C.; WANG, K.Y. (1999) Cloning of a galactose-binding lectin from the 

venom of Trimeresurus stejnegeri. Biochemical Journal, 341:733-737.  

XU, G.; TENG, M.; NIU, L.; LIU, P.; DONG, Y.; LIU, Q.; HUANG, Q.; HAO, Q. (2004) 

Purification, characterization, crystallization and preliminary X-ray crystallographic analysis of 

two novel C-type lectin-like proteins: AaII and AaII-B from Deinagkistrodon acutus venom. 

Biological Crystallography, 60:2035-2037. 

XU, W.T.; WANG, X.W.; ZHANG, ZHAO, X.F.; YU, X.Q.; WANG, J.X. (2010) A new C-type 

lectin (FcLec5) from the Chinese white shrimp Fenneropenaeus chinensis. Amino Acids, 

39(5): 1227-1239. 

YAN, Q.; ZHU, L.; KUMAR, M.; JIANG, Z.; HUANG, L. (2010) Characterization of a novel 

monomeric lectin (AML) from Astragalus membranaceus with anti-proliferative activity. Food 

Chemistry, 122(3): 589-595. 

YAO, Q.; WU, C.F.; LUO, P.; XIANG, X.C.; LIU, J.J.; MOU, L.; BAO, J.K. (2010) A new chitin-

binding lectin from rizhome of Setcreasea purpurea with antifungal, antiviral and apoptosis-

inducing activities. Process Biochemistry, 45(9): 1477-1485. 



43 

 

YE, X.Y.; NG, T.B. (2002) Isolation of a new cyclophilin-like protein from chickpeas with 

mitogenic, antifungal and anti-HIV-1 reverse transcriptase activities. Life Science, 70:1129-

1138. 

ZANG, J.; TENG, M.; NIU, L. (2003) Purification, crystallization and preliminary crystallographic 

analysis of AHP IX-bp, a zinc ion and pH-dependent coagulation factor IX binding protein 

from Agkistrodon halys pallas venom. Acta Crystallographic D, 59:730-733. 

ZBIKOWSKA, H.M.; NOWAK, P.; WACHOWICZ, B. (2006) Protein modification caused by a 

high of gamma irradiation in cryo-sterilized plasma: protective effects of ascorbate. Free 

Radical Biology &amp;amp; Medicine, 40:536-542. 

ZELENSKY, A.N.; GREADY, J.E. (2005) The C-type lectin-like domain superfamily. FESB 

Journal, 272:6179-6217. 

ZHANG, Z.T.; PENG, H.; LI, C.Y.; LIU, J.J.; ZHOU, T.T.; YAN, Y.F.; LI, Y.; BAO, J.K. (2010) 

Polygonatum cyrtonema lectin induces murine fibrosarcoma L929 cell apoptosis via caspase-

dependent pathway as compared to Ophionpogon japonicus lectin. Phytomedicine, 18:25-31.  

ZHAO, Q.; CAO, X.;WANG, C.; YAN, L.; XU,C. (2010) Musca domestica larva lectin induces 

apoptosis in BEL-740 through a mitochondria-mediated reactive oxygen species. Biological &amp;amp; 

Pharmaceutical Bulletin, 33(8): 1274-1278. 

ZHENG, P.; WANG, H.; ZHAO, J.; SONG, L.; QIU, L.; DONG, C.; WANG, B.; GAI, Y.; MU, C.; 

LI, C.; NI, D.; XING, K. (2008) A lectin (CfLEC-2) aggregating Staphylococcus haemolyticus 

from scallop Chlamys farreri. Fish &amp;amp; Shelfish Immunology, 24:286-293. 

ZIEGLER, U.; GROSCRURTH, P. (2004) Morphological features of cell death. News Physiology 

Science, 12:124-128. 

ZORNING, M.; HUEBER, A.; BAUM, W.; EVAN, G. (2001) Apoptosis regulators and their role 

in tumorigenesis. Biochimica et Biophysical Acta, 1551:1-37. 

 

 

 

 



44 

 

5 ARTIGO CIENTÍFICO I 

 

 

 

 

 

 

Purification of a lectin with antibacterial activity from Bothrops leucurus snake 
venom 

 

 

Artigo submetido ao periódico Comparative Biochemistry and Physiology - Part B: 

Biochemistry &amp;amp; Molecular Biology 

 

 

 

 

 

 

 

 

 

 



45 

 

Erika dos Santos Nunesa,*, Mary Angela Aranda de Souzaa, Antônio Fernando de Melo Vaza, 

Giselly Maria de Sá Santanaa, Francis Soares Gomesa, Luana Cassandra Breitenbach Barroso 

Coelhoa, Patrícia Maria Guedes Paivaa, Rejane Maria Lira da Silvab, Rosemeire Aparecida Silva-

Luccac,e, Maria Luiza Vilela Olivac, Miriam Camargo Guarnierid, Maria Tereza dos Santos Correiaa 

  
a
Departamento de Bioquímica, Universidade Federal de Pernambuco, Avenida Professor Moraes 

Rêgo, s/n, Cidade Universitária, 50670-420, Recife, Pernambuco, Brazil 

b
Departamento de Zoologia, Universidade Federal da Bahia, Rua Barão de Geremoabo, s/n, 

Campus de Ondina, 40170-210, Salvador, Bahia, Brazil.  

c
Departamento de Bioquímica, Universidade Federal de São Paulo, Rua Três de Maio, 100, Vila 

Clementino, 04044-020, São Paulo, Brazil.
 

d
Departamento de Zoologia, Universidade Federal de Pernambuco, Avenida Professor Moraes 

Rêgo, s/n, Cidade Universitária, 50670-420, Recife, Pernambuco, Brazil. 

e
Centro de Engenharias e Ciências Exatas, Universidade Estadual do Oeste do Paraná, Rua da 

Faculdade, 645, Jardim La Salle, 85903-000, Toledo, Paraná, Brazil. 

 

*Corresponding author. Phone: +558121268540; Fax: +558121268576  

E-mail address: erika.santosnunes@hotmail.com  

 

ABSTRACT  

A novel lectin was isolated from Bothrops leucurus snake venom using a combination of affinity 

and gel filtration chromatographies. The lectin (BlL) agglutinated glutaraldehyde-treated rabbit and 

human erythrocytes with preference for rabbit erythrocytes. Galactose, raffinose, lactose, fetal 

bovine serum and casein inhibited lectin-induced rabbit erythrocyte agglutination. BlL, with a 

molecular mass of 30 kDa and composed of two subunits of 15 kDa, showed dependence on 

calcium. BlL is an acidic protein with highest activity over the pH range of 4.0-7.0 and stable under 

heating to 70 °C. Fluorescence emission spectra showed tryptophan residues partially buried within 

the lectin structure. The percentages of secondary structure revealed by circular dichroism were 1% 

?-helix, 44% ?-sheet, 24% ?-turn and 31% unordered. BlL showed effective antibacterial activity 



46 

 

against Gram-positive bacteria Staphylococcus aureus, Enterococcus faecalis and Bacillus subtilis 

with minimal inhibitory concentrations of 31.25, 62.25 and 125 µ g/mL, respectively. In conclusion, 

B. leucurus snake venom contains a galactoside-binding lectin with antibacterial activity.  

 

Keywords: antibacterial activity; fluorescence; circular dichroism; Bothrops leucurus; lectin; snake 

venom. 

 

1. Introduction 

 Lectins are proteins or glycoproteins that bind reversibly to carbohydrates and 

glycoconjugates (De-Simone et al., 2006). Lectins have been found in a wide range of organisms 

from microorganisms to plants and animals (Utarabhand et al., 2007). C-type lectins are a large 

family of Ca2+ dependent lectins. Animal C-type lectins can be classified into 17 groups according 

to structural and functional characteristics (Zelensky and Gready, 2005). Snake venoms contain C-

type lectins included in group VII, which are true sugar-binding lectins composed by homodimers 

or homooligomers and with Ca2+ and generally galactose binding properties (Clemetson, 2010). 

Snake venoms also contain C-type lectin-like proteins which are heterodimers or oligomeric 

complexes of heterodimers called snaclecs (snake venom C-type lectins); this group is more 

abundant and possesses a loop-swapping or higher order multimerization (Ogawa et al., 2005; 

Clemetson et al., 2009; Clemetson, 2010).  Snake venom lectins are able to inhibit or activate 

specific platelet membrane receptors and blood coagulation factors (Morita, 2004, 2005; Ogawa et 

al., 2005; Wang, 2008) and can promote a diversity of biological effects, such as lymphocyte 

proliferation (Mastro et al., 1986), induction of edema (Lomonte et al., 1990; Panunto et al., 2006), 

induction of Ca2+ release from the sarcoplasmic reticulum (Ohkura et al., 1996), inhibition of cancer 

cell proliferation (Pereira-Bittencourt et al., 1999), erythrocyte agglutination in vitro (Kassab et al., 

2001), cytotoxicity to tumors and endothelial cell lines (Carvalho et al., 2001), renal effects (Havt et 

al., 2005) and induction of rolling of leukocytes (Elífio-Esposito et al., 2007).  

Glycoconjugates present on bacterial cell surfaces, such as peptidoglycans, 

lipopolysaccharides and teichoic acids, constitute potential lectin targets (Lee et al., 1998; Santi-

Gadelha et al., 2006). Recently, it was reported that snake venom lectins are able to inhibit growth 

of phytopathogenic bacteria (Rádis-Baptista et al., 2006; Barbosa et al., 2010); however, the 

interactions between snake venom lectins and human pathogenic bacteria have not been studied. 

Bothrops leucurus (white-tailed-jararaca) is an important venomous snake that inhabits 

northeastern Brazil. B. leucurus was responsible for all cases of envenoming after snakebite 



47 

 

recorded in the metropolitan region of Salvador (State of Bahia, northeastern Brazil) from January 

to June 1990 (Lira-da-Silva and Nunes, 1993) and an epidemiological study in Bahia in 2001 

revealed that this species was responsible for all confirmed cases of envenoming by Bothrops 

species in this state (Mise et al., 2007). Recently, active components from B. leucurus venom were 

isolated, including a fibrinolytic proteinase (Bello et al., 2006), a thrombin-like enzyme (Magalhães 

et al., 2007), phospholipase A2 (Higuchi et al., 2007), a P-III metalloproteinase (Sanchez et al., 

2007), L-amino acid oxidases (Silva et al., 2007; Torres et al., 2010) as well as the 

metalloproteinases leucurolysin-a (Gremski et al., 2007; Ferreira et al., 2009) and BleucMP (Gomes 

et al., 2011). 

This paper reports the purification, characterization and antibacterial activity of a novel 

galactoside-binding lectin isolated from snake venom of B. leucurus, a species with great medical 

importance in northeastern Brazil. 

 

2. Material and Methods 

 

2.1. Chemicals 

Reference samples of 4.4'-Bis 1-anilinonaphthalene 8-sulfonate (bis-ANS) were purchased 

from Molecular Probes Inc., USA. Broad-range protein molecular mass markers, sugars and 

glycoproteins were purchased from Sigma-Aldrich (USA). All the solvents and other chemicals 

used were of analytical grade from Sigma-Aldrich (USA) or Merck (Germany). All solutions were 

prepared with water purified by the Milli-Q® system (Millipore). 

 

2.2. B. leucurus venom 

B. leucurus venom was kindly supplied by the Núcleo Regional de Ofiologia e Animais 

Peçonhentos da Bahia, Universidade Federal da Bahia, Salvador, Bahia, Brazil. 

 

 

 



48 

 

2.3. Protein content  and  neutral carbohydrate analysis  

Protein concentration was determined according to Bradford (1976) using bovine serum 

albumin as a standard. Neutral carbohydrate content was determined by the phenol-sulphuric acid 

method (Dubois et al., 1956) using a mannose as a standard. 

 

2.4. Hemagglutinating activity and carbohydrate specificity 

Hemagglutinating activity (HA) was assessed in microtiter plates according to Correia and 

Coelho (1995) using rabbit and human A, B, AB and O-type erythrocyte suspensions (2.5% v/v; 50 

µ L) treated with glutaraldehyde (Bing et al., 1967). HA was defined as the lowest lectin 

concentration able to promote erythrocyte agglutination. Specific hemagglutinating activity (SHA) 

corresponded to the ratio between HA and protein concentration (mg). Carbohydrate binding 

specificity was evaluated by determining HA in the presence of sugars (D-galactose, D-glucose, D-

fructose, D-lactose, D-mannose, methyl-?-D-glucopyranoside, D-arabinose, L-rhamnose methyl-?-

D-mannopyranoside, N-acetyl-D-glucosamine, D-xylose and L-raffinose) and glycoproteins 

(asialofetuin, casein, fetuin and fetal bovine serum). 

 

2.5. Purification of B. leucurus venom lectin 

Lyophilized B. leucurus venom (30 mg) was dissolved in 1 mL of calcium-Tris-buffered 

saline buffer (CTBS; 20 mM Tris-HCl, 150 mM NaCl and 5 mM CaCl2, pH 7.5) and centrifuged 

(2000 g, 5 min, 25°C) to remove insoluble material. The resulting supernatant was applied to a 

column (10 x 1.0 cm) of guar gel previously equilibrated with CTBS at a flow rate of 10 mL/h. 

Protein elution was monitored by absorbance at 280 nm. After washing to remove unbound 

proteins, the adsorbed proteins were eluted from the column with 200 mM galactose in CTBS. 

Adsorbed fractions with HA were pooled, dialyzed, lyophilized and applied to a Superdex 75 HR 

10/300 GL column coupled to an ÄKTATM purifier system (GE Pharmacia). The column was 

equilibrated and eluted with 50 mM Tris–HCl buffer (pH 8.0) containing 150 mM NaCl at a flow 

rate of 0.5 mL/min; fractions of 1 mL were collected and protein elution was monitored by 

absorbance at 280 nm. Subsequently, active peak from Superdex 75 chromatography (B. leucurus 

lectin; BlL) was submitted to reverse-phase chromatography in a C-4 column (Vydac-Protein 

Peptide Ultrasphere) performed on an HPLC system (Shimadzu LC-10AD-Tokyo, Japan), with 

elution monitored at 280 nm. The column was equilibrated with 0.1% TFA (solvent A) and eluted 



49 

 

using 90% acetonitrile/10% H2O/0.1% TFA (solvent B) in a non-linear gradient, where B = 0% at t 

= 5 min, 45% at t = 10 min, 50% at t = 30 min and 100% at t = 35 min.  

 

2.6. Effects of divalent ions, pH and temperature on HA 

To evaluate the effect of divalent cations on BlL-induced HA, the lectin was previously 

dialyzed against 5 mM EDTA (16 h at 4°C) followed by 150 mM NaCl (6 h at 4°C) to eliminate 

EDTA. Subsequently, the HA of dialyzed BlL was evaluated in the presence of 50, 100 and 200 

mM Ca2+, Mn2+ or Mg2+ in 150 mM NaCl. The effects of pH and temperature on HA were evaluated 

by incubating (45 min at 25°C) of BlL in selected buffers (10 mM citrate phosphate, pH 4.0-6.0; 10 

mM sodium phosphate, pH 7.0; 10 mM Tris-HCl, pH 8.0-9.0) or after heating (30 min) at 30, 40, 

50, 60, 70, 80, 90 and 100°C. 

 

2.7. Polyacrylamide gel electrophoresis (PAGE) 

BlL was evaluated by native PAGE for basic [15% (w/v) gel] or acidic [15% (w/v) gel] 

proteins according to Reisfeld et al. (1962) and Davis (1964), respectively. Electrophoresis in the 

presence of SDS and ?-mercaptoethanol was performed on 15% (w/v) gel according to Laemmli 

(1970). Polypeptide bands were stained with Coomassie Brilliant Blue in 10% acetic acid (0.02%, 

v/v). Glycoprotein staining was performed using the periodic acid-Schiff method (Zacharius et al., 

1969). 

 

2.8. Analysis of polypeptide chains 

Polypeptide chain analyses were performed after reduction of disulfide bridges and 

alkylation. Lyophilized samples were reduced by the Friedman reaction  (Friedman et al., 1970) 

with some modifications: BlL (0.5 mg) was dissolved in 250 µ L of a solution containing 50 mM 

Tris–HCl, pH 8.6, 6 M urea, 10 mM EDTA and 179 mM DTT; the mixture was incubated for 3 h at 

37°C in the dark before N2 purging. Free sulphydryl groups were then exposed to 100 µ L of 

iodoacetate and the reaction continued for another 2 h under the same initial conditions. Iodoacetate 

derivative chains were desalted and separated by HPLC on a reverse-phase C4 column with the 

elution profile monitored at 280 nm.  



50 

 

2.9. Fluorescence spectroscopy  

Intrinsic fluorescence emission of BlL in solution (0.07 mg/mL in 10 mM phosphate buffer 

pH 7.0) was measured at 25°C using a spectrofluorimeter (JASCO FP-6300, Tokyo, Japan) and a 

cuvette (1-cm pathlength rectangular quartz). The excitation wavelengths were 280 and 295 nm; 

emission spectra were recorded at a range of 305 to 450 nm with band passes of 5 nm.  

 

2.10. Circular dichroism (CD) measurements 

CD measurements were carried out on a J-810 JASCO spectropolarimeter. The instrument 

was calibrated with D-10-camphorsulfonic acid. The measurement was carried out at 25°C with a 

protein concentration of a 0.250 mg/mL (8 µ M) in a 1 mm pathlength cuvette. C spectrum was 

recorded at the 191-250 nm range as an average of eight scans. The results were expressed as the 

mean residue ellipticity, [?], defined as [?]= ?obs/(10.C.l.n.), where ?obs is the CD in millidegrees, C 

is the protein concentration (M), l is the pathlength of the cuvette (cm) and n is the number of amino 

acid residues assuming a mean number of 272 residues. The CDPro software was used to estimate 

the fractions of secondary structures (Sreerama and Woody, 2000) and the Cluster program was 

used to determine tertiary structure class of BlL (Sreerama et. al., 2001).  

 

2.11. Antibacterial activity   

Gram-positive (Bacillus subtilis ATCC-6633, Staphylococcus aureus ATCC-6538 and 

Enterococcus faecalis ATCC-6057) and Gram-negative (Escherichia coli ATCC-25922 and 

Klebsiella pneumoniae ATCC-29665) bacterial strains were provided by the Departamento de 

Antibióticos, Universidade Federal de Pernambuco, Brazil. Stationary cultures were maintained in 

nutrient agar and stored at 4°C.  

Bacteria were cultured in nutrient broth and incubated under continuous shaking at 37°C 

overnight. The culture concentrations were turbidimetrically adjusted at 600 nm to 105–106 colony 

forming units (CFU)/mL. Purified lectin (BlL) was diluted (1:2048) in a microtiter plate containing 

nutrient broth (50 µ L per well). Subsequently, 20 µ L of bacterial suspension was applied in each 

well and the plate was incubated at 37°C for 24 h. After incubation, the optical density at 490 nm 

(OD490) was measured using a spectrophotometer for microplates. The assays were performed in 

triplicate. The minimal inhibitory concentration (MIC) corresponded to the lowest lectin 



51 

 

concentration able to inhibit the growth of 50% or more of microorganisms relative to the negative 

control (Amsterdam, 1996). Thereafter, aliquots (20 µ L) of each well in which inhibitory activity 

was observed were transferred to petri plates containing nutrient agar. The plates were incubated at 

37°C for 24 h. The minimal bactericide concentration (MBC) corresponded to the lowest 

concentration of lectin able to reduce the number of CFU to 0.1% relative to the negative control. 

Antibacterial activity of BlL was also determined in presence of 200 mM galactose. 

 

3. Results and Discussion 

Crude extract of B. leucurus venom showed high lectin activity (SHA 136.5 units/mg) 

towards rabbit erythrocytes. The inhibition of HA by galactose suggested the presence of a 

galactoside-binding lectin; this result encouraged us to evaluate the use of affinity chromatography 

on guar gel matrix to purify lectin.  

Lectin activity from crude venom adsorbed on guar gel column and only one active (SHA of 

29,257) peak was detected after elution with 200 mM galactose (Figure 1A). The use of guar gel 

was an inexpensive and innovative protocol for isolation of a snake venom lectin. Guar gum 

consists of straight chains of mannose substituted with ?(1-6) galactose residues and is a versatile 

and viable matrix for the isolation of D-galactopyranosyl- and N-acetyl-galactosaminyl-binding 

lectins (Lonngren and Goldstein, 1976; Gupta et al., 1979). Guar gum has been used as an efficient 

and inexpensive affinity support for the purification of lectins from Bauhinia monandra leaves 

(Coelho and Silva, 2000) and Moringa oleifera seeds (Santos et al., 2009) as well as from the alga 

Vidalia obtusiloba (Melo et al., 2004).  

The adsorbed fractions from guar gel affinity chromatography were loaded onto gel 

filtration column (Figure 1B); three peaks can be seen in the chromatographic profile. The lectin (B. 

leucurus lectin; BlL) was eluted at 18 mL, corresponding to an apparent molecular weight around 8 

kDa; however, this major peak (SHA 10,240) showed a molecular mass of 30 kDa in SDS-PAGE. 

In the presence of reducing agent ?-mercaptoethanol, BlL was revealed to be a dimeric protein 

composed of two subunits with a molecular mass of 15 kDa (Figure 1C). Because lectins may 

interact in undesirable ways with Superdex beads, a possible interaction of BlL with the stationary 

phase may have affected the retention time and apparent molecular weight of BlL in gel filtration 

chromatography as well as may be responsible for the reduction of SHA observed (Table 1).  



52 

 

Evaluation of BlL by native electrophoresis showed a single polypeptide band in PAGE for 

acidic proteins (Figure 1C). No polypeptide band was detected in native PAGE for basic proteins. 

As showed by Lomonte et al. (1990) using isoelectric focusing, other snake venom lectins are 

characterized as acidic proteins. BlL was eluted from C-4 column with about 50% of acetonitrile 

(Figure 1D). The reduction and alkylation reactions of BlL were performed using DTT. After 

desalting on the C-4 column, only one peak was obtained (Figure 1E), suggesting the presence of 

homodimeric chains covalently linked by disulfide bridges; this result agrees with that observed in 

electrophoresis. Several lectins from snake venoms are constituted by disulfide-linked homodimers, 

such as the lectins from Agkistrodon piscivorus piscivorus and Crotalus ruber (Komori et al., 1999; 

Hamako et al., 2007). However, the crystal structure of a galactoside-binding lectin from Crotalus 

atrox revealed a decameric structure composed of two 5-fold symmetric pentamers (Walker et al., 

2004). 

Table 1 summarizes the BlL purification. The amount of protein recovered after gel 

filtration chromatography was less than 1%. The content of BlL in snake venom (&amp;lt;1%) was similar 

to those found for other lectins isolated from snake venoms (Ogilvie et al., 1986; Lomonte et al., 

1990; Carvalho et al., 1998; Nikai et al., 2000; Guimarães-Gomes et al., 2004). 

Table 1 

Summary of B. leucurus lectin (BlL) purification   

 

Sample 

 

Protein (mg) 

 

Total HAa 

 

SHA (HA/mg) 

 

Purification (fold)b 

 

Crude venom 

 

30 

 

4,096 

 

136.5 

 

1 

Affinity chromatography 0.21 6,144 29,257 214.3 

Gel filtration 0.1 1,024 10,240 75 
aHemagglutinating activity (HA) with rabbit erythrocytes. SHA: specific HA (ratio between HA and 

protein content). bPurification fold corresponds to the ratio between SHA of BlL and SHA of crude 

venom. The data corresponds to one purification process. 

 

The HA of BlL was abolished after treatment with the chelating agent EDTA (5 mM); Mn2+ 

and Mg2+  did not restore BlL HA but the activity was gradually increase by addition of Ca2+ and 

completely restored when this ion was added at 200 mM (Figure 1F); this result indicates that Ca2+ 

is essential for the carbohydrate-recognizing property of BlL. The homodimeric structure and 



53 

 

calcium dependence indicate that BlL may be included in the group of true galactoside-binding 

lectins from snake venoms and did not belong to the group of snaclecs described by Clemetson et 

al. (2009). Several other lectins isolated from snake venoms are dependent on calcium (Ozeki et al., 

1994; Kassab et al., 2001; Guimarães-Gomes et al., 2004; Clemetson, 2010). However, this 

statement can only be confirmed after N-terminal sequencing and homology studies. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 1. (A) Purification of BlL by affinity chromatography of B. leucurus venom (30 mg of protein) 

on a guar gel column. Elution with CTBS buffer (-?-) followed by 200 mM D-galactose (-?-; 

arrow). Specific hemagglutinating activity (SHA, -?-). (B) Purification of BlL by chromatography 

in Superdex 75 column coupled to an ÄKTA purifier system. (C) SDS-PAGE of BlL. (MW) 

molecular weight markers; BlL under non-reducing (lane 1) or reducing conditions (lane 2); 



54 

 

electrophoresis under native conditions for acidic proteins (lane 3). (D) Reverse phase HPLC on a 

C4 column. (E) BlL chain separation after desalting on a C4 column. The column was equilibrated 

with 0.1% TFA (solvent A) and eluted using 90% acetonitrile/10% H2O/0.1% TFA (solvent B) in a 

non-linear gradient, where B = 0% at t = 5 min, 45% at t = 10 min, 50% at t = 30 min and 100% at t 

= 35 min. (F) Hemagglutinating activity (HA) of EDTA-treated BlL after addition of Ca2+ in 

different concentrations. 

 

BlL was not detected by glycoprotein staining using periodic acid-Schiff´s reagent and no 

carbohydrate was detected using the phenol-sulphuric acid method. The absence of carbohydrate 

moiety was also reported for lectins from the snakes Bothrops atrox, Lachesis muta, Dendroaspis 

jamesonii, and Bothrops jararacussu (Gartner et al., 1980; Gartner and Ogilvie, 1984; Ogilvie et al. 

1986; Carvalho et al., 2002). BlL recognized the structure of saccharides comprising the surface of 

erythrocyte membranes since it agglutinated glutaraldehyde-treated erythrocytes from rabbits (SHA 

10,240) and human types A, B and O (SHA of 320, 320 and 160, respectively). The difference in 

erythrocyte agglutination, depending on cell type (A, B, AB and O) and species of origin, may be 

due to the presence of different glycoproteins on the erythrocyte surface. Similar to other lectins 

from snakes, HA of BlL was abolished in the presence of galactose, lactose and raffinose (Table 2), 

indicating that that BlL is a galactoside-binding protein. Inhibition assays revealed that BlL was 

partially inhibited by fetal bovine serum and casein, but not by fetuin and asialofetuin (Table 2). 

Casein is a protein with a small carbohydrate fraction and contains phosphorus in its structure 

(Roman and Sgarbieri, 2005). Two N-glycosidic carbohydrate complex-type rich in galactose are 

present in the structure of ?-fetoprotein, a protein found in fetal bovine serum (Krusius and 

Ruoslahti, 1982); the presence of galactose may be responsible for inhibition of BlL in presence of 

fetal bovine serum. The results indicate that BlL recognizes complex glycoproteins. 

   

 

 

 

 

 



55 

 

Table 2 

Inhibition of hemagglutinating activity of BlL by carbohydrates and glycoproteins 

Inhibitor Minimal inhibitory concentrationa 

D-galactose 0.78 

D-lactose 1.56 

L-raffinose 1.56 

D-glucose 12.5 

N-acetyl-D-glucosamine NI 

D-arabinose NI 

D-mannose NI 

D-fructose NI 

D-xylose NI 

L-rhamnose NI 

Methyl-?-D-mannopyranoside NI 

Methyl-?-D-glucopyranoside NI 

Asialofetuin NI 

Fetuin NI 

Casein 0.25 

Fetal bovine serum 0.25 

Assays were performed with rabbit erythrocytes and in triplicate. aMinimal inhibitory concentration 

corresponds to lowest carbohydrate and glycoproteins concentrations able to inhibit HA of BlL. 

Highest carbohydrates and glycoproteins concentrations used were 200 mM and 0.5 mg/mL, 

respectively. NI indicates that no inhibition was detected. SHA of BlL in absence of sugars or 

glycoproteins: 10,240.  



56 

 

BlL HA was heat-stable up to 70°C, with total loss of activity after heating to 80°C 

indicating that HA depends on BlL native conformation. The HA of BlL was not affected at a pH 

range of 4.0 to 7.0, unlike Bothrops jararacussu lectin, which was more active in neutral pH (Elífio-

Esposito et al., 2007). The intrinsic protein fluorescence spectra of BlL (Figure 2A) revealed a 

single major peak at 344 nm. Tryptophan residues exposed to water show a maximal fluorescence 

emission at wavelengths around 340-350 nm whereas completely buried residues fluoresce at about 

330 nm. The displacement of the mass center of the aromatic residues indicates partially buried 

hydrophobic domains within the lectin structure. C-type lectins are usually a dimer of two identical 

polypeptides, each containing two tryptophan residues and one tyrosine residue (Morita, 2005). The 

individual subunits are able to bind carbohydrates but for the lectin-like function they need at least 

bivalency, which is achieved through a simple interchain disulfide linkage. Although dimerization 

is essential, the two tryptophan residues and the tyrosin are essential to stabilize intra-subunit 

contacts and for biological activities in C-type lectins (Doyle and Kini, 2009). 

The CD spectrum of BIL (Figure 2B) indicated that BlL possessed a large amount of ?-sheet 

structure, characterized by a maximum at approximately 195 nm and a minimum at the range 216-

220 nm (Venyaminov and Yang, 1996). Analysis of the secondary structure content using CDPro 

software yielded following results: 1.0% ?-helix, 44% ?-sheet, 24% ?-turn, 31% unordered 

structures and an RMS (root-mean-square) of 2.0%. Cluster analysis classified BlL as a ?-class 

protein (proteins containing mainly ? structure), corroborated by results of CDPro analysis (68% ? 

structures). The secondary structure content of BlL was similar to that determined for Lachesis 

muta snake venom lectin (Aragón-Ortíz et al., 1989); however, the majority of lectins from snake 

venoms belong to the ?+? class, such as the C-type lectin from B. jararacussu venom which 

possesses 18.8% ?-helix and 32.2% ?-sheet (Silva Jr. et al., 2008). 

 



57 

 

 

Fig.2. (A) Intrinsic fluorescence emission of BlL excited at 280 nm (---) and 295 nm (—). (B) CD 

spectrum of BIL in 50 mM phosphate buffer, pH 7.2, at 25°C. Measurements are the average of 

eight scans using a solution containing 0.25 mg of protein/mL. CD spectrum deconvolution using 

CDPro software calculated 1% ?-helix, 44% ?-sheet, 24% ?-turn, 31% unordered structures and an 

RMS of 2%. 

 

In the present study, antibacterial assays demonstrated that BlL exhibited antibacterial 

effects against the human pathogenic Gram-positive bacteria S. aureus, E. faecalis and B. subtilis. 

Minimal inhibitory (MIC) and minimum bactericidal (MBC) concentrations were determined for 

BlL (Table 3). The lectin was not effective against Gram-negative bacteria E. coli and K. 

pneumoniae. A possible reason for the difference in susceptibility is the difficulty that BlL 

encounters in crossing the outer cell wall of Gram-negative bacteria to reach the periplasmic space. 

BlL may interact with the peptidoglycan present in Gram-positive bacteria cell wall while the lectin 

may not be able to bind peptidoglycans of Gram-negative bacteria whether it does not enter in the 

periplasmic space. BlL showed absence of antimicrobial activity in presence of 200 mM galactose 

assuring that the antibacterial effect involves the carbohydrate-binding property of lectin. MIC 

values of BlL against S. aureus and E. faecalis show the clinical relevance of lectin since these 

concentrations are below the range of 64-100 µ g/mL (Gibbons, 2004). The MBC of BlL against B. 

subtilis (250 µ g/mL) was lower than that (500 µg/mL) described for Phthirusa pyrifolia leaf lectin 

(Costa et al., 2010). 



58 

 

The MBC for bactericidal drugs is generally the same or not more than four-fold higher than 

the MIC. In contrast, the MBC of bacteriostatic drugs are many-fold higher than their MIC 

(Levison, 2004). The term tolerant is applied to bacterial strains which growth stops in the presence 

an antimicrobial concentration but do not rapidly die leading to high values of MBC (Charpentier 

and Tuomanen, 2000). On the basis of MBC/MIC ratio, S. aureus showed to be tolerant to BlL 

since the MBC was 15.8-fold greater than MIC (Ishida et al., 1982). On the other hand, Canillac and 

Mourey (2001) reported that if the MBC/MIC ratio was found to be less than or equal to 4, the 

bacteria were considered to be susceptible. Therefore, B. subtilis was susceptible to BlL. Recently, 

Torres et al. (2010) showed that Bothrops leucurus total venom (BleuTV) inhibited the growth of S. 

aureus. Therefore, according to our results we can suggest that BlL is involved in the antibacterial 

activity of the venom.  

 

Table 3 

Minimum inhibitory (MIC) and minimum bactericidal concentrations (MBC) of BlL 

Bacteria MICa MBCa 

Staphylococcus aureus (+) 31.5 500 

Enterococcus faecalis (+) 62.5 330 

Bacillus subtilis (+) 125 250 

Escherichia coli (-) ND ND 

Klebsiella pneumoniae (-) ND ND 

aMIC and MBC expressed as µ g/mL of lectin. ND: antibacterial activity not detected at 1000 

µ g/mL of BlL. Gram-positive (+) and Gram-negative (-) bacteria.  

 

In conclusion, a new galactoside-binding lectin was isolated from B. leucurus venom. BlL 

showed antibacterial activity against human pathogenic Gram-positive bacteria. Further studies are 

required to determine the mechanisms involved in this bactericidal activity.   

 



59 

 

Acknowledgements 

The authors express their gratitude to the Conselho Nacional de Desenvolvimento Científico 

e Tecnológico (CNPq) and to the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 

(CAPES) for research grants. The authors thank Maria Barbosa Reis da Silva and João Antônio 

Virgínio for technical assistance, and Scott V. Heald for reviewing the English of the manuscript.  

 

References 

Amsterdam, D., 1996. Susceptibility testing of antimicrobials in liquid media. In: Loman, V. (Ed.), 

Antibiotics in Laboratory Medicine. Williams and Wilkins, Baltimore, pp. 52-111. 

Aragón-Ortíz, F., Brenes-Brenes, J.R., Gubensek, F., 1989. Characterization of a lectin-like protein 

isolated from Lachesis muta snake venom. Rev. Biol. Trop. 37, 70-83. 

Barbosa, P.S.F., Martins, A.M.C., Toyama, M.H., Joazeiro, P.P., Beriam, L.O.S., Fonteles, M.C., 

Monteiro, H.S.A., 2010.  Purification and biological effects of a C-type lectin isolated from 

Bothrops moojeni. J. Venom. Anim. Toxins incl. Trop. Dis. 16, 493-504. 

Bello, C.A., Hermógenes, A.L., Magalhães, A., Veiga, S.S., Gremski, L.H., Richardson, M., 

Sanchez, E.F., 2006. Isolation and biochemical characterization of a fibrinolytic proteinase 

from Bothrops leucurus (white-tailed-jararaca) snake venom. Biochimie 88, 189-200. 

Bing, D.H., Weyand, J.G., Stavitsky, A.B., 1967. Hemagglutination with aldehyde-fixed 

erythrocytes for assay of antigens and antibodies. Proc. Soc. Exp. Biol. Med. 124, 1166-

1170. 

Bradford, M.M., 1976. A rapid and sensitive method for the quantification of microgram quantities 

of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254. 

Canillac, N., Mourey, A., 2001. Antibacterial activity of the essential oil of Picea excelsa on 

Listeria, Staphylococcus aureus and coliform bacteria. Food Microbiol. 18, 261-268. 

Carvalho, D.D., Marangoni, S., Oliveira, B., Novello, J.C., 1998. Isolation and characterization of a 

new lectin from the venom of the snake Bothrops jararacussu. Biochem. Mol. Biol. Inter. 

44, 933-938. 



60 

 

Carvalho, D.D., Schmitmeier, S., Novello, J.C., Markland, F.S., 2001. Effect of BJcuL (a lectin 

from the venom of the snake Bothrops jararacussu) on adhesion and growth of tumor and 

endothelial cells. Toxicon 39, 1471-1476.  

Carvalho, D.D., Marangoni, S., Novello, J.C., 2002. Primary structure characterization of Bothrops 

jararacussu snake venom lectin. J. Protein Chem. 21, 43-50. 

Charpentier, E., Tuomanen, E., 2000. Mechanisms of antibiotic resistance and tolerance in 

Streptococcus pneumoniae. Microbes Infect. 2, 1855-1864. 

Clemetson, K.J., Morita, T., Kini, R.M., 2009. Scientific and standardization committee 

communications: classification and nomenclature of snake venom C-type lectins and related 

proteins. J. Thromb. Haemost. 7, 360.  

Clemetson, K.J., 2010. Snaclecs (snake C-type lectins) that inhibit or activate platelets by binding to 

receptors. Toxicon 56, 1236-1246. 

Coelho, L.C.B.B., Silva, M.B.R., 2000. Simple method to purify milligram quantities of the 

galactose-specific lectin from leaves of Bauhinia monandra. Phytochem. Anal. 11, 295-300. 

Correia, M.T.S., Coelho, L.C.B.B., 1995.  Purification of a glucose/manose specific lectin, isoform 

1, from seeds of Cratylia mollis Mart. (Camaratu bean). Applied Biochem. Biotechnol.  55,  

261-273. 

Costa, R.M.P.B., Vaz, A.F.M., Oliva, M.L.V., Coelho, L.C.B.B., Correia, M.T.S., Carneiro-da-

Cunha, M.G., 2010. A new mistletoe Phthirusa pyrifolia leaf lectin with antimicrobial 

properties. Process Biochem. 45, 526-533. 

Davis, B.J.,1964. Disc electrophoresis. II. Method and application to human serum proteins. Ann. 

N. Y. Acad. Sci. 121, 404-427. 

De-Simone, S.G., Netto, C.C., Silva Jr., F.P., 2006. Simple affinity chromatographic procedure to 

purify ?-galactoside binding lectins. J. Chromatogr. B 838, 135-138. 

Doyle, R., Kini, R.M., 2009. Protein complexes in snake venom. Cell. Mol. Life Sci. 66, 2851-

2871. 

Dubois, M., Gilles, K.A., Hamilton, J.K., Rebers, P.A., Smith, F., 1956. Colorimetric  method for 

determination of sugar and related substances. Anal. Chem. 28, 350-356. 



61 

 

Elífio-Esposito, S.L., Hess, P.L., Moreno, A.N., Lopes-Ferreira, M., Ricart, C.A.O., Souza, M.V., 

Hasselman-Zielinski, F., Becker, J.A., Pereira, L.F., 2007. A C-type lectin from Bothrops 

jararacussu venom can adhere to extracellular matrix proteins and induce the rolling of 

leukocytes. J. Venom. Anim. Toxins incl. Trop. Dis. 13, 782-799. 

Ferreira, R.N., Rates, B., Richardson, M., Guimarães, B.G., Sanches, E.O., Pimenta, A.M., Nagem, 

R.A., 2009. Complete amino-acid sequence, crystallization and preliminary X-ray 

diffraction studies of leucurolysin-a, a nonhaemorrhagic metalloproteinase from Bothrops 

leucurus snake venom. Acta Crystallogr. Sect. F - Struct. Biol. Cryst. Commun. 65, 798-

801. 

Friedman, M., Krull, L.H., Cavins, J.F., 1970. The chromatographic determination of cystine and 

cysteine residues in proteins as S-?-(4-pyridylethyl) cysteine.  J. Biol. Chem. 245, 3868-

3871. 

Gartner, T.K., Ogilvie, M.L., 1984. Isolation and characterization of three Ca2+-dependent beta-

galactoside-specific lectins from snake venoms. Biochem. J. 224, 301-307. 

Gartner, T.K., Stocker, K., Williams, D.C., 1980. Thrombolectin: a lectin isolated from Bothrops 

atrox venom. FEBS Lett. 117, 13-16. 

Gibbons, S., 2004. Anti-staphylococcal plant natural products. Nat. Prod. Rep. 21, 263-277. 

Gomes, M.S., de Queiroz, M.R., Mamede, C.C., Mendes, M.M., Hamaguchi, A., Homsi-

Brandeburgo, M.I., Sousa, M.V., Aquino, E.N., Castro, M.S., de Oliveira, F., Rodrigues, 

V.M., 2011. Purification and functional characterization of a new metalloproteinase 

(BleucMP) from Bothrops leucurus snake venom. Comp. Biochem. Physiol. C, 

doi:10.1016/j.cbpc.2010.11.008 

Guimarães-Gomes, V., Oliveira-Carvalho, A.L., Junqueira-de-Azevedo, I.L., Dutra, D.L.S., Pujol-

Luz, M., Castro, H.C., Ho, P.L., Zingali, R.B., 2004. Cloning, characterization and structural 

analysis of a C-type lectin from Bothrops insularis (BiL) venom. Arch. Biochem. Biophys. 

432, 1-11. 

Gupta, K.C., Sahni, M.K., Rathaur, B.S., Narang, C.K., Mathur, N.K., 1979. Gel filtration medium 

derived from guar gum. J. Chromatogr. 169, 183-190. 



62 

 

Hamako, J., Suzuki, Y., Hayashi, N., Kimura, M., Ozeki, Y., Hashimoto, K., Matsui, T., 2007. 

Amino acid sequence and characterization of a C-type lectin purified from the snake venom 

of Crotalus ruber. Comp. Biochem. Physiol. B 146, 299-306. 

Havt, A., Toyama, M.H., do Nascimento, N.R., Toyama, D.O., Nobre, A.C., Martins, A.M., 

Barbosa, P.S., Novello, J.C., Boschero, A.C., Carneiro, E.M., Fonteles, M.C., Monteiro, 

H.S., 2005. A new C-type animal lectin isolated from Bothrops pirajai is responsible for the 

snake venom major effects in the isolated kidney. Int. J. Biochem. Cell Biol. 37, 130-141. 

Higuchi, D.A., Barbosa, C.M.V., Bincoletto, C., Chagas, J.R., Magalhães, A., Richardson, M., 

Sanchez, E.F., Pesquero, J.B., Araujo, R.C., Pesquero, J.L., 2007. Purification and partial 

characterization of two phospholipases A2 from Bothrops leucurus (white-tailed-jararaca) 

snake venom. Biochimie 89, 319-328. 

Ishida, K., Guze, P.A., Kalmanson, G.M., Albrandt, K., Guze, L.B., 1982. Variables in 

demonstrating methicillin tolerance in Staphylococcus aureus strains. Antimicrob. Agents 

Chemother. 21, 688-690. 

Kassab, B.H., Carvalho, D.D., Marangoni, S., Novello, J.C., 2001. Characterization of a 

hemagglutinating glycoprotein isolated Bothrops moojeni snake venom. Protein Pept. Lett. 

8, 13-20.    

Komori, Y., Nikai, T., Tohkai, T., Sugihara, H., 1999. Primary structure and biological activity of 

snake venom lectin (APL) from Agkistrodon p. piscivorus (Eastern cottonmouth). Toxicon 

37, 1053-1064. 

Krusius, T., Ruoslahti, E., 1982. Carbohydrate structure of the concanavalin A molecular variants of 

?-fetoprotein. J. Biol. Chem. 257, 3453-3457. 

Laemmli, U.K., 1970. Cleavage of structural proteins during the assembly of the head of 

bacteriophage T4. Nature 227, 680-685.  

Lee, W., La Barca, A.M.C., Drake, D., Doyle, R.J., 1998. Lectin-oral streptococci interactions. J. 

Med. Microbiol. 47, 29-37. 

Levison, M.E., 2004. Pharmacodynamics of antimicrobial drugs. Infec. Dis. Clin. N. Am. 18, 451-

465. 



63 

 

Lira-da-Silva, R.M., Nunes, T.B., 1993. Ophidic accidents by Bothrops leucurus Wagler, 1824 in 

Bahia, Brazil. Toxicon 31, 143-144. 

Lomonte, B., Rojas, G., Gutiérrez, J.M., Ramírez, G., 1990. Isolation of a galactose-binding lectin 

from the venom of the snake Bothrops godmani (Godmann´s pit viper). Toxicon 28, 75-81. 

Lonngren, J., Goldstein, I.J., 1976. Cross-linked guaran: a versatile immunosorbent for D-

galactopyranosyl binding lectins. FEBS Lett. 68, 31-34. 

Magalhães, A., Magalhães, H.P.B., Richardson, M., Gontijo, S., Ferreira, R.N., Almeida, A.P., 

Sanchez, E.F., 2007. Purification and properties of a coagulant thrombin-like enzyme from 

the venom of Bothrops leucurus. Comp. Biochem. Physiol. A 146, 565-575. 

Mastro, A.M., Hurley, D.J., Winning, R.K., Filipowski, R., Ogilvie, M.L., Gartner, T.K., 1986. 

Mitogenic activity of snake venom lectins. Cell. Tissue Kinet. 19, 557-566. 

Melo, F.R., Benevides, N.M.B., Pereira, M.G., Holanda, M.L., Mendes, F.N.P., Oliveira, S.R.M., 

Freitas, A.L.P., Silva, L.M.C.M., 2004. Purification and partial characterisation of a lectin 

from the red marine alga Vidalia obtusiloba C. Agardh. Rev. Bras. Bot. 27, 263-269. 

Mise, Y.F., Lira-da-Silva, R.M., Carvalho, F.M., 2007. Envenomation by Bothrops in the State of 

Bahia: epidemiological and clinical aspects. Rev. Soc. Bras. Med. Trop. 40, 569-573.   

Morita, T., 2004. C-type lectin-related proteins from snake venoms. Curr. Drug Targets Cardiovasc. 

Haematol. Disord. 4, 357-373. 

Morita, T., 2005. Structures and functions of snake venom CLPs (C-type lectin-like proteins) with 

anticoagulant-, procoagulant-, and platelet-modulating activities. Toxicon 45, 1099-1114. 

Nikai, T., Kato, S., Komori, Y., Sugihara, H., 2000. Amino acid sequence and biological properties 

of the lectin from the venom of Trimeresurus okinavensis (himehabu). Toxicon 38, 707-711. 

Ogawa, T., Chijiwa, T., Oda-Ueda, N., Ohno, M., 2005. Molecular diversity and accelerated 

evolution of C-type lectin-like proteins from snake venom. Toxicon 45, 1-14. 

Ogilvie, M.L., Dockter, M.E., Wenz, L., Gartner, T.K., 1986. Isolation and characterization of 

lactose-binding lectins from the venoms of the snakes Lachesis muta and Dendroaspis 

jamesonii. J. Biochem. 100, 1425-1431. 



64 

 

Ohkura, M., Miyashita, Y., Nikai, T., Suzuki, J., Komori, Y., Sugihara, H., Ohizumi, Y., 1996. 

Properties of Ca++ release induced by puff adder lectin, a novel lectin from the snake Bitis 

arietans, in sarcoplasmic reticulum. J. Pharmacol. Exp. Ther. 277, 1043-1048. 

Ozeki, Y., Matsui, T., Hamako, J., Suzuki, M., Fujimura, Y., Yoshida, E., Nishida, S., Titani, K., 

1994. C-type galactoside-binding lectin from Bothrops jararaca venom: comparison of its 

structure and function with those of botrocetin. Arch. Biochem. Biophys. 308, 306-310. 

Panunto, P.C., Silva, M.A., Linardi, A., Buzin, M.P., Melo, S.E., Mello, S.M., Prado-Franceschi, J., 

Hyslop, S., 2006. Biological activities of a lectin from Bothrops jararacussu snake venom. 

Toxicon 47, 21-31. 

Pereira-Bittencourt, M., Carvalho, D.D., Gagliard, A.R., Collins, D.C., 1999. The effect of a lectin 

from the venom of the snake, Bothrops jararacussu, on tumor cell proliferation. Anticancer 

Res. 19, 4023-4025. 

Rádis-Baptista, G., Moreno, F.B., de Lima Nogueira, L., Martins, A.M., Toyama, D.O., Toyama, 

M.H., Cavada, B.S., Azevedo, W.F., Yamane, T., 2006. Crotacetin, a novel snake venom C-

type lectin homolog of convulxin, exhibits an unpredictable antimicrobial activity. Cell. 

Biochem. Biophys. 44, 412-423.  

Reisfeld, R.A., Lewis, U.J., Williams, D.E., 1962. Disk electrophoresis of basic protein and 

peptides on polyacrylamide gels. Nature 195, 281-283. 

Roman, J.A., Sgarbieri, V.C., 2005. Obtenção e caracterização química e nutricional de diferentes 

concentrados de caseína. Rev. Nutr. 18, 75-83. 

Sanchez, E.F., Gabriel, L.M., Gontijo, S., Gremski, L.H., Veiga, S.S., Evangelista, K.S., Eble, J.A., 

Richardson, M., 2007. Structural and functional characterization of a P-III 

metalloproteinase, leucurolysin-B, from Bothrops leucurus venom. Arch. Biochem. 

Biophys. 468, 193-204. 

Santi-Gadelha, T., de Almeida Gadelha, C.A., Aragão, K.S., Oliveira, C.C., Mota, M.R.L., Gomes, 

R.C., Pires, A.F., Toyama, M.H., Toyama, D.O., Alencar, N.M.N., Criddle, D.N., Assreuy, 

A.M.S., Cavada, B.S., 2006. Purification and biological effects of Araucaria angustifolia 

(Araucariaceae) seed lectin. Biochem. Biophys. Res. Commun. 350, 1050-1055. 



65 

 

Santos, A.F.S., Luz, L.A., Argolo, A.C.C., Teixeira, J.A., Paiva, P.M.G., Coelho, L.C.B.B., 2009. 

Isolation of a seed coagulant Moringa oleifera lectin. Process Biochem. 44, 504-508. 

Silva, E.F., Richardson, M., Gomes, M.V., Sanchez, E.F., 2007. Biochemical properties of a L-

amino acid oxidase from Bothrops leucurus (white-tailed jararaca). Comp. Biochem. 

Physiol. A 148, S105.  

Silva Jr., F.P., Alexandre, G.M.C., Ramos, C.H.I., De-Simone, S.G., 2008. On the quaternary 

structure of a C-type lectin from Bothrops jararacussu venom – BJ-32 (BJcuL). Toxicon 52, 

944-953. 

Sreerama, N., Woody, R.W., 2000. Estimation of protein secondary structure from circular 

dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an 

expanded reference set. Anal. Biochem. 287, 252-260. 

Sreerama, N., Venyaminov, S.Y., Woody, R.W., 2001. Analysis of protein CD spectra with a 

reference protein set based on tertiary structure class. Anal. Biochem. 299, 271-274.  

Torres, A.F.C., Dantas, R.T., Menezes, R.R.P.P.B., Toyama, M.H., Filho, E.D., Oliveira, M.F., 

Nogueira, N.A.P., Oliveira, M.R., Monteiro, H.S.A., Martins, A.M.C., 2010. Antimicrobial 

activity of an L-amino acid oxidase isolated from Bothrops leucurus snake venom. J. 

Venom. Anim. Toxins incl. Trop. Dis. 16, 614-622.  

Utarabhand, P., Riitidach, W., Paijit, N., 2007. Bacterial agglutination by sialic acid-specific lectin 

in the hemolymph of the banana shrimp, Penaeus (Fenneropenaeus) merguiensis. Sci. Asia 

33, 41-46. 

Venyaminov, S.Y., Yang, J.T., 1996. Determination of protein secondary conformation. In: 

Fasman, G.D. (Ed.), Circular dichroism and the conformational analysis of biomolecules. 

Plenum. New York, pp. 69-105 

Walker, J.R., Nagar, B., Young, N.M., Hirama, T., Rini, J.M., 2004. X-ray crystal structure of a 

galactose-specific C-type lectin possessing a novel decameric quaternary structure. 

Biochem. 43, 3783-3792. 

Wang, W.J., 2008. Agglucetin, a tetrameric C-type lectin-like venom protein, regulates endothelial 

cell survival and promotes angiogenesis by activating integrin ?v?3 sinaling. Biochem. 

Biophys. Res. Commun. 369, 753-760. 



66 

 

Zacharius, R.M., Zell, T.E., Morrison, J.H., Woodlock, J.J., 1969. Glycoprotein staining following 

electrophoresis on acrylamide gels. Anal. Biochem. 30, 148-152. 

Zelesnky, A.N., Gready, J.E., 2005. The C-type lectin-like domain superfamily. FESB J. 272, 6179-

6217.   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



67 

 

6 ARTIGO CIENTÍFICO II 

 

 

 

 

 

Cytotoxic effect and apoptosis induction by Bothrops leucurus venom lectin on 

tumor cell lines 

 

Artigo a ser submetido ao periódico Toxicology in vitro 

 

 

 

 

 

 

 

 

 

 

 

 



68 

 

Erika S. Nunesa,*; Mary A.A. Souzaa; Antônio F.M. Vaza; Teresinha G. Silvab; Jaciana S. Aguiarb; 

André M. Batistac; Maria M.P. Guerrac; Miriam C. Guarnierid; Luana C.B.B. Coelhoa; Maria T.S. 

Correiaa 

 
a
Departamento de Bioquímica, CCB, Universidade Federal de Pernambuco, Avenida Professor 

Moraes Rêgo, s/n, Cidade Universitária, 50670-420, Recife, Pernambuco, Brazil 

b
Departamento de Antibióticos, Universidade Federal de Pernambuco, Avenida Prof. Arthur de Sá, 

s/n, Cidade Universitária, 50670-901, Recife, Pernambuco, Brazil.
 

c
Departamento de Medicina Veterinária, Rua Dom Manoel Medeiros, s/n, Dois Irmãos, 52171-900, 

Universidade Federal Rural de Pernambuco, Recife, Pernambuco, Brazil.
 

d
Departamento de Zoologia, CCB, Universidade Federal de Pernambuco, Avenida Professor 

Moraes Rêgo, s/n, Cidade Universitária, 50670-420, Recife, Pernambuco, Brazil. 

 

*Corresponding author. Phone: +558121268540; Fax: +558121268576.  

E-mail address: erika.santosnunes@hotmail.com  

 

 

ABSTRACT  

Neoplastic transformation results from cell changes that escaped of control mechanisms leading to 

an increased growth potential as well as alterations in cell surface and other attributes that give to 

the tumor cells the ability to invade and metastasize. These transformations are often related to 

changes in cell surface glycoconjugates which can be detected by lectins. In this study we evaluated 

the anti-tumor potential of BlL, a galactoside-binding lectin isolated from Bothrops leucurus 

venom. BlL was evaluated for its cytotoxicity using MTT assay against tumor cell lines (K562, 

NCI-292 and Hep-2) and hemolysis assay on mice erythrocytes. The annexin-V and JC-1 assays 

were used to determine the phosphatidylserine externalization and mitochondrial membrane 

potential in K562 cells, respectively. BlL exhibited cytotoxic activity against all tumor cell lines 

tested with IC50 values of 6.63, 11.75 and 15.42 µ g/mL for Hep-2, NCI-H292 and K562, 

respectively, but was not able to induce hemolysis in mice erythrocytes. BlL treatment induced 

phosphatidylserine externalization and mitochondrial depolarization, indicating cell death by 



69 

 

apoptosis.Our results suggest that BlL has a promising potential for application in cancer therapy 

and/or diagnosis. 

 

Keywords: antitumor activity; apoptosis; Bothrops leucurus; lectin; cytotoxicity; mitochondria.  

 

1. Introduction 

 

 Cancer is the second cause of mortality worldwide (Hemalswarya and Doble, 2006) and in 

Brazil the estimate for the year 2010 (also valid for 2011) is the occurrence of 489,270 new cases of 

cancer (Instituto Nacional do Câncer, 2009). Etiologic factors associated with cancer include 

improper diet, genetic predisposition and environment conditions; the majority of human cancers 

result from exposure to environmental carcinogens (Reddy et al., 2003).    

Glycosylation is the most frequent form of post-translational modifications of proteins 

(Chen et al., 2007; Rek et al., 2009) and alterations in  the pattern of cell surface glycoconjugates 

are remarkable characteristic of malignant cells associated with induction of tissue invasion and 

metastasis (Hakomori, 2002; Kobata and Amano, 2005; Reis et al., 2010). Due to their peripheral 

location, oligosaccaride epitopes of glycoproteins and glycolipids are recognized by membrane-

anchored carbohydrate-recognition domains of different molecules, including lectins (Jiménez-

Castells et al., 2008).  

Lectins comprise proteins or glycoproteins which bind specifically to mono or 

oligosaccharides and glyconconjugates (Wu et al., 2009). Carbohydrate-specificity of lectins has 

been shown to be a versatile and useful molecular tool for study of glycoconjugates on cell surface, 

in particular the changes that cells suffer in malignancy (Sharon and Lis, 2004). Thus, lectins are 

excellent candidates to be explored in cancer research as therapeutics agents.  

Lectins from snake venoms exhibit several biological activities like ability to inhibit 

integrin-dependent proliferation, migration and invasion of tumor cells (Sarray et al., 2004; Sarray 

et al., 2007) as well as to reduce the growth of tumor and endothelial cells (Carvalho et al., 2001). 

However, the induction of tumor cell apoptosis by snake venom lectins has not been studied.  

The BlL is a lectin isolated from the venom of Bothrops leucurus (white-tailed-jararaca). 

BlL is a Ca2+-dependent and galactoside-binding protein of 30 kDa composed by dissulfide-linked 

dimers of 15 kDa and exhibits antibacterial activity against human pathogenic Gram-positive 

bacteria (Nunes et al., 2011).  



70 

 

Apoptosis (programmed cell death) is an essential cellular homeostasis mechanism that 

ensures the correct development and function of multi-cellular organisms. However, cancer cells 

show a reduced sensitivity towards apoptosis and tumors are dependent on the mechanisms of this 

resistance to continue alive. Therefore, it is of enormous therapeutic interest the discovery of drugs 

that selectively affect the balance of tumor cellular functions towards apoptosis. According 

Taraphdar et al. (2001), induction of apoptosis is an important strategy for cancer therapy and 

prevention.  

The aims of this study were to evaluate the in vitro cytotoxicity of BlL on different human 

tumor cell lines (K562, NCI-292 and Hep-2), its lytic property on mouse erythrocytes and its ability 

to induce apoptosis in human tumor cells.     

  

2. Material and Methods 

 

2.1. Chemicals 

Phosphate buffered saline (PBS), penicillin, streptomycin and DMEM (Dulbecco’s Modified 

Eagle’s Medium) were purchased from GibcoTM. MTT (3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-

2H-tetrazolium bromide) was purchased from InvitrogenTM. Eposide (Etoposide) was purchased 

from Blausiegel. Fetal bovine serum, glutamine, Triton X-100 and JC-1 (5,5?,6,6?-Tetrachloro-

1,1?,3,3? tetraethylbenzimidazolocarbocyanine iodide) were  purchased from Sigma-Aldrich®. 

Annexin V FITC Apoptosis Kit was purchased from Calbiochem. DMSO (Dimethil sulfoxide) was 

purchased from Vetec. 

 

2.2. BlL purification 

BlL was purified according to the protocol previously described by Nunes et al. (2011). 

Lyophilized crude venom of B. leucurus (30 mg) was dissolved in 1 mL of CTBS buffer (20 mM 

Tris-HCl, 150 mM NaCl and 5 mM CaCl2, pH 7.5) and centrifuged (2000 g, 5 min, 25 °C) to 

remove insoluble material. The resulting supernatant was applied to a column (10 x 1.0 cm) of guar 

gel previously equilibrated with CTBS at a flow rate of 10 mL/h. BlL was eluted from the column 

with 200 mM galactose in CTBS. 

 



71 

 

2.3. Cell lines and cell culture 

The cell lines used in cytotoxicity assays were K562 (chronic myelocytic leukemia), NCI-

H292 (human lung mucoepidermoid carcinoma cells) and Hep-2 (human larynx epidermoid 

carcinoma cells) obtained from Instituto Adolfo Lutz (São Paulo, Brazil). The cells were maintained 

in DMEM supplemented with 10% fetal bovine serum, 2 mM glutamine, 100 U/mL penicillin and 

100 µ g/mL streptomycin and maintained at 37 °C with 5 % CO2.  

 

2.4. MTT assay 

Cytotoxicity of BlL was tested on K562, NCI-H292 and Hep-2 tumor cell lines. The cells 

(105 cells/mL for adherent cells or 0.3x106 cells/mL for suspended cells) were plated in 96-well 

microtiter plates and after 24 h, BlL (0.07–50 µ g/mL) dissolved in DMSO was added to each well 

and incubated for 72 h  at 37 °C.  Then, MTT (5.0 mg/mL) was added to the plate and growth of 

tumor cells was estimated by the ability of living cells to reduce the yellow tetrazolium to a blue 

formazan product (Mosmann, 1983; Alley et al., 1988). Negative control groups received only 

DMSO; etoposide (1.25–20 µ g/mL) was used as positive control. After 3 h (for suspend cells) or 2 

h (for adherent cells), the formazan product was dissolved in DMSO and absorbance was measured 

using a multi-plate reader (Multiplate Reader Thermoplate). The BlL effect was quantified by 

measuring the absorbance at 450 nm resulting from MTT reduction. The results were compared 

with negative control absorbance and the values of 50% inhibition of cell proliferation (IC50) were 

calculated. 

 

2.5. Hemolytic assay 

Assay was performed in 96-well microtiter plates according to the method described by 

Costa-Lotufo et al. (2002). Each well received 100 µ L of 0.85% NaCl solution containing 10 mM 

CaCl2. The first well was the negative control and contained only the vehicle (10 % DMSO). To the 

second well, 100 µ L of BlL (10–2000 µ g/mL) were added and serial dilution was performed until 

1:1024. Positive control used 20 µ L of 0.1% Triton X-100 (in 0.85% NaCl) to obtain 100% 

hemolysis. Then, each well received 100 µ L of a 2 % suspension of mice (Mus musculus) 

erythrocytes in 0.85 % NaCl containing 10 mM CaCl2. After incubation at 28 ºC for 30 min and 

centrifugation, the supernatant was removed and the haemoglobin released by hemolysis was 

determined by measurement of absorbance at 450 nm.  



72 

 

2.6. Annexin/PI cell death assay   

The K562 suspension (0.3 x 106 cells/mL) was seeded in 96-well microtiter plates and 

incubated at 37 °C at 5 % CO2 for 24 h; after this period, BlL at IC50 was added. After 48 h the cells 

were stained with annexin V and propidium iodide using Annexin V–FITC Kit (Calbiochem®) 

following the protocol provided by the manufacturer and analysed by epifluorescence  microscope 

(Carl Zeiss, Gottingen, Germany) with increase of 1000x under oil immersion with filters for LP 

515 nm emission and BP 450-490 nm for excitement. A minimum of 200 cells was counted in 

every sample. 

 

2.7. Measurement of mitochondrial membrane potential 

Mitochondria depolarization was evaluated by incorporation of JC-1 (5,5´,6,6´-tetrachloro-

1,1´,3,3´-tetraethilbenzimidazolcarbocyanine iodide), a fluorescent lipophilic cationic probe (Kang 

et al., 2002; Guthrie and Welch, 2006). The probe JC-1 is freely permeable to cells and undergoes 

reversible transformation from a monomer to an aggregate form (Jagg). K562 suspension (0.3 x 10
6 

cells/mL) was seeded into 96-well microtiter plates and incubated at 37 °C and 5 % CO2; after 24 h, 

BlL at IC50 was added and plates incubated for 48 h. Then, 50 µ L of treated cell suspension were 

collected and incubated with JC-1 (10 µ L/mL) for 30 min in the dark followed by washing two 

times with PBS. The cells were fixed with paraformaldehyde 4% (10 µ L), mounted on glass slides 

and observed using an epifluorescence microscope (Carl Zeiss, Gottingen, Germany), with increase 

of 1000x under oil immersion with filter for LP 515 nm emission and BP 450-490 nm excitement. 

A minimum of 200 cells was counted in every sample. Cells with high potential of mitochondrial 

membrane were stained in red while cells with low membrane potential were stained in green. 

    

2.8. Statistical analysis 

All data are presented as mean ± S.D. The IC50 and EC50 values were obtained by nonlinear 

regression with 95% confidence interval using the SigmaPlot software (Systal Software Inc., San 

Jose, USA). The differences between experimental groups were determined using one-way analysis 

of variance (ANOVA) followed by Newman-Keuls test at significance level of 1%.  

 



73 

 

3. Results     

 

Cytotoxicity of BlL on tumor cell lines was evaluated after 72 h using MTT assay and the 

results are presented in Table 1. BlL exhibited cytotoxic activity against all cell lines with IC50 

values of 6.63, 11.75 and 15.42 µ g/mL for Hep-2, NCI-H292 and K562, respectively. 

 

Table 1 

Cytotoxic activity of BlL against tumor cell lines. 

IC50 (µ g/mL) Sample 

Hep-2 NCI-H292 K562 

BlL 11.75±0.035 6.63±0.052 15.42±0.060 

Etoposide 6.10±0.19 2.75±0.10 4.48±0.23 

The IC50 values at 95% confidence interval were obtained by non linear regression. Etoposide was 

used as positive control. 

 

In order to verify whether the cytotoxicity was related to injury of cell plasma membrane, 

BlL was tested for lytic activity on mice erythrocytes. The results showed that it does not cause 

membrane damage even at the upper concentration (2000 µ g/mL).   

The involvement of apoptosis induction on K562 death was verified by evaluation of 

phosphatidylserine externalization using the Annexin V-FITC kit and fluorescence microscope. We 

observed that after treatment with BlL (15.42 µ g/mL), the number of cells in early apoptosis (Ann 

Vpos/PIneg) corresponded to 70.5% (Figure 1). Treatment with BlL exhibited values less than 1% of 

late apoptotic cells (AnnVpos/PIpos) and values less than 2% of cell necrosis (AnnVneg/PIpos). 

 

 

 

 



74 

 

 

 

 

 

 

 

 

 

Fig. 1. Effect of BlL in K562 cell population determined by fluorescence microscopy using 

Annexin V–FITC Kit, after 48 h incubation. The negative control (NC) was the vehicle used 

(DMSO). Etoposide was used as positive control (E). *p &amp;lt;0.01 in comparison to control by 

ANOVA followed by Newman Keulls test. Data are presented as mean ± S.D. from three 

independent experiments. 

 

Figure 2 shows that the treatment of K562 cells with BlL caused mitochondrial membrane 

potential loss, as fluorescence microscopy analysis determined that BlL treatment induced 

significant increase in cells with depolarized mitochondria (63.8%) as compared to control cells, as 

measured by JC-1 incorporation.     

 

 

 

 

 

 

Fig. 2. Effect of BlL in K562 cell population determined by fluorescence microscopy using JC-1, 

after 48 h incubation. The negative control (NC) was the vehicle used (DMSO). Etoposide was used 

as positive control (E). *p &amp;lt;0.01 in comparison to control by ANOVA followed by Newman 

Keulls test. Data are presented as mean ± S.D. from three independent experiments. 

0

10

20

30

40

50

60

70

NC E BlL

M
it

o
c
h

o
n

d
r
ia

l 
D

e
p

o
la

ri
za

ti
o

n
 (

%
)

*
*

0

10

20

30

40

50

60

70

NC E BlL

M
it

o
c
h

o
n

d
r
ia

l 
D

e
p

o
la

ri
za

ti
o

n
 (

%
)

*
*

0

10

20

30

40

50

60

70

80

90

NC E BlL

C
e

ll
 n

u
m

b
e

r 
(%

)

Vi a bl e Apoptos i s Ne cros i s

*

*

*

*

0

10

20

30

40

50

60

70

80

90

NC E BlL

C
e

ll
 n

u
m

b
e

r 
(%

)

Vi a bl e Apoptos i s Ne cros i s

*

*

*

*



75 

 

4. Discussion 

Uncontrolled proliferation and decreased apoptotic signals are attributes of oncogenic 

transformation (Hill et al., 2003), and activation of apoptosis constitutes a fundamental mechanism 

by which drugs may kill tumor cells (Debatin, 2004). Therefore, compounds with the ability to 

induce apoptosis in tumor have potential for anticancer agents (Reed, 2003).  

MTT assay demonstrated that BlL showed significant cytotoxic effect against human tumor 

cell lines Hep-2, NCI-H292 and K562 indicating that the activity of this lectin was not specific to a 

particular tumor cell type. However, different IC50 values were determined for the lectin revealing a 

different cytotoxic activity on the different cell lines. Glycoconjugates or saccharides present on the 

surface of tumor cells are binding sites for lectins (Luo et al., 2007) and differences in sugar pattern 

between different tumor cells may be a reason for the differential effect of BlL. Differences in the 

effect snake venom lectins towards human tumor cell lines have been reported (Pereira-Bittencourt 

et al., 1999; Carvalho et al., 2001). In addition, cells that not express specific carbohydrates may be 

insensitive to cytotoxic lectins (Gorelik et al., 2001).  

The presence of 10% fetal bovine serum in culture medium did not exert any effect in 

cytotoxicity induced by BlL on tumor cell lines. Pereira Bittencourt et al. (1999), studying the 

action of C-type lectin from Bothrops jararacussu (BJcuL) on the proliferation of human cancer 

cell lines, observed marked toxicity in presence of 5% fetal bovine serum, however incubation with 

10% fetal bovine serum decreased the inhibitory activity of BJcuL lectin by approximately 50%. 

The lectin BJcul was highly cytotoxic to OVCAR-5 cells in the presence of 5% fetal bovine serum 

and has no inhibitory effect on cell growth when 10% fetal bovine serum was used (Carvalho et al., 

2001). One possible explanation for this is that fetal bovine serum contains specific sugars that 

inhibit the cytotoxic action of BJcuL. Our results suggest that fetal bovine serum contains a low 

amount of glycoligands specific for BlL in comparison with BJcuL.  

Despite their cytotoxic action, BlL was inactive against erythrocytes of mice, suggesting that 

the cytotoxic mechanism is not related to lytic property or induction of membrane instability by 

BlL. 

Morphological and biochemical characteristics of apoptosis are nuclear chromatin 

condensation, DNA fragmentation, membrane blebbing (Okada and Mak, 2004; Vermeulen et al., 

2005), externalization of phosphatidylserine (Hengartner, 2000) and depolarization of the 

membrane potential (Ly et al. 2003). In this study, apoptosis induction in BlL-treated K562- cells 



76 

 

was assessed by fluorescence microscopy analysis of phosphatidylserine externalization on cell 

surface and mitochondrial membrane potential.        

The loss of plasma membrane asymmetry represents and early event of apoptosis resulting 

in translocation of phosphatidylserine from the inner to the outer surface while membrane integrity 

remains unchanged (Van Engeland et al., 1998, Fadok et al., 2000; Kagan et al., 2000); this 

externalization provides the recognition and removal of apoptotic cells by phagocytes 

(Zimmermann et al., 2001; Taylor et al., 2008). The phospholipid-binding protein annexin V has a 

high affinity for phosphatidylserine and binds to cells fluorescently labeled with FITC (Reyes-

Zurita et al., 2009). However, translocation de phosphatidylserine also occurs during necrosis, so 

propidium iodide is often used to bind to nucleic acids (Gong et al., 2007). We observed by staining 

with annexin V-FITC simultaneously with dye propidium iodide that BlL was able to increase 

significantly the number of apoptotic cells. The results suggest that the cytotoxic effect is due to 

induction of apoptosis in K562 cells.  

The mitochondrial apoptotic pathway is one of the major routes to initiate apoptosis (Kuo et 

al., 2010). Different stimuli cause changes in the inner mitochondrial membrane leading to the 

opening of the mitochondrial permeability transition pore, loss of the mitochondrial transmembrane 

potential (Ly et al., 2003; Saelens et al., 2004) and pro-apoptotic proteins release from the 

intermembrane space into the cytosol (Mayer and Oberbauer, 2003; Borutaite, 2010). One of these 

proteins is the cytochrome C which triggers the formation of the apoptosome complex culminating 

with the activation of caspases (Gogvadze et al., 2009). 

The loss of mitochondrial membrane potential is the early change in the mitochondria-

mediated apoptosis (Zhao et al., 2010). Our studies demonstrated that treatment with BlL increased 

mitochondrial membrane potential loss, which may indicate cell death by apoptosis in K562 cells. 

Some lectins such as Con A, POL, PCL and MLL may cause disruption of the mitochondrial 

membrane potential as an event associated with apoptosis (Liu et al., 2009a; Liu et al., 2009b; Liu 

et al., 2009c; Zhao et al., 2010). 

In conclusion, the galactoside-binding lectin from B. leucurus snake venom (BlL) exhibited 

cytotoxic activity on tumor cells and induced apoptosis in K562 cells, as verified by 

phosphatidylserine externalization analysis and mitochondrial membrane potential determination. 

These results suggest that BlL has a promising potential for application in therapy and / or diagnosis 

of cancer. Future studies are needed to elucidate the details of BlL induced-apoptosis mechanism in 

several tumor cell lines.  

 



77 

 

Conflict of interest statement 

The authors declare that there are no conflicts of interest. 

 

Acknowledgements 

The authors express their gratitude to the Conselho Nacional de Desenvolvimento Científico e 

Tecnológico (CNPq) for research grants and fellowship (LCBBC and MTSC) and to the 

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) for research grants. 

Authors are deeply grateful to Maria Barbosa Reis da Silva, Maria D. Rodrigues and João Antônio 

Virgínio for the technical assistance.  

 

References 

Alley, M.C., Scudiere, D.A., Monks, A., Hursey, M.L., Czerwinski, M.J., Fine, D.L., Abbott, B.J., 

Mayo, J.G., Shoemaker, R.H., Boyd, M.R., 1988. Feasibility of drug screening with panels 

of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48, 589-601. 

Borutaite, V., 2010. Mitochondria as decision-makers in cell death. Environ. Mol. Mutagen. 51, 

406-416.   

Carvalho, D.D., Schmitmeier, S., Novello, J.C., Markland, F.S., 2001. Effect of BJcuL (a lectin 

from the venom of the snake Bothrops jararacussu) on adhesion and growth of tumor and 

endothelial cells. Toxicon 39, 1471-1476.  

Chen, S., LaRoche, T., Hamelinck, D., Bergsma, D., Brenner, D., Simeone, D., Brand, R.E., Haab, 

B.B., 2007. Multiplexed analysis of glycan variation on native proteins captured by antibody 

microarrays. Nature Methods 4, 437-444. 

Costa-Lotufo, L.V., Cunha, G.M.A., Farias, P.A.M., Viana, G.S.B., Cunha, K.M.A., Pessoa, C., 

Moraes, M.O., Silveira, E.R., Gramosa, N.V., Rao, V.S.N., 2002. The cytotoxic and 

embryotoxic effects of kaurenoic acid, a diterpene isolated from Copaifera langsdorffii oleo-

resin. Toxicon 40, 1231-1234. 

Debatin, K.M., 2004. Apoptosis pathways in cancer and cancer therapy. Cancer Immunol. 

Immunother. 53, 153-159. 



78 

 

Fadok, V.A., Bratton, D.L., Rose, D.M., Pearson, A., Ezekewitz, R.A., Henson, P.M., 2000. A 

receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405, 85-90. 

Gong, F., Ma, Y., Ma, A., Q., Zhang, J., Nie, H., Chen, X., Shen, B., Li, N., Zhang, D., 2007. A 

lectin from Chinese Mistletoe increases ?? T cell-mediated cytotoxicity through induction of 

caspase-dependent apoptosis. Acta Biochim. Biophys. Sin. 39, 445-452. 

Gogvadze, V., Orrenius, S., Zhivotovsky, B., 2009. Mitochondria as targets for cancer 

chemotherapy. Semin. Cancer Biol. 19, 57-66. 

Gorelik, E., Galili, U., Raz, A., 2001. On the role of cell surface carbohydrates and their binding 

proteins (lectins) in tumor metastasis. Cancer Metastasis Rev. 20, 245-277. 

Guthrie, H.D., Welch, G.R., 2006. Determination of intracellular reactive oxygen species and high 

mitochondrial membrane potential in Percoll-treated viable boar sperm using fluorescence-

activated flow cytometry. J. Anim. Sci. 84, 2089-2100. 

Hakomori, S., 2002. Glycosylation defining cancer malignancy: New wine in an old bottle. Proc. 

Natl. Acad. Sci. 99, 10231-10233. 

Hemalswarya, S., Doble, M., 2006. Potential synergism of natural products in the treatment of 

cancer. Phytother. Res. 20, 239-249. 

Hengartner, M.O., 2000. The biochemistry of apoptosis. Nature 407, 770-776. 

Hill, M.M., Adrain, C., Martin, S.J., 2003. Portrait of a killer: The mitochondrial apoptosome 

emerges from the shadows. Mol. Interv. 3, 19-26. 

Instituto Nacional de Câncer, 2009. Estimativa 2010: Incidência de Câncer no Brasil, INCA, Rio de 

Janeiro. http//www.inca.gov.br/estimativa/2010/estimativa20091201.pdf. 

Jiménez-Castells, C., de la Torre, B.G., Andreu, D., Gutiérrez-Gallego, R., 2008. Neo-

glycopeptides: the importance of sugar core conformation in oxime-linked glycoprobes for 

interaction studies. Glycoconj. J. 25, 879-887. 

Kagan, V.E., Fabisiak, J.P., Shedova, A.A., Tyurina, Y.Y., Tyurin, V.A., Schor, N.F., Kawai, K., 

2000. Oxidative signaling pathway for externalization of plasma membrane 

phosphatidylserine during apoptosis. FEBS Lett. 477, 1-7. 



79 

 

Kang, K.S., Yun, J.W., Lee, Y.S., 2002. Protective effect of l-carnosine against 12-

Otetradecanoylphorbol-13-acetate- or hydrogen peroxide-induced apoptosis on v-myc 

transformed rat liver epithelial cells. Cancer Lett. 178, 53-62. 

Kobata, A., Amano, J., 2005. Altered glycosylation of proteins produced by malignant cells, and 

application for the diagnosis and immunotherapy of tumors. Immunol. Cell Biol. 83, 429-

439. 

Kuo, W.T., Ho, Y.J., Kuo, S.M., Lin, F.H., Tsai, F.J., Chen, Y.S., Dong, G.C., Yao, C.H., 2010. 

Induction of the mitochondria apoptosis pathway by phytohemagglutinin 

erythroagglutinating in human lung cancer cells. Ann. Surg. Oncol., doi:10.1245/s10434-

010-1351-2 

Liu, B., Cheng,Y., Bian, H.J., Bao, J.K., 2009c. Molecular mechanisms of Polygonatum cyrtonema 

lectin-induced apoptosis and autophagy in cancer cells. Autophagy 5, 253-255. 

Liu, B., Li, C.Y., Bian, H.J., Min, M.W., Chen, L.F., Bao, J.K., 2009a. Antiproliferative activity 

and apoptosis-inducing mechanism of Concanavalin A on human melanoma A375 cells. 

Arch. Biochem. Biophys. 482, 1-6. 

Liu, B., Zhang, B., Min, M.W., Bian, H.J., Chen, L.F., Liu, Q., Bao, J.K., 2009b. Induction of 

apoptosis by Polygonatum odoratum lectin and its molecular mechanisms in murine 

fibrosarcoma L929 cells. Biochim. Biophys. Acta 1790, 840-844.  

Luo, Y., Xu, X., Liu, J., Li, J., Sun, Y., Liu, Z., Liu, J., Van Damme, E., Balzarini, J., Bao, J., 2007. 

A novel mannose-binding tuber lectin from Typhonium divaricatum (L.) Decne (family 

Araceae) with antiviral activity against HSV-II and anti-proliferative effect on human 

cancer cell lines. J. Biochem. Mol. Biol. 40, 358-367.  

Ly, J.D., Grubb, D.R., Lawen, A., 2003. The mitochondrial membrane potential (deltapsi(m)) in 

apoptosis; an update. Apoptosis 8, 115-128.  

Mayer, B., Oberbauer, R., 2003. Mitochondrial regulation of apoptosis. News Physiol. Sci. 18, 89-

94. 

Mosmann, T., 1983. Rapid colorimetric assay for cellular growth and survival: application to 

proliferation and cytotoxicity assays. J. Immunol. Methods 16, 55-63.  

Okada, H., Mak, T.W., 2004. Pathways of apoptotic and non-apoptotic death in tumor cells. Nat. 

Rev. Cancer 4, 592-603. 



80 

 

Pereira-Bittencourt, M., Carvalho, D.D., Gagliard, A.R., Collins, D.C., 1999. The effect of a lectin 

from the venom of the snake, Bothrops jararacussu, on tumor cell proliferation. Anticancer 

Res. 19, 4023-4026. 

Reddy, L., Odhav, B., Bhoola, K.D., 2003. Natural products for cancer prevention: a global 

perspective. Pharmacol. Ther. 99, 1-13. 

Reed, J.C., 2003. Apoptosis-targeted therapies for cancer. Cancer Cell 3, 17-22. 

Reis, C.A., Osorio, H., Silva, L., Gomes, C., David, L., 2010. Alterations in glycosylation as 

biomarkers for cancer detection. J. Clin. Pathol. 63, 322-329. 

Rek, A., Krenn, E., Kungl, A.J., 2009. Therapeutically targeting protein-glycan. J. Pharmacol. 157, 

686-694. 

Reyes-Zurita, F.J., Rufino-Palomares, E.E., Lupiáñez, J.A., Cascante, M., 2009. Maslinic acid, a 

natural triterpene from Olea europaea L., induces apoptosis in HT29 human colon-cancer 

cells via the mitochondrial apoptotic pathway. Cancer Lett. 273, 44-54.  

Saelens, X., Festjens, N., Walle, L.V., Van Gurp, M., Van Loo, G., Vandenabeele, P., 2004. Toxic 

proteins released from mitochondria in cell death. Oncogene 23, 2861-2874. 

Sarray, S., Berthet, V., Calvete, J.J., Secchi, J., Marvaldi, J., El-Ayeb, M., Marrakchi, N., Luis, J., 

2004. Lebectin, a novel C-type lectin from Macrovipera lebetina venom, inhibits integrin-

mediated adhesion, migration and invasion of human tumour cells. Lab. Invest. 84, 573-581. 

Sarray, S., Delamarre, E., Marvaldi, J., El Ayeb, M., Marrakchi, N., Luis, J., 2007. Lebectin and 

lebecetin, two C-type lectins from snake venom, inhibit ?5?1 and ?v-containing integrins. 

Matrix Biol. 26, 306-313. 

Sharon N., Lis, H., 2004. History of lectins: from hemagglutinins to biological recognition 

molecules. Glycobiology 14, 53-62. 

Taraphdar, A.K., Roy, M., Bhattacharya, R.K., 2001. Natural products as inducers of apoptosis: 

implication for cancer therapy and prevention. Curr. Sci. 80, 1387-1396. 

Taylor, R.C., Cullen, S.P., Martin, S.J., 2008. Apoptosis: controlled demolition at the cellular level. 

Nature Reviews Mol. Cell Biol. 9, 231-241. 



81 

 

Van Engeland, M., Nieland, L.J.W., Ramaekers, F.C.S., Schutte, B., Reutelingsperger, C.P.M., 

1998. Annexin V-afinnity assay: A review on an apoptosis detection system based on 

phosphatidylserine exposure. Cytometry 31, 1-9. 

Vermeulen, K., Bockstaele, V., Berneman, Z.N., 2005. Apoptosis: mechanisms and relevance in 

cancer. Ann. Hematol. 84, 627-639. 

Wu, A.M., Lisowska, E., Duk, M., Yang, Z., 2009. Lectins as tools in glycoconjugate research. 

Glycoconj. J. 26, 899-913. 

Zhao, Q., Cao, X., Zheg, B., Wang, C., Yan, L., Xu, C., 2010. Musca domestica larva lectin induces 

apoptosis in BEL-7402 cells through a mitochondria-mediated reactive oxygen species way. 

Biol. Pharm. Bull. 33, 1274-1278. 

Zimmermann, K.C., Bonzon, C., Green, D.R., 2001. The machinery of programmed cell death. 

Pharmacol. Ther. 92, 57-70. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



82 

 

7 ARTIGO CIENTÍFICO III 

 

 

 

 

 

Gamma irradiation abolish in vitro cytotoxicity of lectin of Bothrops leucurus 

snake venom 

 

Artigo a ser submetido ao periódico Toxicon 

 

 

 

 

 

 

 

 

 

 

 

 



83 

 

Erika dos Santos Nunesa*, Mary Angela Aranda de Souzaa, Antônio Fernando Melo Vaza, Maria 

Luiza Vilela Olivab, Jaciana Santos Aguiarc, Teresinha Gonçalves da Silvac, Miriam Camargo 

Guarnierid, Luana Cassandra Breitenbach Barroso Coelhoa, Ana Maria M. de Albuquerque Meloe, 

Maria Tereza dos Santos Correia.a 

  
a
Departamento de Bioquímica, Universidade Federal de Pernambuco, Avenida Professor  Moraes 

Rêgo, s/n, Cidade Universitária, 50670-420, Recife, Pernambuco, Brazil 

b
Departamento de Bioquímica, Universidade Federal de São Paulo, Rua Três de Maio, 100,  Vila 

Clementina, 04044-020, São Paulo, Brazil.
 

c
Departamento de Antibióticos, Universidade Federal de Pernambuco, Avenida Arthur de Sá, s/n, 

Cidade Universitária, 50670-901, Recife, Pernambuco, Brazil.
 

d
Departamento de Zoologia, Universidade Federal de Pernambuco, Avenida Professor Moraes 

Rêgo, s/n, Cidade Universitária, 50670-420, Recife, Pernambuco, Brazil. 

e
Departamento de Biofisica e Radiobiologia,  Universidade Federal de Pernambuco, Avenida 

Professor Moraes Rêgo, s/n, Cidade Universitária, 50670-420, Recife, Pernambuco, Brazil. 

 

*Corresponding author. Phone: +558121268540; Fax: +558121268576  

E-mail address: erika.santosnunes@hotmail.com  

 

ABSTRACT  

Gamma radiation alters the molecular structure of biomolecules and has been able to mitigate snake 

venoms and its isolated toxins. The aims of this work was to evaluate the effects of ionizing 

radiation in Bothrops lecurus venom lectin (BlL) by fluorescence spectroscopy and in vitro 

cytotoxicity. BlL has been structurally altered and hemagglutinating assay shows significant change 

after gamma irradiation. SDS-PAGE analyses indicated that irradiation caused fragmentation and 

aggregation of lectin. The reverse phase chromatography analysis revealed a loss of the peak area 

with structural fragmentation. The effect of ?-radiation on the folding of the lectin was measured by 

intrinsic and bis-ANS fluorescence. Cytotoxic activity of BlL on Hep-2, K562 and NCI-H292 

tumor cell lines was abolished after irradiation. To improve antivenom and extend the useful life of 



84 

 

immunized horses effort has been devoted to decrease chronic venom toxicity, the irradiation may 

acts as a detoxification strategy in snake venoms avoiding its cytotoxicity. 

 

Keywords: Bothrops leucurus; lectin; fluorescence; Bis-ANS; gamma rays. 

 

1. Introduction 

 Snake venoms are complex mixtures of bioactive proteins and polypeptides (Koh et al., 

2006). These toxins are enzymatic and non enzymatic proteins and synergistic interactions between 

venom proteins enhanced the lethal potency of the snake venom. Complexes of proteins families, 

such as metalloproteases, serine proteases, C-type lectins (CTLs), C-type lectin-related proteins 

(CLRPs) and three-finger toxins (3FTxs), have also been reported in venoms (Doley and Kini, 

2009). CTLs are true sugar-binding lectin composed by homodimers or homooligomers and with 

Ca2+ and generally galactose binding properties (Clemetson, 2010). C-type lectin-like proteins are 

heterodimers or oligomeric complexes of heterodimers called Snaclecs (Snake venom C-type 

lectins) (Ogawa et al., 2005; Clemetson et al., 2009; Clemetson, 2010). Lectins are proteins or 

glycoproteins that are ubiquitous in nature and bind reversibly to carbohydrates (Sharon and Lis, 

2004).  

Ionizing radiation causes changes in the function and integrity of biomolecules, including 

proteins, by two different effects. First, interacting directly on target proteins (Kempner, 2001); and 

second, the formation of major products from radyolisis water and its subsequent interaction with 

proteins are described as indirect mechanism, which are responsible for most of the radiation effects 

on proteins (Riley, 1994; Wang and Wang, 2007). The exposure of proteins at low dose radiation 

produces chemical and physical damage that may result in changes in its primary structure, 

secondary or tertiary, keeping intact their immunological properties (Nascimento et al., 1996).  

The intimate relationship existing structure-activity proteins may be affected by the use of 

ionizing radiation, which functions to an important tool in the study of attenuation of snake venoms. 

This aspect has received attention from researchers, on many occasions show the effects of gamma 

radiation the molecular level, with the involvement of biological activity de snake venom, which 

result in a decrease or loss of enzymatic and toxic actions (Gallaci et al., 2000; Souza et al., 2002; 

Casare et al., 2006). This phenomenom has led scientists to the formulation of concepts and ideas 

extremely relevant, increasing interest in experiments such as the detoxification from snake venoms 

by radiation, without affecting its immunogenic properties in order to optimize the production of 

antiserum (Moreira et al., 1997; Netto et al., 2002; Ferreira Junior et al., 2005; Ferreira Junior et al., 



85 

 

2006; Ferreira et al., 2009). Traditional methods to reduce unwanted or intolerant immunological 

effects of lectins have been ineffective (Sathe et al., 2005). However, an alternative treatment was 

recently reviewed to abolish allergenicity of lectins in food using gamma irradiation (Vaz et al., 

2011). 

A valuable feature of intrinsic protein fluorescence is the high sensitivity of tryptophan to its 

local environment. Changes in the emission spectra of tryptophan often occur in response to 

conformational transitions, subunit association, substrate binding, or denaturation (Lakowicz, 

2006). Bis-ANS have proved to be sensitive probes for partially folded intermediates in protein-

folding pathways. The basis of these applications is the strong fluorescence enhancement exhibited 

by these amphiphilic dyes when their exposure to water is lowered (Semisotnov et al., 1991). The 

majority of misfolding states are involving the self-aggregation of specific proteins (or protein 

fragments) into filamentous deposits known as amyloid fibrils, which adopt a characteristic cross-?-

sheet structure. Thioflavin T (ThT) dye fluorescence is used regularly to quantify the formation of 

amyloid fibrils in the presence of stress physics or oxidative (Hawe et al., 2008). 

Bothrops leucurus venom lectin (BlL) has been purified by affinity chromatography of 

venoms snake. The galactoside-binding, a protein of 30 kDa composed of 15 kDa subunits, presents 

inhibitory activity against antibacterial, citotoxicity on human tumor cell lines as well as induction 

of apoptosis (Nunes et al., 2011). Here, the interest lies in studying the effects of ionizing radiation 

in the lectin isolated from venom of Bothrops leucurus and evaluated if gamma radiation attenuates 

its citotoxicity in tumor cell.  

 

2. Material and Methods 

 

2.1. Chemicals 

Reference samples of 4.4'-Bis 1-anilinonaphthalene 8-sulfonate (bis-ANS) were purchased 

from Molecular Probes Inc., USA. The broad-range standard marker proteins were purchased from 

Sigma Chemical Co. USA. Phosphate buffered saline (PBS), penicillin – streptomycin liquid and 

DMEM (Dulbecco’s Modified Eagle’s Medium) were purchased from GibcoTM. MTT (3-(4,5-

Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) were  purchased from InvitrogenTM. 

Eposide (Etoposide) was purchased from Blausiegel. Fetal bovine serum (FBS) and glutamine were 



86 

 

purchased from Sigma-Aldrich®. All the solvents and other chemicals used were of analytical grade 

from Merck, Germany. All solutions were made with water purified by the Milli-Q system.   

2.2. Cell line and Cell culture 

The cell lines used in vitro cytotoxicity were K562 (chronic myelocytic leukemia), NCI-

H292 (human lung mucoepidermoid carcinoma cells) and Hep-2 (human larynx epidermoid 

carcinoma cells) all obtained from Adolph Lutz Institute (São Paulo, Brazil). The cells were 

maintained in DMEM supplemented with 10% fetal bovine serum, 2mM glutamine, 100 U/mL 

penicillin, 100 µ g/mL streptomycin at 37 °C with 5% CO2.  

 

2.3. Purification of Bothrops leucurus lectin (BlL) 

B. leucurus venom was kindly supplied by the Núcleo Regional de Ofiologia e Animais 

Peçonhentos da Bahia, Universidade Federal da Bahia, Salvador, Bahia, Brazil. BlL was purified 

according to the protocol previously described by Nunes et al. (2011). Lyophilized crude venom of 

B. leucurus (30 mg) was dissolved in 1 mL of CTBS buffer (20 mM Tris-HCl, 150 mM NaCl and 5 

mM CaCl2, pH 7.5) and centrifuged (2000 g, 5 min, 25 °C) to remove insoluble material. The 

resulting supernatant was applied to a column (10 x 1.0 cm) of guar gel previously equilibrated with 

CTBS at a flow rate of 10 mL/h. BlL was eluted from the column with 200 mM galactose in CTBS. 

 

2.4. Lectin irradiation 

The lectin aliquots (0.07 mg/mL) in phosphate buffer (pH 7.0) in borosilicate glass vials 

(16-125 mm) were frozen and irradiated under atmospheric O2 using a Gammacell 220 Excel 
60Co 

gamma ray irradiator (Ontario, Canada) with doses of 1 and 2 kGy at a rate of 7.2 kGy/h. Each 

sample was analyzed after irradiation by the following methods. 

 

2.5. Hemagglutination activity and protein concentration  

Hemagglutination activity (HA), which was defined as the lowest sample dilution that 

showed hemagglutination, was evaluated as described by Correia and Coelho (1995). Specific HA 

(SHA) corresponded to the relationship between the HA and protein concentration measured 

according to Bradford (1976) using bovine serum albumin (BSA) as a standard. The percentage of 



87 

 

the remaining SHA (%SHAREM) was calculated according to the equation: %SHAREM = (SHA)GM / 

(SHA)GO x 100, where GM is the lectin SHA of each radiation dose (1 and 2 kGy) and G0 is the of 

non-irradiated lectin (control). 

 

2.6. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) 

SDS-PAGE was performed according to Laemmli (1970). Protein samples were mixed with 

loading buffer (60 mM Tris-HCl, pH 6.8, with 2% SDS, 25% glycerol, and 0.1% bromophenol 

blue), resolved on a 15% separating gel and stained using Coomassie Brilliant Blue (Sigma). The 

following standard molecular weight markers were used: rabbit muscle myosin (205 kDa), E. coli 

?-galactosidase (116 kDa), rabbit muscle phosphorylase b (97.4 kDa), rabbit muscle fructose-6-

phosphate kinase (84 kDa), bovine serum albumin (66 kDa), bovine liver glutamic dehydrogenase 

(55 kDa), egg albumin (45 kDa), rabbit muscle glyceraldehyde-3-phosphate dehydrogenase (36 

kDa), bovine erythrocyte carbonic anhydrase (29 kDa), bovine pancreas trypsinogen (24 kDa), 

soybean trypsin inhibitor (20 kDa), bovine milk ?-lactalbumin (14.2 kDa) and bovine lung aprotinin 

(6.5 kDa).  

 

2.7. Reverse phase chromatography analysis    

BlL (0.07 mg/mL) was irradiated (1 and 2 kGy) and submitted to reverse phase 

chromatography on a C-4 column (Vydac-protein peptide ultrasphere), performed on a HPLC 

system (Shimadzu LC-10AD, Kyto, Japan) and monitored at 280 nm. The column was equilibrated 

with solvent A (0.1% TFA in H2O) at a flow rate of 0.7 mL/min,
 and a non-linear gradient elution 

was used with solvent B (90% acetonitrile, 10% H2O, 0.1% TFA) in A, with 0% B at t = 5 min; 

45% B at t = 10 min; 50% B at t = 30 min; and 100% B at t = 35 min. 

 

2.8. Fluorescence spectroscopy 

The fluorescence emission intensity of the irradiated 0.07 mg/mL BlL solution in phosphate 

buffer at pH 7.0 was measured at 25°C using a spectrofluorometer (JASCO FP-6300, Tokyo, Japan) 

in a rectangular quartz cuvette with a 1-cm path length. The excitation wavelengths were 295 and 

280 nm; emission spectra were recorded in the range of 305 to 450 nm, and band passes were 5 nm. 

Light scattering was measured at 90° for the aggregation assays; light scattering values at 320 nm 



88 

 

were monitored (300 to 340 nm). The spectra displayed in the figures are the average of three scans 

that were corrected for the solution signal by subtracting the solution spectrum. 

 

2.9. Hydrophobic surface analysis 

The lectin hydrophobic surface was measured using the same conditions employed for the 

intrinsic fluorescence experiment. Samples were transferred to a quartz cuvette and then mixed with 

5 µ M bis-ANS; fluorescence was measured in the JASCO spectrofluorometer. The fluorescence 

emission was obtained at 400 to 600 nm with an excitation at 360 nm (Bhattacharyya et al., 2000). 

 

2.10. Thioflavin T (ThT) fluorescence assay 

The amyloid fibrils detection was measured using the same conditions employed for the 

intrinsic fluorescence experiment. Samples were transferred to a quartz cuvette and then mixed with 

13 µ M ThT; fluorescence intensity of each sample was recorded every 5 min in the JASCO 

spectrofluorometer. The fluorescence emission was obtained at 465 to 550 nm with an excitation at 

450 nm (LeVine, 1999). 

 

2.11. MTT assay 

The cytotoxicity of the BlL irradiated in dose of 1 and 2 kGy was tested against K562, NCI-

H292 and Hep-2 tumor cell lines. The cells (105 cells/mL for adherent cells or 0.3x106 cells/mL for 

suspended cells) were plated in 96-well microtiter plates and after 24 h, irradiated BlL (0.07 

mg/mL) dissolved in DMSO was added to each well and incubated for 72 h  at 37 °C.  Then, MTT 

(5.0 mg/mL) was added to the plate and growth of tumor cells was estimated by the ability of living 

cells to reduce the yellow tetrazolium to a blue formazan product (Mosmann, 1983; Alley et al., 

1988). Negative control groups received only DMSO; etoposide (1.25–20 µ g/mL) was used as 

positive control. After 3 h (for suspend cells) or 2 h (for adherent cells), the formazan product was 

dissolved in DMSO and absorbance was measured using a multi-plate reader (Multiplate Reader 

Thermoplate). The BlL effect was quantified by measuring the absorbance at 450 nm resulting from 

MTT reduction. The results were compared with negative control absorbance and the values of 50% 

inhibition of cell proliferation (IC50) were calculated. 



89 

 

2.12. Statistical analysis 

Data are presented as mean ± S.D. The IC50 values and their 95% confidence intervals were 

obtained by nonlinear regression using the SigmaPlot graphing software Inc. San Jose, USA. The 

differences between experimental groups were compared by one-way of variance (ANOVA) 

followed by Newman-Keuls test and the significance level was also set at 1%.  

 

3. Results and Discussion    

Ionizing radiation has been widely employed to attenuate venoms and isolated toxins, 

preserving and even enhancing their immunogenic properties. However, little is know about the 

molecular changes that irradiated proteins undergo. Thus, we compared native and irradiated 

Bothrops leucurus snake venom lectin (BlL) aiming to characterize the structural modifications that 

radiation induces. BlL SHA was determined after irradiation. In dose of 1 kGy, no significant 

change was observed. However, in dose of 2 kGy shows significantly loss of SHA (Figure 1a). C-

type lectins exhibit biological activities like adhesion, via CRDs (carbohydrate recognition domain), 

for recognition of oligosaccharides in cell surface. The CRD can function independently of the rest 

of the protein and thus may be employed to assess whether agglutination or clumping is maintained 

or disrupted after irradiation (Taylor and Drickamer, 1991). Thus, the loss of HA after irradiation 

suggests modification of the dimmers interact which can result in dissociation pentamer and loss of 

interaction sites on surface cells (Walker et al., 2004).    

The precipitate was run on SDS-PAGE after centrifugation to detect any insoluble 

aggregates that formed, and the supernatant was separated by RP-HPLC. In dose of 1 kGy, initial 

degradation of the BlL (MW 30.0 kDa) was observed. Degradation of the main band was detected 

in dose of 2 kGy, indicating that the aggregate formed was composed of fragmented polypeptides 

(Figure 1b). The reverse phase chromatography analysis showed the loss of the peak area with the 

structural fragmentation (Figure 1c) and aggregation can be evaluated by light scattering (Figure 

1d). According Puchala and Schuessler (1995), in fragile bonds in the polypeptide chain break 

points occurring protein caused by radiation. Because of the generation of inter-protein cross-

linking reactions, formation of disulfide bonds, as well as hydrophobic and electrostatic 

interactions, proteins can be converted to higher molecular weight aggregates (Moon and Song, 

2001; Xu and Chance, 2005). The analysis of molecular weight pattern and RP-HPLC shows 

conditions that induce denaturation, with subsequent precipitation into insoluble amorphous 

aggregates.  



90 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 1. Effect of ?-radiation on lectin activity and molecular weight. (a) The percentage of 

remaining specific hemagglutination activity, %SHAREM is represented after irradiation. Error in the 

determination of %SHAREM for the different doses was approximately ± 1%, which is less than the 

size of the symbols. * Significant difference (p &amp;lt;0.05) compared to non-irradiated lectin. (b) SDS-

PAGE from irradiated BlL. SDS-PAGE was performed in a discontinuous system with 15% 

separating and 5% stacking gels. (MW) Molecular weight; (C) non-irradiated control; (1) 1 kGy and 

(2) 2 kGy. (c) Reverse phase chromatography on an HPLC system: (?) control and irradiated 

lectins at (?) 1 kGy and (?) 2 kGy. (d) Light scattering was measured at 90° for the aggregation 

assays. 

Nascimento et al. (1996) observed that crotoxin, the main neurotoxin isolated from snake 

venom Crotalus durissus terrificus, when irradiated with 2 kGy dose of gamma rays produced 

protein aggregation and generation of lower molecular weight breakdown products. Such clusters 

applaud less myotoxic, devoid of phospholipase activity and are virtually non-toxic in mice when 

compared with native crotoxin. The bothropstoxin-1, the main myotoxic component of Bothrops 

jararacussu snake venom, after irradiation com 60Co gamma rays, promoted structural 

modifications in the toxin characterized aggregates and oligomers (Caproni et al., 2009).  

0

20

40

60

80

100

Control 1 2

Dose (kGy)

S
H

A
 R

em
 (

%
)

205
116

66
55

45
36

24
20

14.2

6.5

29

84

97.4

MW 1 2C

*

a
b

0

50

100

150

200

250

300

300 310 320 330 340

Wave le ngth (nm)

F
lu

o
re

s
c

e
n

c
e

 i
n

te
n

s
it

y
 (

A
.U

.)

c

-50

150

350

550

750

950

0 10 20 30 40

Time (min)

A
b

s
o

rb
a
n

c
e
 a

t 
2
8
0
 n

m
 (

m
A

U
)

d

non-irradiated

1 kGy

2 kGy

0

20

40

60

80

100

Control 1 2

Dose (kGy)

S
H

A
 R

em
 (

%
)

205
116

66
55

45
36

24
20

14.2

6.5

29

84

97.4

MW 1 2C

*

a
b

0

50

100

150

200

250

300

300 310 320 330 340

Wave le ngth (nm)

F
lu

o
re

s
c

e
n

c
e

 i
n

te
n

s
it

y
 (

A
.U

.)

c

-50

150

350

550

750

950

0 10 20 30 40

Time (min)

A
b

s
o

rb
a
n

c
e
 a

t 
2
8
0
 n

m
 (

m
A

U
)

d

non-irradiated

1 kGy

2 kGy



91 

 

CTLs display anticoagulant and hemagglutinating activity. Its activity depends on the extent 

of association to dimmers. The intrinsic fluorescence of BlL was used to study its association into 

dimmers. CTLs is usually a dimer of two identical polypeptides, each containing two tryptophan 

residue and one tyrosine residues (Morita, 2005). The emission spectrum of the BlL dimer displays 

emission from both tyrosine and tryptophan when excited at 280 nm. Only tryptophan emission is 

seen for 295 nm excitation. The intrinsic fluorescence emission decreased (1 and 2 kGy) with 

changing the ?max at approximately 347 and 345 nm for hydrophobic and thryptophan residues, 

respectively, after irradiation (Figure 2 a-b). To tryptophan residues that are exposed to water have 

a maximal fluorescence at wavelengths around 340-350 nm, whereas completely buried residues 

fluoresce at about 330 nm. In CTLs individual subunits are able to bind to carbohydrates, but for the 

lectin-like function they need at least bivalency, which is achieved through a simple interchain 

disulfide linkage. Although dimerization is essential, two Trp residues (one at each end) and a Tyr 

residue in the middle of the interaction interface are essential to stabilize intra-subunit contacts and 

for the expression of their biological activities (Doyle and Kini, 2009). The displacement of the 

mass center of the aromatic residues indicates a possible protein denaturation and exposure of 

hydrophobic domains to the solvent. Thus, the subtle differences in the positioning of interactive 

segment may lead to distinct quaternary structures of these proteins after irradiation.  

 

 

 

 

 

 

Fig. 2. BlL intrinsic fluorescence. (a) Mass center; Lectin excitation (280 nm) and emission (295–

450 nm). (b) Mass center tryptophan; Lectin excitation (295 nm) and emission (305-450 nm).    

The aromatic amino acid residues of proteins are major targets of reactive oxygen species by 

oxidation (ROS) (Stadtman and Levine, 2003), which are produced after water radiolysis. Partial 

aromatic amino acid substituition caused by hydrogen abstraction promote a decrease in the 

intensity fluorescence emission being the magnitude of the intensity very informative in itself. 

338

339

340

341

342

343

344

345

346

control 1 kGy 2 kGy

Dose (kGy)

C
en

te
r 

of
 m

as
s 

(n
m

)

0

100

200

300

400

500

300 320 340 360 380

Wavelength (nm)

F
lu

o
re

sc
en

ce
 i

nt
en

si
ty

 (
A

.U
.)

342

342.5

343

343.5

344

344.5

345

345.5

346

346.5

347

347.5

Control 1 kGy 2 kGy

Dose (kGy)

C
en

te
r 

of
 m

as
s 

(n
m

)

0

150

300

450

600

750

900

300 320 340 360 380 400

Wavelength (nm)

F
lu

o
re

sc
en

ce
 in

te
n

si
ty

 (
A

.U
.)

a b

338

339

340

341

342

343

344

345

346

control 1 kGy 2 kGy

Dose (kGy)

C
en

te
r 

of
 m

as
s 

(n
m

)

0

100

200

300

400

500

300 320 340 360 380

Wavelength (nm)

F
lu

o
re

sc
en

ce
 i

n
te

n
si

ty
 (

A
.U

.)

342

342.5

343

343.5

344

344.5

345

345.5

346

346.5

347

347.5

Control 1 kGy 2 kGy

Dose (kGy)

C
en

te
r 

of
 m

as
s 

(n
m

)

0

150

300

450

600

750

900

300 320 340 360 380 400

Wavelength (nm)

F
lu

o
re

sc
en

ce
 in

te
n

si
ty

 (
A

.U
.)

a b



92 

 

Oxidative damage distorts the intra-subunit contacts and the hydrophobic core of proteins, allowing 

dissociation of chains and denaturation. 

Compared with the buffer, bis-ANS was weakly detected in the non-irradiated control BlL. 

Bis-ANS fluorescence, after irradiation, increased in two doses used in this study, with a maximum 

to 500 nm to above 1 kGy (Figure 3). Hydroxyl radicals may attack hydrophobic surfaces in 

proteins, causing changes in the protein hydrophobicity, which are considered the determining 

factor for structural collapse. Molten globule intermediates and insoluble amorphous aggregates are 

characterized by particularly high bis-ANS fluorescence intensities due to the exposure of 

hydrophobic core regions that are inaccessible to the dye in the native structure (Semisotnov et al., 

1991). Despite of misfold states involve the self-aggregation of specific proteins (or protein 

fragments) into filamentous deposits know as amyloi fibrils, was not observed fluorescence 

Thioflavin T after irradiation. For a lectin isolated from Sebastiana jacobinensis, a variety of 

conditions was observed that induce denaturation, with subsequent precipitation into insoluble 

amorphous aggregates or structured intermediates after irradiation (Vaz et al., 2011). 

 

 

 

 

 

 

 

 

Fig. 3. BlL bis-ANS fluorescence. Mass center; Lectin excitation (360 nm) and emission (400–600 

nm).   

In previous reports, was observed by MTT assay showed that BlL significant cytotoxic 

effect against human tumor cell lines Hep-2, NCI-H292 and K562 (Nunes et al., 2011). In this 

work, we found that in contrast to native BlL, BlL irradiated (1 and 2 kGy) did not show cytotoxic 

activity on tumor cell lines used in the study cited above. Baptista et al. (2010) showed that the 

465

470

475

480

485

490

495

500

505

510

C ontrol 1 kGy 2 kGy

D os e  (k Gy)

C
en

te
r 

of
 m

as
s 

(n
m

)

0

50

100

150

200

250

400 435 470 505 540 575

Wave le ngth (nm)

F
lu

o
re

sc
en

ce
 in

te
n

si
ty

 (
A

.U
.)

465

470

475

480

485

490

495

500

505

510

C ontrol 1 kGy 2 kGy

D os e  (k Gy)

C
en

te
r 

of
 m

as
s 

(n
m

)

0

50

100

150

200

250

400 435 470 505 540 575

Wave le ngth (nm)

F
lu

o
re

sc
en

ce
 in

te
n

si
ty

 (
A

.U
.)



93 

 

irradiated bothropstoxin-I was 5 folds less toxic than its native counterpart, but still immunogenic. 

Souza-Filho et al. (1992), in a study on detoxification of the crotoxin complex by gamma radiation 

found structural changes that occurred in this neurotoxin venom of the rattlesnake, were due to the 

formation of intermolecular covalent bonds and to the rupture of disulfide bonds. Gallaci et al. 

(1998), suggest that the breaking of the disulfide bonds of crotoxin by gamma radiation may be an 

important role in the loss of its neuromuscular blocking action. The homodimer BJcuL, a lectin 

isolated from Bothrops jararacussu snake proved to be active only as a dimeric configuration 

(Carvalho et al., 2002). According to Kassab et al (2004), the presence of the monomers without the 

formation of a correct inter-chain disulfide bond, as well as structural instability of dimer 

configuration avoiding may be favorable activity. 

Based on these considerations, we suggest that the loss in cytotoxicity ascribed to 

irreversible may be structural changes in BlL, induced by gamma radiation, which may have 

affected the interaction of lectin with glicoconjugates exposed on the surface of tumor cells. In 

conclusion, our results indicates that gamma irradiation of BlL can induce significant modifications 

in their structure, as well as promote its effective detoxification.   

 

Conflict of interest statement 

The authors declare that there are no conflicts of interest. 

 

Acknowledgements 

The authors express their gratitude to the Conselho Nacional de Desenvolvimento Científico e 

Tecnológico (CNPq) and to the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 

(CAPES) for research grants. We are grateful to the Departamento de Energia Nuclear from the 

universidade Federal de Pernambuco (UFPE). The authors thank Maria D. Rodrigues and João 

Antônio Virgínio for technical assistance.  



94 

 

References 

Alley, M.C., Scudiero, D.A., Monks, A., Hursey, M.L., Czrwinski, M.J., Fine, D.L., Abbott, B.J., 

Mayo, J.G., Shoemaker, R.H., Boyd, M.R., 1988. Feasibility of drug screening with panels 

of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48, 589-601. 

Baptista, J.A., Vieira, D.P., Galisteo Júnior, A.J., Higa, O.Z., Casare, M., Yonamine, C.M., 

Caproni, P., Campos, L.A., Andrade Júnior, H.F., Spencer, P.J., Nascimento, N., 2010. 

Structure alteration and immunological properties of 60C0-gamma-rays irradiated 

bothropstoxin-I. J. Radioanal. Nucl. Chem. DOI 10.1007/s10967-009-0399-6. 

Bhattachryya, A., Mandal, A.K., Banerjee, R., Roy, S., 2000. Dynamics of compact denatured 

states of glutaminyl-tRNA synthetase probed by bis-ANS binding kinetics. Biophys. Chem. 

87, 201-212. 

Bradford, M.M., 1976. A rapid and sensitive method for the quantification of microgram quantities 

of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254. 

Caproni, P., Baptista, J.A., Almeida, T.L., Passos, L.A.C., Nascimento, N., 2009. Study of 

irradiated bothropstoxin-1 with 60Co gamma rays: immune system behavior. J. Venom. 

Anim. Toxins Incl. Trop. Dis. 15(2), 216-225. 

Carvalho, D.D., Marangoni, S., Novello, J.C., 2002. Primary structure characterization of Bothrops 

jararacussu snake venom lectin. J. Protein Chem. 21, 43-50.  

Casare, M.S., Spencer, P., Campos, L.A., Nascimento, N., 2006. Study of gamma-radiation effects 

on crotamine and crotoxin. J. Radioanalytical Nucl. Chem. 269(3), 571-577. 

Clemetson, K.J., Morita, T., Kini, R.M., 2009. Scientific and standardization committee 

communications: classification and nomenclature of snake venom C-type lectins and related 

proteins. J. Thromb. Haemost. 7, 360. 

Clemetson, K.J., 2010. Snaclecs (snake C-type lectins) that inhibit or activate platelets by binding to 

receptors. Toxicon 56, 1236-1246. 

Correia, M.T.S., Coelho, L.C.B.B., 1995.  Purification of a glucose/manose specific Lectin, isoform 

1, from seeds of Cratylia mollis Mart. (Camaratu bean). Appl. Biochem. Biotechnol.  55,  

261-273. 

Doyle, R., Kini, R.M., 2009. Protein complexes in snake venom. Cell. Mol. Life Sci. 66, 2851-

2871. 



95 

 

Ferreira Junior, R.S., Nascimento, N., Martinez, J.C., Alves, J.B., Meira, D.A., Barraviera, B., 

2005. Immunization with native and cobalt 60-irradiated Crotalus durissus terrificus venom 

in swiss mice: assessment of the neutralizing potency of antisera. J. Venom. Anim. Toxins 

Incl. Trop. Dis. 11(3), 299-314. 

Ferreira Junior, R.S., Nascimento, N., Couto, R., Alves, J.B., Meira, D.A., Barraviera, B., 2006. 

Laboratory evaluation of young ovines inoculated with natural or 60Co-irradiated Crotalus 

durissus terrificus venom during hyperimmunization process. J. Venom. Anim. Toxins Incl. 

Trop. Dis. 12(4), 620-631. 

Ferreira, R.S., Nascimento, N., Couto, R., Alves, J.B., Meira, D.A., Barraviera, B., 2009. Immune 

response and neutralization capacity of antibodies produced in young sheep immunized with 

Crotalus durissus terrificus native or cobalt-60 irradiated venom. Braz. J. Vet. Res. Anim. 

Sci. 46(3), 207-214. 

Gallaci, M., Nunes, E.C., Moreira, E.G., Nascimento, N., Rogero, J.R., Vassilieff, V.S., 1998. 

Reduction of crotoxin-induced neuromuscular blockade by gamma radiation. Toxicon, 

36(6), 941-945.  

Gallaci, M., Nascimento, N., Rogero, J.R., Vassilieff, V.S., 2000. Influence of temperature upon 

effects of crotoxin and gamma-irradiated crotoxin at rat neuromuscular transmission. 

Toxicol. Lett.114, 77-80. 

Hawe, A., Sutter, M., Jiskoot, W., 2008. Extrinsic fluorescent dyes as tools for protein 

characterization. Pharm. Res. 25, 1487-1499. 

Kassab, B.H., Carvalho, D.D., Oliveira, M.A., Baptista, G.R., Pereira, G.A.G., Novello, J.C., 2004. 

Cloning, expression, and structural analysis of recombinant BJcuL a C-type lectin from the 

Bothrops jararacussu snake venom. Protein Expr. Purif. 35, 344-352.  

Kempner, E.S., 2001. Effects of high-energy electrons and gamma rays directly on protein 

molecules. J. Pharm. Sci. 90, 1637-1646. 

Koh, D.C.I., Armugan, A., Jeyaseelan, K., 2006. Snake venom components and their applications in 

biomedicine. Cell. Mol. Life sci. 63, 3030-3041. 

Lakowicz, J.R., 2006. Principles of fluorescence spectroscopy. Springer Science Business Media, 

LLC, 233 Spring Street, New York, NY, USA.  



96 

 

Laemmli, U.K., 1970. Cleavage of structural proteins during the assembly of the head of 

bacteriophage T4. Nature 227, 680-685.  

Le Vine, H., 1999. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods 

Enzymol. 309, 274-284. 

Moon, S., Song, K.B., 2001. Effect of ?-irradiation on the molecular properties of ovalbumin and 

ovomucoid and protection by ascorbic acid. Food Chem. 74(4), 479-83. 

Moreira, E.G., Nascimento, N., Rosa, G.J.M., Rogero, J.R., Vassilieff, V.S., 1997. Effect of gamma 

irradiation on the behavioral properties of crotoxin. Braz. J. Med. Biol. Res. 30(2), 245-249. 

Morita, T., 2005. Structures and functions of snake venom CLPs (C-type lectin-like proteins) with 

anticoagulant-, procoagulant-, and platelet-modulating activities. Toxicon 45, 1099-1114. 

Mosmann, T., 1983. Rapid colorimetric assay for cellular growth and survival: application to 

proliferation and cytotoxicity assays. J. Immunol. Methods 16, 55-63.  

Nascimento, N., Seebart, C.S., Francis, B., Rogero, J.R., Kaiser, I.I., 1996. Influence of ionizing 

radiation on crotoxin: biochemical and imunological aspects. Toxicon 34(1), 123-131. 

Netto, D.P., Chiacchio, S.B., Bicudo, P.L., Alfieri, A.A., Nascimento, N., 2002. Humoral response 

and neutralization capacity of sheep serum inoculated with natural and cobalt 60-irradiated 

Crotalus durissus terrificus venom (Laurenti, 1768). J. Venom. Anim. Toxins 8(2), 297-

314. 

Ogawa, T., Chijiwa, T., Oda-Ueda, N., Ohno, M., 2005. Molecular diversity and accelerated 

evolution of C-type lectin-like proteins from snake venom. Toxicon 45, 1-14. 

Puchala, M., Schuessler, H., 1995. Oxygen effect in the radiolysis of proteins. IV. Myoglobin. 

Intern. J. Pept. Protein Res. 46, 326-332. 

Riley, P.A., 1994. Free radicals in biology: oxidative stress and the effects of ionizing radiation. Int. 

J. Radiat. Biol. 65, 27-33. 

Sathe, S.K., Teuber, S.S., Roux, K.H., 2005. Effects of food processing on the stability of food 

allergens. Biotechnol. Adv. 23, 423-429. 



97 

 

Semisotnov, G.V., Rodionova, N.A., Razgulyaev, O.I., Uversky, V.N., Gripas´, A.F., Gilmanshin, 

R.I., 1991. Study of the “molten globule” intermediate state in protein folding by a 

hydrophobic fluorescent probe. Biopolymers 31, 119-128. 

Sharon, N., Lis, H., 2004. History of lectins: from hemagglutinins to biological recognition 

molecules. Glycobiology 14, 53-62.  

Souza, F.A.D., Spencer, P. J., Rogero, J.R., Nascimento, N., Dal Pai-Silva, M., Gallaci, M., 2002. 

60Co gamma irradiation prevents Bothrops jararacussu venom neurotoxicity and 

myotoxicity in isolated mouse neuromuscular junction. Toxicon 40, 1101-1106. 

Souza-Filho, J.N., Guarnieri-Cruz, M.C., Murata, Y., Rogero, J.R., 1992. Detoxification of the 

crotoxin complex by gamma radiation. Braz. J. Med. Biol. Res. 25, 103-113. 

Stadtman, E.R., Levine, R.L., 2003. Free radical-mediated oxidation of free amino acids and amino 

acid residues in proteins. Amino Acids 25, 207-218. 

Taylor, M.E., Drickamer, K., 1991. Carbohydrate-recognition domains as tools for rapid 

purification of recombinant eukaryotic proteins. Biochem. J. 274, 575-580. 

Vaz, A.F.M., Costa, R.M.P.B., Coelho, L.C.B.B., Oliva, M.L.V., Santana, L.A., Melo, A.M.M.A., 

Correia, M.T.S., 2011. Gamma irradiation as an alternative treatment to abolish allergenicity 

of lectins in food. Food Chem. 124, 1289-1295. 

Walker, J.R., Nagar, B., Young, N.M., Hirama, T., Rini, J.M., 2004. X-ray crystal structure of a 

galactose-specific C-type lectin possessing a novel decameric quaternary structure. 

Biochem. 43, 3783-3792. 

Wang, J., Wang, J., 2007. Application of radiation technology to sewage sludge processing: a 

review. J. Hazard. Mater. 143, 2-7.  

Xu, G., Chance, M.R., 2005. Radiolytic modification of sulfur-containing amino acid residues in 

model peptides: fundamental studies for protein footprinting. Anal. Chem. 77, 2437-2499. 

 

 

 

 



98 

 

8 CONCLUSÕES 

 

- Num protocolo eficiente, cromatografias de gel de Guar e Superdex, purificaram uma lectina tipo-

C (BlL) do veneno da serpente Bothrops leucurus. 

- BlL é dependente de cálcio e inibida por açúcares contendo galactosídeos. Estruturalmente BlL é 

um dímero composto de subunidades de 15 kDa unidas por ligações dissulfeto; 

- O Dicroísmo Circular revelou que BlL pode ser classificada como uma proteína toda ? (contendo 

principalmente estrutura ?); 

- BlL possui atividade antibacteriana contra bactérias gram-positivas (Staphylococcus aureus, 

Enterococcus faecalis e Bacillus subtilis);  

- BlL apresentou significante atividade citotóxica em células tumorais (K562, Hep-2 e NCI-H292) e 

induziu morte celular por apoptose em células tumorais K562; 

- A radiação gamma de 60Co causou alterações funcionais e estruturais em BlL, além de abolir a sua 

atividade citotóxica em linhagens tumorais. 

 

 

 

   

 

 

 

 

 

 

 

 

 


</field>
	</doc>
</add>